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Providence virus (PrV) is a member of the Tetraviridae, a family of small, positive 
sense, single-stranded RNA viruses, which characteristically infect the midgut tissue 
of heliothine larvae.  PrV is the only known tetravirus that replicates in cultured insect 
cells.  The virus comprises a monopartite genome resembling members of the genus 
Betatetravirus with the capsid precursor protein undergoing autoproteolytic cleavage 
at its C-terminus consistent with other tetravirus capsid precursor proteins.    
 
Analysis of viral cDNA predicted the presence of three potential overlapping gene 
products (from 5` to 3`): (1) p130, a protein of unrecognized nucleotide or amino acid 
homology with a 2A-like processing site at its N-terminus; (2) p104, the replicase 
ORF, which was found to be phylogenetically related to tombus-and umbraviruses 
replicases.  The presence of a read-through stop signal in the p104 ORF was 
proposed to produce and amino terminal product with a predicted MW of 40 kDa 
(p40) and (3) the capsid protein precursor (81 kDa) which has two 2A-like processing 
sites at its N-terminus.    Metabolic radiolabelling of viral translation products in 
persistently infected MG8 cells and in vitro translation of the individual ORFs were 
performed in order to analyse the expression of PrV gene products.  p130 was 
translated with no evidence of 2A-like processing.  Two products of 40 kDa and 104 
kDa were translated from the p104 ORF, indicating that the read-through stop signal 
was likely to be functional.  Finally, the capsid protein precursor ORF produced a 
major translation product of 68 kDa corresponding to the capsid protein precursor as 
well a peptide of 15 kDa that was attributed to the activity of the second 2A-like site 
at the N-terminus of the p81 ORF.   
 
The subcellular distribution of viral RNA (vRNA) and p40 in MG8 cells was 
investigated using immunofluorescence and biochemical fractionation.   The results 
showed that p40/p104 and vRNA accumulated in polarized, punctate structures in 
some but not all MG8 cells and in some cases, co-localization was observed.  This 
thesis concludes that PrV is a novel tetravirus with significant similarities plant carmo-
like viruses that should be re-classified at the family level. 
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CHAPTER 1 
Literature Survey   
 
 
1.1. INTRODUCTION 
 
 
It is surprising how little is known about most of the classified viruses that 
infect insects, when one considers the fact that the total number of insect 
species is likely greater than the rest of the classes of eukaryotes 
combined (Rossmann and Tao, 1999).  Insects comprise over 80 % of the 
existing species on the planet and viruses infect most orders of insects 
including both beneficial and pest species.  The first noted case of insect 
viral disease can be traced back as far as the 16th and 17th centuries 
where scientific records exist describing the “wilting” disease of silkworms, 
indicating that insect viruses have been of interest for the last four 
centuries (Fields et al., 1996).   
 
A number of virus families are known to infect insects.  These include both 
DNA and RNA viruses as well as retroviruses (Fauquet et al., 2005).  The 
latest phylogenetic classification of these virus families and examples of 
their hosts are summarized in Table 1.1. Interestingly, only a small number 
of the families listed have a host range limited only to insects.  These 
include the Ascoviridae, Baculoviridae, Tetraviridae and the 
Polydnaviridae (Fauquet et al., 2005).  Furthermore, only the Tetraviridae 
have a limited host range consisting of a single insect order, whereas the 
Polydnaviridae and Baculoviridae infect a broad range of insect host 
families. 
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Table 1.1.  List of virus families known to infect insects  
 
Genome  Family Examples of hosts 
dsDNA  Poxviridae, Iridoviridae, 
Baculoviridae, Polydnaviridae 
(Ichnoviridae and Bracoviridae) 
and the Ascoviridae 
Red Hairy caterpillar, Spodoptera spp. 
and the Codling moth.   
dsRNA Reoviridae and Birnaviridae Silk worms, Spodoptera spp. and 
Drosophila spp. 
ssDNA Circoviridae and Parvoviridae Silk worms and yellow fever mosquito 
(-)ssRNA Rhabdoviridae and Bunyaviridae Drosophila spp. and mosquitoes 
(+)ssRNA Togoviridae, Flaviviridae, 
Picornaviridae, Nodaviridae, 
Tetraviridae and Dicistroviridae 
Pine Emperor moth, Cotton bollworm, 
various cricket species, Gypsy moth 
and Drosophila spp. 
RT-RNA Metaviridae Drosophila spp.   
Key:  ss = single stranded; ds = double stranded; (-) = negative sense; (+) = positive 
sense; RT = reverse transcription. (Fauquet et al., 2005) 
 
Relatively little research has focused on the fundamental analysis of small, 
unenveloped insect RNA viruses; although much work has been focused 
on viruses with potential medical or agricultural applications.  A classic 
example of an agriculturally important family of viruses is the 
Baculoviridae, a family of large dsDNA viruses.  The type member, 
Autographa californica multiple nucleopolyhedrosis virus (AcMNPV) and 
its natural host, the alfalfa looper, Autographa californica (Fauquet et al., 
2005) have been extensively studied with regards to their agricultural 
impact, and in the last three decades, significant advances in eukaryotic 
vector research (O’ Reilly et al. 1992; Possee, 1997 and Kost et al., 2005). 
 
The Tetraviridae are a family of icosahedral, non-occluded viruses that 
have a host range limited to a single order of insects, the Lepidoptera.  
They are structurally closely related to the Nodaviridae, a family of small 
RNA viruses known to infect both animals and insects (Johnson et al., 
1994).  In terms of genome processing strategies, tetraviruses also display 
similarities to the recently taxonomically partitioned picorna-like family, 
Dicistroviridae and more distantly to the Picornaviridae, a diverse family 
that infects animals and perhaps also insects (Johnson et al., 1994; Mayo, 
2002; Fauquet et al., 2005).   The survey serves to describe the 
Tetraviridae and provides information on these viruses which served as 
motivation for this body of work.  Thereafter, this survey discusses two 
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other (+)ssRNA virus families and the important similarities that exist 
between them and the Tetraviridae.   
 
1.2. THE TETRAVIRIDAE 
The first members of the Tetraviridae to be discovered were found some 
forty years ago in South Africa and infected the larvae of the Pine Emperor 
moth, Nudaurelia cytherea capensis (Hendry et al., 1968).  In 1974, five 
small viruses were purified from moribund N. capensis larvae (Juckes, 
1974).  The viruses were named Nudaurelia α, β,  γ,  δ, and ε  viruses in 
order of increasing prevalence.  Structural analysis on Nudaurelia 
capensis β virus showed that this virus exhibited a unique T=4 icosahedral 
symmetry, making it the first official member of a new family of viruses, the 
Tetraviridae (Olson et al., 1990).   More than 10 years after the initial 
characterization of NβV, another dominant virus was isolated from N. 
capensis larvae, the Nudaurelia ω virus (NωV), which had biophysical 
properties similar to those of NβV but differed by the presence of a second 
genomic RNA strand (Hendry et al., 1985).   
NωV virus became the type virus for a second genus within the 
Tetraviridae, the ω-like genus, and was joined by a second similar virus 
from Australia, Helicoverpa armigera stunt virus (HaSV) by Hanzlik et al., 
in 1993.   HaSV was isolated from a laboratory-bred colony of the cotton 
bollworm, Helicoverpa armigera (Hanzlik et al., 1993).  In 2004, a third 
omegatetravirus was discovered infecting larvae of Dendrolimus 
punctatus, a member of the Lasiocampidae family (Yi et al., 2005) and 
was thus named Dendrolimus punctatus tetravirus (DpTV).   
These and other potential members of the Tetraviridae, with the distinctive 
T=4 symmetry, containing either a monopartite or bipartite genome, were 
separated into two genera: the beta-like now known as the genus 
Betatetravirus and omega-like now known as the genus Omegatetravirus 
(Hanzlik and Gordon, 1997).  Viruses in the family Tetraviridae are 
(+)ssRNA, unenveloped particles with an average diameter of 40 nm  and 
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display an icosahedral geometric symmetry  (Hendry and Agrawal, 1994; 
Fauquet et al., 2005).  
 
1.2.1. Tetravirus capsid structure 
 
The first structural information on tetravirus particles was obtained by cryo-
electron microscopic analysis of NβV and NωV particles (Olson et al., 
1990).  At 3.2 nm resolution, each face of the virus particle has distinct 
structures at points of symmetry protruding approximately 4 nm above the 
contiguous surface (Olson et al., 1990).  However, the NβV face is 
distinguishable from NωV as it is more planar with deeper grooves 
between the faces and has three prominent pits on each triangular face 
(Johnson et al., 1994) (Figure 1.1). 
 
        
Figure 1.1. Image reconstruction of frozen-hydrated Nudaurelia viruses by cryo-
electron microscopy.  The bar represents 25 nm. Taken from Johnson et al., 1994. 
 
 
Tetravirus capsids consist of multiple domains created by 240 protein 
subunits each adapting one of four slightly different conformations to form 
an icosahedral particle (Munshi et al., 1996).  The classical, highly 
conserved eight-stranded antiparallel β-barrel motif that forms the 
contiguous shell of all icosahedral virus particles is also found in the 
tetraviruses (Olson et al., 1990; Johnson et al., 1994; Munshi et al., 1996; 
Helgstrand et al., 2004).  Interestingly, an immunoglobulin C-like fold is 
 NβV NωV
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positioned on the outer capsid surface, inserted between two strands of 
this shell domain (Munshi et al., 1996).  A third structural domain, the 
internal helical domain, is situated below the surface of the capsid shell 
and is composed of a pentameric bundle of coiled helices predicted to play 
a role in the membrane translocation of viral RNA (vRNA) (Munshi et al., 
1996; Helgstrand et al., 2004).  
 
During the assembly process, the provirion structure is characterized as 
being larger, rounder and more porous than the mature virion although 
relatively stable at a higher pH, and each capsid precursor is cleaved to 
form an infectious particle (Canady et al., 2000).  The cleavage 
mechanism and resultant mature particle containing both β and γ proteins 
will be described later, with reference to particular examples of 
tetraviruses. 
 
 
1.2.2. Phylogenetic organization of the Tetraviridae 
Currently, the complete genome sequences of three betatetraviruses, 
namely NβV, Thosea asigna virus (TaV), Euprosterna elaeasa virus (EeV); 
and two omegatetraviruses, HaSV and DpTV, are known (Pringle et al., 
1999; Gorbalenya et al., 2002; Gordon et al., 1995; Hanzlik et al., 1995; Yi 
et al., 2005).  In addition, the capsid coding sequences of one other 
omegatetravirus, NωV, (du Plessis et al., 2005) and a further 
betatetravirus, Providence virus (PrV), have also been reported (Pringle et 
al., 2003).   
The Tetraviridae are grouped into two genera according to their genome 
organization (Fauquet et al., 2005).  The betatetraviruses are monopartite, 
with the replicase and capsid coding sequences present on a single 
genomic RNA and the capsid precursor is translated from a subgenomic 
RNA (Figure 1.2) (Gordon et al., 1999; Pringle et al., 2003).  NβV is 
considered the type member for this particular genus (Fauquet et al., 
2005).  The omegatetraviruses are characterized by the encapsidation of 
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two genomic RNAs:  RNA1 encodes the replicase and three small 
overlapping ORFs (Gordon et al., 1995; Yi et al., 2005), while RNA2 
encodes the capsid precursor protein as well as a smaller overlapping 
ORF designated p17 (Figure 1.2) (Hanzlik et al., 1995;  du Plessis et al., 
2005; Yi et al., 2005).  NωV is considered the type virus for this particular 
genus (Fauquet et al., 2005). 
 
 
Figure 1.2.  Genome organization and translation products of the viruses belonging 
to the genus Betatetravirus and genus Omegatetravirus.  The site of subgenomic 
RNA initiation of the capsid precursor is indicated by the arrow. UTRs are represented by 
horizontal lines.  Questions marks represent theoretical ORFs. The * represents the end 
of a PEST-like sequence in a theoretical ORF and the site of a potential protein cleavage 
event.   The ‡ represents the site of an autoproteolytic cleavage event occurring after 
particle formation resulting in large and small capsid proteins (Adapted from Fauquet et 
al., 2005). 
 
The current classification of the betatetraviruses, as well as the 
Tetraviridae in general, is currently under review (A.E. Gorbalenya pers. 
comm., 2008).  Analyses of the replicase sequences, and in particular the 
core motif arrangement of the RNA-dependent RNA polymerase (RdRp), 
has raised questions on the validity of a phylogenetic arrangement which 
was based on genome structure and particle appearance (A.E. 
Gorbalenya pers. comm., 2008). 
Replicase ? Capsid precursor 
sg 
5` 3`
* ‡ 
5` 3`? ? ?
? Capsid precursor 
* ‡ 
5` 3`
Replicase 
RNA1 
RNA1 
RNA2 
Betatetraviruses 
Omegatetraviruses 
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1.2.3. The omegatetraviruses 
 
Three species have been classified within the genus Omegatetravirus, 
including HaSV, NωV and DpTV (Fauquet et al., 2005).  To date, no 
omegatetraviruses have been shown to replicate in insect cell lines and 
only the cDNA of HaSV has been shown to be infectious (Bawden et al., 
1999; Gordon et al., 2001).   
 
RNA1 encodes the viral replicase (187 kDa) consisting of the 
methyltransferase, helicase and RdRp domains as well as three small 
potential ORFs which, if translated, would result in proteins of 11, 15 and 8 
kDa proteins, respectively (Gordon et al., 1995; Yi et al., 2005). Whether 
or not these small predicted peptides function in the virus lifecycle is not 
known.  Phylogenetic analysis of the RdRp domain of RNA1 and the 
presence of methyltransferase and helicase domains, groups HaSV and 
DpTV with members of the alpha-like superfamily (Gordon et al., 1995; 
Gorbalenya et al., 2002; Yi et al., 2005).    
 
RNA2 is translated into the capsid precursor protein often described as 
‘VCap’ or protein α (Hanzlik et al., 1995; Agrawal and Johnson, 1992; Yi et 
al., 2005).  During particle maturation, VCap is autoproteolytically cleaved 
at a scissile bond to produce the large capsid protein of 62 – 64 kDa 
(protein β) and a small capsid protein of 6 – 8 kDa (protein γ) (Agrawal 
and Johnson, 1995; Taylor et al., 2002; Yi et al., 2005).  The ORF at the 
N-terminal of RNA2 of HaSV has been shown to contain a large 
percentage of the amino acids, P, E, S and T (Hanzlik et al., 1995) and is 
thus considered as a PEST-like protein sequence.  Such sequences have 
been found in proteins which are often found to be rapidly degraded in a 
cellular environment (Rogers et al., 1986).   Expression of p17 within 
bacterial heterologous systems lead to the production of hexagonal tube-
like structures similar to those described in the expression of plant 
movement proteins (Hanzlik et al., 1995).  The heterologous expression of 
the homologous p17 proteins of both TaV and DpTV did not result in the 
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accumulation of tube-like multimers, although dimers and trimers were 
observed upon translation of the DpTV p17 coding sequence in a bacterial 
expression system (Zhou et al., 2008). 
 
 
1.2.4. The betatetraviruses 
At present this genus comprises ten official members (Fauquet et al., 
2005), with a further two potential members (Walter et al., 2008).   Table 
1.2 lists these twelve betatetraviruses, the host lepidopteran family and 
accession numbers of their genome sequences.   
 
Table 1.2.  The ten confirmed and two tentative members of the genus 
Betatetravirus 
Species 
name 
Abbreviation Host family Reference Genome 
sequence 
accession # 
Antheraea 
eucalypti virus 
AeV Saturniidae  Grace and  Mercer, 
1965 
n.d 
Darma trima 
virus 
DtV Limacodidae Reinganum et al., 
1978 
n.d 
Dasyichira 
pudibunda 
virus 
DpV Lymantriidae Greenwood and 
Moore, 1984.   
n.d 
Euprosterna 
elaesa virus 
EeV Limacodidae Zeddam et al. u.d. AF461742 
Nudaurelia 
capensis 
β virus 
NβV Saturniidae Gordon et al., 1999 AF102884 
Philosamia 
cynthia x ricini 
virus 
PxV Saturniidae Reinganum et al., 
1978 
n.d 
Providence 
virus 
PrV Noctuidae Pringle et al., 2003 AF548354 
Pseudoplusia 
includens 
virus 
PiV Noctuidae Chao et al., 1983 n.d 
Thosea asigna 
virus 
TaV Limacodidae Pringle et al., 1999 AF062037 
Trichoplusia ni 
virus 
TnV Noctuidae Morris et al., 1979 n.d 
Nudaurelia 
ψ virus* 
NψV Saturniidae Walter et al., 2008 n.d 
Nudaurelia ζ 
virus* 
NζV Saturniidae Walter et al., 2008 n.d 
Key:  n.d = not determined, u.d = unpublished data, * = potential members of the genus 
Betatetravirus 
Chapter 1 – Literature survey 
 
9
The size of the betatetravirus genome ranges between 5.7 and 6.6 kb and 
typically contains two open reading frames (Figure 1.2).  The first open 
reading frame encodes the replicase protein, while the second encodes 
the capsid precursor protein (Fauquet et al., 2005).  The capsid precursor 
protein is translated from a subgenomic copy of the gene and is 
autoproteolytically cleaved to form large and small capsid proteins of 
about 55 - 60 kDa and 6 - 8 kDa, respectively (Gordon et al., 1999; Pringle 
et al., 1999; 2001; 2003).  
 
1.2.4.a. Nudaurelia β virus 
The NβV, the type member, encapsidates a monocistronic genome of 
6625 nucleotides with the 5' proximal ORF of 5778 nucleotides encoding a 
protein of 215 kDa containing the three functional domains characteristic 
of a viral replicase: the methyltransferase, helicase and RdRp domains 
(Gordon et al., 1999).  The replicase gene covers 87 % of the NβV 
genomic RNA, terminating at a stop codon over nucleotides 5868 - 5870.  
The capsid precursor ORF is located from nucleotides 4039 - 5874 with no 
intervening sequence between the replicase and VCap ORFs.  A 
surprising feature of the genome of NβV is the degree of overlap - 1827 
nucleotides, which represents virtually the entire capsid gene (Gordon et 
al., 1999).   
 
The size of the coding sequence of the subgenomic RNA is 1.9 kb and 
there are no other significant ORFs on the NβV sequence, including the 
636 nucleotide stretch between the end of the capsid gene and the 
beginning of the tRNA-like structure at nucleotide 6514 (Gordon et al., 
1999).   The molecular weight of the major coat protein has been reported 
as 58.4 kDa with a minor protein of 8 kDa and the N-terminal of this 
precursor protein appears to be blocked – a common feature amongst the 
tetraviruses (Gordon et al., 1999).   
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1.2.4.b. Thosea asigna virus 
Thosea asigna virus (TaV), another well-studied member of the 
betatetraviruses, has a substantially different gene presentation at the 3` 
proximal region of its genome with a PEST-like protein, p17, being 
translated from the subgenomic copy of the capsid precursor ORF (Pringle 
et al., 1999).  This protein, although not detected in purified TaV particles, 
is cleaved first from the capsid precursor protein of virus-like particles 
(VLPs).  Next, autoproteolytic cleavage of the large and small capsid 
proteins occurs, a processing event demonstrated in VLPs using in a 
baculovirus-mediated heterologous expression system (Pringle et al., 
2001).  This initial cleavage event, leading to the release of p17 from the 
large and small capsid proteins, is mediated by a 2A-like cleavage site  - 
the first (highly efficient) report of a 2A-like mediated ‘cleavage event’ in a 
tetravirus (Donnelly et al., 2001b).   
The p17 protein is proposed to play a non-structural role, since TaV VLPs 
produced by recombinant baculoviruses still assembled in the absence of 
the p17 ORF (Pringle et al., 2001).  This sequence of protein processing 
and the presence of a processed and unblocked N-terminus of the capsid 
precursor protein (Pringle et al., 2001) are characteristics not shared by 
other tetraviruses. Another tetravirus, EeV, shares a high amino acid 
sequence homology of both the replicase and capsid protein precursor 
proteins with those of TaV (Gorbalenya et al., 2002).  The positioning of 
replicase and capsid precursor protein ORFs in these two viruses show far 
less overlap (Figure 1.3) than that observed in NβV (Figure 1.2) (Gordon 
et al., 1999).  Furthermore, both TaV and EeV lack any identifiable 
helicase and methyltransferase domains within their respective replicase 
ORFs.  The RdRp domain within the replicase ORF of both of these 
viruses is unusual in that the motif arrangement is permuted, unlike the 
overwhelming majority of viruses where the canonical motif presentation 
characterizes the RdRp arrangement (Gorbalenya et al., 2002). The 
significance of this motif permutation in the RdRp domains of these two 
viruses is discussed in more detail later in this work. 
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Figure 1.3.  Genome organization of the betatetraviruses, TaV and EeV.  The 
schematic diagram represents (to scale) the positioning and relative size of the replicase 
and capsid precursor ORFs.  The size and positioning of these two ORFs within the 
genomes of TaV and EeV are virtually identical.  The site of subgenomic RNA initiation of 
capsid precursor is indicated by the arrow and is in a +1 position relative to the RdRp 
reading frame.  UTRs are represented by horizontal lines. The question mark refers to the 
PEST-like sequence within a theoretical ORF.  The * represents the site of a 2A-like co-
translational processing signal and the ‡ represents the site of the autocatalytic cleavage 
event. 
 
The unusual processing signals, ORF positioning, permuted RdRp motif 
arrangement and PEST-like sequences make TaV and EeV divergent 
members of the genus Betatetravirus which may warrant a potential 
reclassification of the Tetraviridae based on factors other than the capsid 
homology approach alone.   
 
1.2.4.c. Providence virus 
 
In 2002, Pringle and co-workers in Providence, USA, discovered a unique 
tetravirus persistently infecting a midgut cell line (MG8) derived from the 
corn earworm (Helicoverpa zea) (Pringle et al., 2003).  The virus, named 
Providence virus (PrV), is the first tetravirus able to replicate in tissue 
culture and purified virions are also able to infect two other insect cell 
lines, one from H. zea fat body (FB33) and one from the larval tissue of 
beet armyworm larvae, Spodoptera exigua (Se1) (Pringle et al., 2003).  
PrV virions are typical icosahedral particles that encapsidate both the 
genomic (6.4 kb) and subgenomic (2.5 kb) RNAs.   Negative sense 
replication intermediates of the PrV genome were also uncovered (Pringle 
et al., 2003), a feature so far unproven in other tetraviruses.  Virions have 
an average diameter of 40 nm and an external capsid appearance 
resembling NβV and TaV (Pringle et al., 2003).    
?Replicase Capsid precursor 5` `3 
* ‡ 
sg 
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PrV capsid particles were shown to be composed of both the major (60 
kDa) and minor capsid (8 kDa) proteins.  As observed in TaV, the N-
terminus of the PrV major capsid protein is also unblocked (Pringle et al., 
2003) unlike most of the other tetraviruses (Fauquet et al., 2005).  PrV 
encodes a capsid protein precursor of 81 kDa with a 2A-like ‘cleavage’ 
sequence (‘PrV-2A3’) at its N-terminus, in a similar position to TaV (Pringle 
et al., 2003; Luke et al., 2008).  Co-translational processing of the capsid 
precursor results in the production of a 13 kDa protein, which has not been 
detected in virus particles (Pringle et al., 2003).  In addition, a second 2A-
like ‘cleavage’ sequence (PrV-2A2) is present in the 13 kDa protein coding 
sequence (Luke et al., 2008).  This coding sequence is positioned at the 
N-terminal of the capsid protein precursor and has a high P, E, S and T 
amino acid content (Pringle et al., 2003) similar to the suspected PEST-
like sequences of HaSV (Hanzlik et al., 1995), DpTV (Yi  et al., 2005), and 
TaV (Pringle et al., 2001).   
 
Attempts by Taylor et al. (2005) to produce VLPs using a baculovirus-
mediated heterologous expression system were unsuccessful when the 
capsid protein precursor and capsid protein alpha (virus capsid before 
autoproteolytic cleavage) were individually expressed in this system. 
Heterologously expressed capsid protein precursor was marginally more 
stable than capsid protein alpha alone, even though both proteins proved 
highly insoluble and were expressed at very low levels (Taylor et al., 
2005). The roles of the 2A-like processing in the regulation and expression 
of viral proteins will be discussed in detail later in this survey.  
 
Further unpublished studies on PrV revealed an interesting genome 
organisation and a highly divergent replicase sequence (F.M. Pringle and 
L.A. Ball, pers. comm., 2005).  At the 5` end of the genome, a large ORF 
spanning from nucleotides 45-3708 which, if translated, would produce a 
protein with a predicted molecular weight of 130 kDa, exists.  This protein 
contains a 2A-like ‘cleavage’ sequence at its N-terminus (PrV-2A1) and the 
processing ability of this sequence has been shown to be active in vitro, 
using a reporter-based system (Luke et al., 2008).     Furthermore, neither 
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the nucleotide nor amino acid sequences show any homology with other 
deposited sequences in the National Centre for Biotechnology Information 
(NCBI) database.   
 
The replicase ORF is positioned between nucleotides 1027 and 3775 and, 
if translated, should produce a protein of 104 kDa in a +1 frame relative to 
p130 (F.M. Pringle and L.A. Ball, pers. comm., 2005).  Analysis of the 
amino acid sequence of this ORF revealed no identifiable 
methyltransferase or helicase domains.  Comparison of this amino acid 
sequence with non-redundant sequences in the NBCI databases aligned 
p104 with replicase and RdRp sequences associated with (+)ssRNA plant 
viruses belonging to the Tombusviridae and Umbraviridae  families (F.M. 
Pringle pers. comm., 2005).    Repeated sequence analysis of the p104 
ORF revealed the presence of an in-frame amber stop codon (UAG), a 
feature not previously observed in other tetraviruses.   
 
The discovery of Providence virus has not only added more uncertainty to 
the phylogenetic classification of the Tetraviridae, but also provides an 
opportunity to study a renewable source of tetravirus in the context of 
capsid formation, assembly and disassembly, replication and coupled 
mechanisms associated with genome transcription and translation, the 
real-time genome processing of viral translation products and finally the 
site of replication within the infected cell line(s).  Virtually nothing is known 
about the replication of tetraviruses nor the host and accessory viral 
factors involved in the life cycle.  The sections below describe viral RNA-
dependent RNA polymerases, their interactions with host cell membranes 
and proteins as well as a survey of two model viral replication systems:  
the Picornaviridae and Tombusviridae.    Finally, the remainder of this 
survey serves to create a foundation to understanding the gene 
expression and protein processing strategies employed by the tetravirus, 
Providence virus.   
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1.3.  RNA-DEPENDENT RNA POLYMERASES  
 
The template-dependent polynucleotide polymerases (TDPPs) that 
replicate cellular and viral genomes can be described as one of the few 
classes of enzymes which bridge the gap between eukaryotic, prokaryotic 
and viral replication (Gorbalenya et al., 2002).  These enzymes are usually 
present as one of three to four enzymatic domains in an ORF broadly 
referred to as a replicase protein.  The DNA genomes of cellular 
organisms and the majority of DNA viruses are replicated by a DNA-
dependent DNA polymerase (DdDp).  Positive strand RNA viruses 
encompass over one-third of all virus genera and include numerous 
important pathogens such as severe acute respiratory syndrome (SARS) 
coronavirus, Hepatitis C virus (HCV) and Ebola virus (Ahlquist et al., 
2003).  The RNA genomes of these viruses are classified as (+)ssRNA  
and (-)ssRNA viruses, or dsRNA viruses and retroviruses that reverse 
transcribe their genomes using a reverse transcriptase (Fauquet et al., 
2005).   
 
The RdRp is the only enzyme universally conserved in all of the thousands 
of known non-satellite RNA viruses (Ahlquist, 2002).   The replication 
complexes of positive sense viruses usually contain one or more viral 
proteins.  Additional domains corresponding to RNA helicase, 
methyltransferase and proteinase activities may be present (van der 
Heijden and Bol, 2002).  RdRps are used to replicate the genomes of 
viruses with no DNA stage and RNA-dependent DNA polymerase (RdDp 
and reverse transcriptase) is used only by viruses with a DNA stage in the 
life cycle (Baltimore, 1971).  RdRps share multiple sequence motifs that 
are conserved across all three major virus superfamilies and crystal 
structures of RdRps of positive strand RNA and dsRNA viruses show 
structural similarity not only to each other, but also to DNA-dependent 
RNA and DNA polymerases and reverse transcriptases (Ahlquist, 2002).  
All of the above-mentioned polymerases share a tertiary structure similar 
to that of a cupped right hand, with three subdomains termed palm, thumb, 
and fingers (Ollis et al., 1985). This structural and functional conservation 
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implies that palm subdomains of all TDPPs may have evolved from a 
common ancestor (Gorbalenya et al., 2002). 
 
 
1.3.1. Structure of RNA-dependent RNA polymerases 
 
Poch and co-workers (1989) originally proposed a core polymerase 
module whose four well-ordered motifs (motifs A to D) in a region of 120 - 
210 amino acids were essential for RNA polymerization (Poch et al., 
1989). This group also went on to compile a loosely based phylogenetic 
map of viruses based on their polymerase sequences.   This lead to the 
proposal of the essential nature of these four motifs as well as the 
relatedness of the RNA-dependent RNA polymerases to DNA 
polymerases which probably originate from a common, putative RNA 
polymerase ancestor, encompassing all current polymerases (Poch et al., 
1989).  This work was explored further by Koonin (1991) and later Koonin 
and Dolja (1993) who identified a total of eight motifs (I - VIII) in the RdRps 
of positive-stranded RNA viruses, although only three (IV, V and VI) 
showed complete conservation among all RdRps, which overall can share 
very little sequence identity amongst closely related viruses (Johnson et 
al., 2001).  These three highly conserved motifs; IV, V and VI (Koonin and 
Dolja, 1993), correspond to motifs A, B and C, originally discovered by 
Poch et al., (1989) thus making them ideal for basic analysis between 
RdRp sequences.   
 
The palm domain structure of the RdRp is especially conserved and 
contains the four sequence motifs (A - D) preserved in all RNA and DNA 
polymerases (Ahlquist, 2002).  The palm subdomain consists of a four-
stranded antiparallel β-sheets with two α-helices packed beneath the 
sheet, and comprises the four ordered motifs A – D (reviewed in 
Gorbalenya et al., 2002).  Motif A contains two aspartate residues 
separated by four or five residues and is responsible for structural features 
in the polymerase resulting in catalysis, while motif C (GDD), the 
polymerase active site, contains an Asp-Asp dipeptide, which is often 
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preceded by a glycine residue.  Motif B, the ribose-binding pocket, 
contains an asparagine that contributes to the discrimination between 
dNTPS and NTPs and thus determines whether DNA or RNA is 
synthesized (reviewed in Gorbalenya et al., 2002). This asparagine 
residue is present at the same structurally homologous position in all plant 
and animal RNA virus polymerases and only differs in RNA 
baceteriophages resulting in an elevated mutation frequency in this group 
(Korneeva and Cameron, 2007).  Figure 1.4 depicts a typical RdRp 
compared to other polymerase enzymes all encoding the four highly 
conserved motifs, A - D and if present, motif E, annotated on each 
structure. 
 
                      
 
Figure 1.4.  Polymerase modules in representative structures from each of the four 
categories of polymerases.  Structures of a Klenow polymerase (a DNA polymerase), 
T7 RNA polymerase (a DNA-dependent RNA polymerase), Human immunodeficiency 
virus 1 reverse transcriptase (an RNA-dependent DNA polymerase) and Poliovirus 
polymerase (a RNA-dependent RNA polymerase).  The thumb is positioned on the right 
of each structure.  The structural/sequence motifs are colour coded:  A = red; B = green; 
C = yellow; D = purple; E = navy blue.  Taken from Hansen et al. (1997).   
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1.3.2. Subgroup classification of viruses based on conserved 
domains within the replicase protein 
 
Sequence analysis of viral RdRps has been used to phylogenetically 
cluster RNA viruses to the supergroup level (Koonin, 1991; Koonin and 
Dolja, 1993).   The existence and diversity of other enzymatic modules 
within the replicase protein, such as helicase, guanylyltransferase or 
methyltransferase and proteinase activities are also used to distinguish 
members of the three supergroups (reviewed in van der Heijden and Bol, 
2002).   
 
Typically, RNA viruses that replicate in the cytoplasm of the host cell 
contain RdRps that have RNA guanylyl- and methyltransferase domains.  
RNA helicase domains are found in the sequence of most RdRps (Koonin 
and Dolja, 1993) although larger quantities of these translated domains 
are usually present relative to the RdRp (van der Heijden and Bol, 2002).  
All RNA viruses are classified into either supergroup I, II or III.  
Supergroup I, the picorna-like viruses contain a replicase expressing a 
type I polymerase, type 1, 2 or 3 helicase, no guanylyltransferase 
/methyltransferase and a cysteine or serine-like proteinase.  Supergroup II 
is split into two major lineages.  The first, the carmo-like viruses, contain a 
replicase expressing only a type II polymerase.    The second clade, the 
flavi-like viruses also contain a type II polymerase in addition to a type 2 
helicase, type 2 guanylyltransferase /methyltransferase and a serine-like 
proteinase.  Finally supergroup III, the alpha-like viruses, contain a 
replicase expressing a type III polymerase, a type 1 helicase and type 1 
guanylyltransferase /methyltransferase (reviewed in van der Heijden and 
Bol, 2002).  The core RdRp component of any virus requires host proteins 
in order to be active: often post-translational modification of the RdRp 
within the host cellular environment as well as its particular location or 
micro-environment within the cell are all essential requirements for 
polymerase activity. The sections below describe some of these 
requirements and modifications, using well-studied (+)ssRNA virus RdRps 
and their replication complexes as examples.   
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1.3.3. Associated proteins and replication complexes of RNA-
dependent RNA polymerases 
 
Although certain RdRps have polymerase activity as individual proteins, 
they may still require additional viral polypetides for complete functionality 
and have often been shown to oligomerize the catalytic components of the 
replication complex (Dye et al., 2005). The polymerase itself may require a 
protein primer in order to be active (termed primer-dependent initiation) or, 
in certain virus families, can be primer-independent (Buck, 1996).  
Differentiation between the two types of polymerases and their modes of 
initiation can be determined by structural analysis of the template binding 
site within the polymerase structure (Ferrer-Orta et al., 2006).   
 
An example of RdRp self-interaction has been shown for the nodavirus, 
Flock House Virus (FHV), which functions as a multimer rather than a 
monomer, in one or more steps during genome replication (Dye et al., 
2005).  The model picornavirus, Poliovirus (PV), is another example of 
polymerase self-interaction based on the number of regions involving 
polymerase-polymerase interactions observed in the crystal structure of 
3DPOL, the polymerase component of PV (Hansen et al., 1997).  
Oligomerization of the RdRp is important for its functioning since RNA 
binding and polymerization activities are highly cooperative with respect to 
the concentration of polymerase (Pata et al., 1995). 
The single catalytic centres of a replication complex are also often 
biochemically modified in order to be active (Ahlquist et al., 2003).  Such is 
the case with FHV whose RdRp requires glycerophospholipids for activity 
in vitro (Wu et al., 1992).  This discovery has since been supported by 
findings that phosphorylation of RdRps is often required to regulate some 
aspects of their function (Jakubiec and Jupin, 2007).  Phosphorylation is a 
reversible post-translational modification seen in an increasing number of 
viral non-structural proteins and is a means of modulating protein 
properties such as stability, enzymatic activities, subcellular localization 
etc. (Jakubiec and Jupin, 2007).  Phosphorylation of the replicase 
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component of the Tymovirus, Turnip yellow mosaic virus (TYMV), was 
documented when the protein was expressed both individually and in the 
context of an infection (Jakubiec et al., 2006).  Phosphorylation of the 
TYMV RdRp showed a role in the infectivity of the virus but interestingly, 
not in the interaction between viral replication proteins (Jakubiec et al., 
2006).  
Direct interactions between host proteins and viral replication components 
are essential for the relatively gene-poor viruses to continue propagation 
(Kushner et al., 2003).  Many regulatory and other host cell proteins have 
been identified as playing a key role in virus replication and one such 
study was performed by Kushner and co-workers in 2003, whereby the 
entire genome of the Brome Mosaic virus-permissive Saccharomyces 
cerevisiae was screened for the up- or down-regulation of genes during 
infection with BMV (Kushner et al., 2003).  The results both confirmed 
previous studies of this nature and introduced new theories and cellular 
pathways involved during viral infection of a (simple) eukaryote.  
Replication was found to be down-regulated by host genes such as 
histone modification enzymes, glutathione synthesis, RNA polymerase 
regulation genes, RNA cap-binding protein and ubiquitin modification.  In 
contrast, genes involved in organelle morphology, phosphorylation, 
transcription, elongation and phospholipid biosynthesis were found to be 
up-regulated during BMV viral replication (Kushner et al., 2003).   
The role of some of the host cell proteins involved in the replication of the 
FHV in Drosophila cells has been studied (Kampmueller and Miller, 2005; 
Weeks and Miller, 2008).  Analyses showed the involvement of the 
chaperone, heat shock protein 90, as a key host protein that facilitates 
viral RNA replication by FHV sequestering the chaperone pathway to 
assemble its RNA replication complexes on mitochondrial membranes 
(Kampmueller and Miller, 2005).  Interestingly, parallel infection of FHV in 
S. cerevisiae requires the heat shock protein 70 co-chaperone, YDJ1, 
(Weeks and Miller, 2008) highlighting how these viruses adapt to different 
hosts.  This was achieved in part by utilizing different, perhaps more 
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metabolically available, host factors in their replication life cycle (Weeks 
and Miller, 2008).   
 
1.3.4. Anchoring of the RdRp to accessible intracellular membranes 
 
The self-interaction, protein modification and host protein sequestering by 
a viral replication complex often involves the host cell undergoing 
morphological and biochemical changes (Marcotte et al., 2007).  
Importantly, RdRps and their associated replication complexes must 
interact with a host intracellular membrane for the following reasons:  (i.) 
physical support to the RNA/protein complexes, (ii.) concentrating and 
compartmentalizing of the components, (iii.) supplying essential lipids that 
are required for RNA synthesis and (iv.) providing attachment of viral RNA 
during unwinding (Lee et al., 2006).  It is also speculated that the 
membranous structures formed during virus replication could shield this 
process, as well as the RdRp and potential dsRNA replication 
intermediates, from host antiviral mechanisms (Jonczyk et al., 2007).  It is 
because of this association with intracellular membranes that all RNA 
viruses produce replication complexes made up of both host and cellular 
factors and are located at a host intracellular membrane normally provided 
by a cellular organelle (Ahlquist et al., 2003).   
 
Recent evidence points to the use of aggresomes and auotophagy within 
the host cell in order for the infecting virus to generate sites for viral 
replication (Wileman, 2006).  The use of these two physical characteristics 
of a eukaryotic cell as a means of concentrating and localizing viral factors 
has been described in dsDNA viruses (reviewed in Wileman, 2006).  Only 
a few ssRNA viruses, including PV, have been shown to be dependent 
(e.g. virus yield, pH sensitivity) on the presence of cellular proteins directly 
involved in the formation of either of these two subcellular formations 
(Wileman, 2006; Netherton et al., 2008).  Due to limited information on the 
role of aggresomes and autophagy in the lifecycles of other ssRNA viruses 
available at present, the impending discussion of replicase complex 
formation and localization will centre mainly on interaction and anchoring 
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of replication complexes with an intracellular membrane using well studies 
(+)ssRNA plant viruses as examples.   
 
 
1.4. TRANSCRIPTIONAL AND TRANSLATIONAL REGULATORY 
MECHANISMS IN RNA VIRUSES 
 
1.4.1 Translational control in plant viruses and associated host 
factors 
 
Approximately 20 % of plant (+)RNA viruses have genomic (and 
subgenomic) RNAs with a 5`-cap and poly-(A) tail, thus requiring a closed 
loop conformation of these viral transcripts in order for efficient translation 
to occur (Dreher and Miller, 2006). The closed loop conformation is 
achieved by sequestering various cellular translation factor proteins such 
as elongation initiation factor 4E (eIF4E), eIF1A and eIF4G although the 
arrangement and presence of these translation factors has been found to 
be very different in infected plant cells compared to that seen in the 
standard cellular mRNA pool (Dreher and Miller, 2006).  The binding of 
40S ribosomal subunit of the host’s translation machinery to the 5`-end of 
the vRNA is mediated by the eIF3 and eIF4 groups (Dreher and Miller, 
2006).  The eIF1 group factors are required to promote the ‘scanning step’ 
necessary to find the start codon (reviewed in McCarthy, 2000), as well as 
potentially, to act as a molecular bridge between the 5` and 3` RNA ends 
(Dreher and Miller, 2006).  
 
A number of 5` to 3` bridging mechanisms exist in positive strand viral 
RNAs, but these are variable in nature due to varying 3` structures and 
sequences adopted by the virus genome (Dreher and Miller, 2006).  Virus 
genome-linked proteins or ‘protein primers’ such as those employed by the 
Picornaviridae are often used as replacements in cap-independent 
translation (Buck, 1996).  Regulation of cap-independent translation by 
members of the Tombusviridae is often controlled by sequences in the 3`-
UTR.  These sequences form stem-loop structures and rRNA-binding 
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tracts as a means of recruiting ribosomes to these enhancer signals 
(Dreher and Miller, 2006).  Interestingly, pseudoknot structures in this 
region play a vital role in re-initiation of translation resulting from leaky 
stop codons (Feng et al., 1992), which themselves play an essential 
regulatory role in the translation of replication proteins of the 
Tombusviridae (Skuzeski et al., 1991).   
 
If present, a poly-A tail acts as a potent translational enhancer and also 
stabilizes the RNA (Dreher and Miller, 2006).  Translation is also 
enhanced by the aminoacylatable tRNA-like structures found at the 3`-end 
of many plant virus RNAs.  These structures enhance the production of 
protein because they bind tightly to eIF1A. Once translation has been 
optimized by one of these mechanisms, translational recoding is often 
utilized as a means of expressing more than one gene, and in asymmetric 
quantities (Dreher and Miller, 2006; Ahlquist, 2006).  
 
A common method of translation recoding besides leaky scanning, 
missense codon reading and frameshifting is the presence of a read-
through stop codon, usually a UAG or UGA, found in frame with a coding 
sequence and used to express asymmetric levels of the 5` versus the 3` 
coding sequence (Skuzeski et al., 1991; Beier and Grimm, 2001).  
Alternatively, the stop codon is position in the capsid protein ORF, where 
extensions of structural proteins are essential for infectivity (Schmitt et al., 
1992).  When found in a particular sequence context, the stop codon does 
not result in termination of translation but rather the addition of a tyrosine, 
glutamine, tryptophan or leucine at this codon, thus continuing with the 
peptide elongation and not “hopping” over the stop codon to re-initiate at a 
similar codon as was originally proposed (Beier and Grimm, 2001).  These 
misread stop codons are found in certain plant, animal and (rarely) insect 
virus families (Skuzeski et al., 1991; Harrell et al., 2002) as well as tissue-
specific full-length protein in eukaryotic translation (Dalphine et al., 1997; 
Beier and Grimm, 2001).  A scan of the NCBI nucleotide database by 
Harrell et al. (2002), revealed that at least 23 different virus genera had 
confirmed read-through stop signals in their genomes, yet only one insect 
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virus species, Plautia stali intestine virus (PSIV) of the Cripavirus genus 
(Dicistroviridae), was predicted to contain one of these highly conserved 
recoding signals (Harrell et al., 2002).  
 
Virus read-through stop signals have been categorized into three groups 
based on: the 3` sequence immediately downstream of the stop, the type 
of stop codon and the frequency of occurrence within certain virus groups 
(Beier and Grimm, 2001).  An alternative categorization of these signals 
has also been compiled based on the 3` sequence downstream of the 
leaky stop codon (Harrell et al., 2002).   More data is now available on the 
cis- and trans-acting elements responsible for the frequency of 
readthrough in viral, prokaryotic and eukaryotic sequences (Craigen et al., 
1985; Beier and Grimm, 2001; Harrell et al., 2002).  A basic stop signal 
component has been described for many in-frame stop codons 
characterized mainly in plant viruses but also including examples found in 
animal viruses such as the Reoviridae, a number of  Alphaviruses, 
gammaretroviruses and epsilonretroviruses, and many encephalitis-
causing virus species  (Beier and Grimm, 2001; Harrell et al., 2002).  The 
most common functional and also effective read-through stop signal was 
characterized by the nucleotide sequence UAG CAR YYA where Y 
represents a pyrimidine base and R, a purine base (Skuzeski et al., 1991; 
Harrell et al., 2002) 
 
When present in the retroviruses, these signals are thought to function 
better in the presence of short RNA hairpin-loop/pseudoknot structures in 
the sequence downstream of the stop codon (Feng et al., 1992).  In 
prokaryotes, the read-through stop signal has been shown to operate in 
conjunction with a frameshift after the stop signal creating alternative 
proteins beyond this point, which are dependant on the nature of the 
structural motif encoded by the re-initiated 3`-UTR (Craigen et al., 1985).  
Not only do read-through stop signals moderate translation levels of the C-
terminally extended protein, but have also been found to be a pre-requisite 
in virion assembly in the case of luteoviruses, where the longer capsid 
protein is essential for particle formation (Schmitt et al., 1992).  This in 
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turn, facilitates the transmission and infectivity of these viruses during the 
course of infection (Schmitt et al., 1992).   
 
 
1.4.2. Translation initiation, control and modification in insect RNA 
viruses 
 
In general, animal viruses exhibit less tightly controlled translational 
control than plant and insect viruses (Dreher and Miller, 2006).  However 
they have to adopt a more ‘aggressive’ means of evading and 
sequestering immunomodulatory factors and transcription and/or 
translation factors, respectively.  Alternatively, some insect viruses such 
as the Dicistroviridae employ an internal ribosome entry site (IRES) at the 
5`-UTR of ORF2 and contained within the intergenic region of the two 
cistrons (Masoumi et al., 2003; reviewed in Martínez-Salez et al., 2008).  
Translation resulting from ribosome entry from this structure does not 
require the activities of eIF1, eIF1A or the cap-binding protein eIF4 
(McCarthy, 2000).  An additional advantage of such a secondary RNA 
structure guiding the binding of the 40S ribosomal subunit and a 
pseudoknot structure occupying the P-site, is that these viruses can 
initiate translation using alternative start codons such as CUG, CUU or 
ACG, without competing for host initiation factors or initiator tRNA 
(RNAiMet) (McCarthy, 2000; Sasaki and Nakashima, 1999).  These 
initiation codons do not function in a scanning-dependent manner during 
translation and are found with IRES structures, which direct the host 
ribosome to the start of translation (Sasaki and Nakashima, 1999). 
 
Interestingly, IRES elements have been implicated in the direct transfer of 
ribosomes from the initial binding site on the 5`-UTR to the second or third 
AUG.  The reasons for the “dropping” of an accessible in-frame AUG have 
yet to be uncovered, but is thought that cell-specific factors could facilitate 
an IRES conformation allowing for translation of products from an 
alternative upstream AUG (Sarnow, 2003).  The polypetides translated 
from the ORFs of the Dicistroviridae are post-translationally processed via 
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2A-like ‘cleavage’, a mechanism similar to that observed in the 
picornaviruses and certain members of the genus Betatetravirus 
(Rossmann and Tao, 1999; McCarthy, 2000; Pringle et al., 2001; Luke et 
al., 2008).  In contrast, the tetraviruses make use of overlapping reading 
frames, subgenomic RNAs or bicistronic genomes in order to translate the 
various ORFs of their genomes (Hendry and Agawal, 1994; Gordon et al., 
1999).   
 
An interesting co-translational modification that is well documented in the 
picorna- and tetraviruses is the presence of a functional 2A-like 
polypeptide ‘cleavage site’ usually positioned at the N-terminal of a protein 
coding sequence (Donnelly et al., 2001b; Luke et al., 2008).  2A-like 
processing is characterized by a co-translational ribosome skipping event 
which can be 90 - 95 % efficient in vitro (Donnelly et al., 2001a; Luke et 
al., 2008).  2A-like ‘cleavage’ occurs by ribosomonal stuttering over a 
prolyl-tRNA (within a consensus sequence), which is stearically hindered, 
resulting in the hydrolysis of the ester bond between the nascent peptide 
and tRNAGly (Ryan et al., 1999; Donnelly et al., 2001).  The end products 
of this processing are small quantities of a full length protein resulting in 
immediate re-initiation of translation at the downstream glycine residue of 
the consensus sequence, and large quantities of a small peptide and large 
protein (Ryan and Drew, 1994).  The core 2A-like sequence 
(DxExNPG↓P), where x represents any amino acid, is highly conserved 
within the Cardiovirus and Apthovirus genera of the Picornaviridae, some 
members of the Dicistroviridae and the Tetravirus genus Betatetravirus, 
type C rotaviruses (Donnelly et al., 2001b), and more recently discovered 
in eukaryotic sequences usually embedded in non-LTR retrotransposon 
regions within the genome (Donnelly et al., 2001b; Heras et al., 2006).  
Most of these sequences have been found to be active in vitro (Luke et al., 
2008) and function in the picornaviruses by mediating the 2A and 2B 
protein partitioning during translation, while the 2AB precursor is also 
functional during the virus lifecycle (Ryan and Drew, 1994).   
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As described for the tetraviruses earlier (Section 2.4.3), these sequences 
are situated at the N-terminal ends of the capsid precursor ORF and are 
functional in vitro (Pringle et al., 2001, Luke et al., 2008).  These 2A-like 
sequences could represent an alternative processing mechanism of the 
capsid precursor polyprotein.   Apart from the obvious involvement of host 
translation factors in insect virus genome replication and the few 
regulatory mechanisms discussed above, what other cis-acting viral 
factors control insect virus gene expression?  Transcriptional and 
translational control mechanisms have been studied in-depth using the 
nodavirus, FHV, as a model insect virus and PV as a model animal virus, 
yet the most progressive research to date on virus replication, replication 
complexes and genome processing has been conducted on (+)ssRNA 
plant viruses, in particular the Tombusviridae (Rajendran and Nagy, 2003; 
Panaviene et al., 2003; Panavas et al., 2005a; Nagy and Pogany, 2006).  
During the course of this study, it was shown that PrV uses at least one 
expression strategy utilised by this family of viruses during genome 
replication, thus qualifying the inclusion of the well-characterized 
replication strategies employed by the Tombusviridae in the discussion 
below. 
 
1.5. THE TOMBUSVIRIDAE 
 
The Tombusviridae family of viruses are a group of small, (+)ss 
monopartite RNA viruses, which infect a number of agriculturally important 
plant species (Rubino and Russo, 1998).  Much research has been 
dedicated to studying the viral proteins involved in genome replication of 
these viruses, in particular the interaction of the RdRp and its associated 
viral accessory protein at the site of replication (Scholthof et al., 1995; 
Panavas et al., 2005; Batten et al., 2006).  The burgeoning field of plant 
virology partially owes its success to the ease of manipulation of these 
viruses in the laboratory, the robustness of infection and the availability of 
the model eukaryotes S. cerevisiae and Arabidopsis thaliana as 
permissive hosts for many of the species in this family (Weber-Lotfi et al., 
2002; Panaviene et al., 2004 and Jonzcyk et al., 2007).  In addition, the 
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availability of RNAi technology for fully sequenced host genomes allows 
for a rapid, systematic identification of host factors involved in the 
replication of these viruses.  These tombusviruses employ a complex 
multicomponent approach of gene duplication (Lin et al., 2007) and a 
selection of these mechanisms are summarized below. 
 
 
1.5.1. Genome organization, translation products and processing 
Tombusvirus genomes are characterized by five ORFs encoding proteins 
for the capsid (~41 kDa), cell-to-cell movement (~22 kDa), suppression of 
gene silencing (~19 kDa), and two proteins required for genome 
replication (~33 kDa and ~92 kDa) (Figure 1.5) (Russo et al., 1994).  The 
two replicase proteins (both located at the very 5` end of the genome), 
often referred to as the accessory/auxiliary protein and replicase protein, 
are necessary for genome replication within the host plant cell (Scholthof 
et al., 1995).  The auxiliary protein, 25 - 40 kDa in molecular weight, is 
translated first from the multicistronic genome, followed by leaky read-
through translation of the replicase component (85 - 100 kDa) in a much 
lower (approximately 20 fold) concentration (Scholthof et al., 1995).   
 
 
Figure 1.5.  Genome organization of a model tombusvirus, Tomato Bushy Stunt 
virus (TBSV).  The ORFs are represented by the open rectangles with the name (and 
molecular weight in kDa) of the product in each box.  The characteristic read-through stop 
codon is labelled UAG and the sites of subgenomic RNA initiation are indicated by the 
bent arrows.  The replicase proteins, p33 and p92 are indicated by black and grey ovals, 
respectively, while arrows below the ovals represent the relative proportions of each 
product.  UTRs are represented by horizontal lines (Taken from Monkewich et al., 2005).  
 
  
 
 
  
3`5` 
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Read-through translation in the replicase ORFs of the most well-studied 
tombusviruses, Tomato Bushy Stunt virus  (TBSV) and Cucumber necrosis 
virus (CNV), occurs at a frequency of about 5 -10 % in plant cells and 10 
% in yeast (Scholthof et al., 1995; Panaviene et al., 2004).  Both N-
terminal (‘accessory’) and full length (RNA polymerase) read-through 
products are essential for virus replication (Scholthof et al., 1995; Weber-
Lotfi et al., 2002) with species-specific interaction between the two 
proteins in TBSV shown to be essential for replicase assembly and thus 
infectivity (Rajendran and Nagy, 2006).  The auxiliary protein of CNV, 
which has no recognizable enzymatic activity or recognizable catalytic 
motifs (Panaviene et al., 2003) is phosphorylated by a membrane-bound 
plant kinase (Shapka et al., 2005).   The modified version of this accessory 
protein is one of the cis-acting components responsible for replicase and 
RNA template interactions during infection (Shapka et al., 2005).   The 
regulation of full-length replicase translation by various recoding 
mechanisms is in fact a highly conserved characteristic in both (+) RNA 
viruses and retroviruses.  Although different mechanisms are employed in 
the control of expression of these proteins, the ratios of replication-related 
proteins leading to what is essentially polymerase down-regulation implies 
a functional requirement in not only plant (and animal) alphaviruses but 
also retroviruses and arteriviruses (Ahlquist, 2006). 
The control of tombusvirus genome transcription and translation is 
regulated by at least two highly unusual cis-acting RNA elements, one of 
which is unique in that it regulates RNA replication (Sit et al., 1998; 
Pantaleo et al., 2004; Monkewich et al., 2005; Lin et al., 2007).   This 
particular element is an internal RNA element (RII) comprising a helical 
stem-loop structure found within the read-through section of p92 as well as 
a functionally essential C-C mismatch in the loop region (Figure 1.6).  This 
component is dispensable late in the RNA replication cycle and is thus 
thought to play a crucial role in template recruitment and/or replicase 
complex assembly (Monkewich et al., 2005).   RII, which is only active on 
the positive strand, is essential for virus infectivity and as has been found 
with other secondary RNA elements that come into contact with 
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ribosomes, is functionally inhibited by the translation of the viral RNA in 
vivo (Figure 1.6) (Monkewich et al., 2005).    
Recently, a multicomponent model comprising RNA-RNA interactions has 
been proposed for the premature termination of tombusvirus transcription 
(Lin et al., 2007).  Premature termination of transcription of genomic vRNA 
is proposed to occur in a number of ssRNA virus families and the result of 
this RdRp halt in activity is that the 3` truncated minus strands are used for 
templates in subgenomic mRNA transcription (Sit et al., 1998).  A 
complicated system of RNA-RNA interactions and long-distance base 
pairing results in a genomic RNA structure primed for premature 
termination of transcription before the subgenomic RNA sequences are 
reached (Lin et al., 2007)   
 
 
 
Figure 1.6.  A model of the role of the RII replication element during tombusvirus 
replication and the effect of translation on this internal RNA element.  A:  The 
(infrequent) translation of p92 results in the inactivation of the RII replication element.  B:  
When not undergoing translation the RII replication element takes on its secondary 
structure and is thus active.  The dotted, double-headed arrow reinforces the dynamic 
state of an active/inactive RII replication element C:  Activities and roles of active RII 
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replication element.  D:  later in the lifecycle of the virus, the RII replication element is no 
longer required for successful genome replication (Taken from Monkewich et al., 2005).   
 
 
In summary, the two models discussed above, represent a small portion of 
data available on the transcriptional and translational control mechanism 
employed by these viruses.  It is important to compare these mechanisms 
with those utilised by other RNA families and integrate this knowledge 
within other spheres of the tombusvirus lifecycle, in particular, the 
subcellular localization and components of tombusvirus replication 
complexes. 
 
1.5.2. Subcellular localization and functional roles of replication 
proteins 
 
Scholthof and co-workers were the first group in the field of tombusvirus 
replication to show that both the auxiliary and replicase proteins of the 
type member, TBSV, were not only asymmetrically expressed but also 
membrane-associated (Scholthof et al., 1995).  Subsequently the sites of 
replication of many tombusvirus species, as well as the roles of their 
replication proteins, have been characterized (Jonczyk et al., 2007).   
These subcellular sites often vary between virus species, but the 
localization signals can be altered to create an alternative yet authentic 
site of replication (Jonczyk et al., 2007). What advantages might be 
conferred at each variable subcellular site of replication for viral replication 
is currently unknown since the exact role of a membrane surface in RNA 
replication complexes has yet to be elucidated (Jonczyk et al., 2007).  
 
The two replication proteins of Carnation Italian ringspot virus (CIRV) are 
targeted to the mitochondria by an import-independent signal-anchor 
mechanism relying on two transmembrane segments and multiple 
recognition signals present in the N-terminal of the accessory protein, p36 
(Weber-Lotfi et al., 2002).  Both of these proteins localize to the 
mitochondria independently of one other (Pantaleo et al., 2004).  Within 
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the overlapping sequence of the auxiliary and replicase proteins there 
exists an essential RNA-binding domain that has been shown to play 
different roles, depending on which protein it originates from, during virus 
replication (Panaviene et al., 2003).  In CIRV, p36 has also been shown to 
play a role in stabilizing and targeting template RNA (by the presence of 
an RNA-binding motif) to the replication site in conjunction with the 
replicase, p92 (Pantaleo et al., 2004).    
 
The auxiliary (p48) and replicase (p112) proteins of another tombusvirus, 
Panicum mosaic virus (PMV), are not only unusual in their substantially 
larger molecular weights compared to the analogous proteins of other 
tombusviruses, but have also been shown to play a crucial role in 
accumulation of newly synthesized virus (Batten et al., 2006).  The 
potential targeting of these replication proteins to the peroxisome within 
infected host cells has also been suggested in PMV (Batten et al., 2006).    
In CNV, p33 interacts with other p33 molecules in yeast cells and 
facilitates the formation of multimolecular complexes.  These complexes 
include p33, p92, viral RNA and host factors which are then targeted to the 
site of replication – namely the peroxisomal membrane  (Panavas et al., 
2005a; reviewed by Nagy and Pogany, 2006).  This emphasises the 
essential role of these nonstructural proteins in the replication lifecycle of 
these viruses as well as in other virus families (Chen and Ahlquist, 2000).   
 
The discoveries on the use of two replication proteins and their roles and 
interactions during the vRNA replication process cumulatively represent 
one of the few models published to date that describes, not only the viral 
factors involved in a ‘pre-targeted’ replication complex, but also the ratios 
of accessory to replicase protein involved (Panavas et al., 2005).   One 
could assume, based on the literature, that the major driving force 
shuttling replication proteins and/or pre-formed complexes to a subcellular 
membrane is the (often ambiguous) targeting signal present on one or 
more of the replication proteins.   
 
This conclusion is supported by the results obtained by Jonczyk et al. 
(2007), who replicated TBSV in a yeast strain with the PEX3 and PEX19 
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genes deleted from its genome.  The products of these two genes are 
essential for peroxisome biogenesis in yeast (Jonczyk et al., 2007).  
Replication of TBSV in the peroxisome-minus yeast strain suggested that 
TBSV replicons were targeted to and were functional at the endoplasmic 
reticulum (E.R.) at a fidelity and activity level comparable to that in wild 
type yeast (Jonczyk et al., 2007).  
 
These replication proteins serve as attractive niches of interest in the 
investigation of virus replication, host cell-virus interactions and possibly 
targets in the popular field of silent interference (si) RNA studies.    In 
order to understand more about virus replication and the evolution of this 
process between related virus families, one should understand the roles 
that replication proteins and the replication event itself plays on the 
lifecycle of viruses.   These processes are often coupled to one another 
and are tightly regulated by a variety of factors during the lifecycle of the 
virus.  A family which is well studied in almost all aspects of its life cycle is 
the Picornaviridae.  Insight into the processes used by members of this 
family in the replication, host cell interactions and genome processing 
ability are summarized as a means of supplementing and diversifying this 
review on (+)ssRNA virus replication and genome processing.   
 
 
1.6. THE PICORNAVIRIDAE 
 
 
The Picornaviridae, which are among the smallest (+)ssRNA viruses 
known, comprise one of the largest and most important families of 
medically and agriculturally significant viruses (Fauquet et al., 2005).  
Many picornaviruses cause disease in humans and animals.  PV, the 
prototypic picornavirus, has caused severe poliomyelitis in the past and 
brought financial burden to many developing countries attempting to 
eradicate the disease (Bedard and Semler, 2004).  Human rhinovirus 
causes one of the most widespread viral diseases, the common cold, for 
which there is still no cure or cost-effective prevention (Bedard and 
Semler, 2004).  Foot-and Mouth Disease virus (FMDV), a highly 
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contagious apthovirus, is the most economically important disease of 
domesticated cloven hoof animals causing regular outbreaks and loss of 
substantial income (Ferrer-Orta et al., 2004).   The Picornaviridae are 
divided into seven genera based on similarities in virion physical 
properties, RNA sequence and genome organization (Bedard and Semler, 
2004).  The seven genera are enteroviruses, rhinoviruses, cardioviruses, 
apthoviruses, hepatoviruses, parechoviruses and teschoviruses (Fauquet 
et al., 2005).   
 
Surprisingly for such a large family of animal viruses, this family has been 
shown to infect relatively few species of insects and lately, and most of the 
few documented members that infect insects are now classified in distinct 
taxonomic clusters outside the family Picornaviridae (Christian et al., 
1999).  In 2000, Cricket Paralysis virus (CrPV), Infectious Flacherie virus 
of silkworms and other invertebrates were classified as unassigned 
members of the Picornaviridae, but have since been grouped into the new 
Dicistroviridae family made up of the one genus, Cripavirus (Masoumi et 
al., 2003;) and the floating genus, Inflavirus, which has yet to be grouped 
in a particular family (Mayo, 2002; Fauquet et al., 2005). To add to the 
uncertainty of the phylogenetics of these picorna-like viruses, it has been 
discovered that CrPV, has a wide range of insect hosts in the wild, and is 
most likely responsible for the etiology of many viral diseases associated 
with a variety of insect species exhibiting similar symptoms (Fauquet et al., 
2005).   
 
More and more picorna-like viruses have been discovered in recent times 
and appear to make up a (structurally, genomically and pathogenically) 
diverse group of viruses (Wu et al., 2002; Fujiyuki et al., 2004; Fauquet et 
al., 2005).    IFV lethally infects the ficus transparent wing moth, Perina 
nuda, and has been the subject of many classification studies based on its 
unusual genome arrangement, since the monocistronic genome is 
considered more similar to mammalian picornaviruses (Isawa et al., 1998).  
The lethal disease, termed flacherie, has since been demonstrated to be 
the result of a mixed infection consisting of the dicistrovirus, P. nuda 
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picorna-like virus (PnPV) and the baculovirus, P. nuda 
nucleopolyhedrovirus (PenuNPV) (Wang et al., 1998; 1999).  
 
Phylogenetic analysis of the insect virus Ectropis obliqua picorna-like virus 
has suggested that it is most closely related to PnPV and bioinformatic 
analysis of the RdRp alone showed that these two viruses along with 
Sacbrood virus (SBV) and IFV, should actually be classified in a group 
distinct from the dicistroviruses (Wang et al., 2004).  Many such examples 
of phylogenetic ambiguity have arisen from analyses of these picorna-like 
viruses grouped in the Dicistroviridae and Inflaviruses and consequently 
classification of the Dicistroviridae is still ongoing (Fauquet et al., 2005). 
 
 
1.6.1. Genome organization 
 
Picornaviruses contain a 7.0 - 8.5 kb (+)ssRNA genome (Bedard and 
Semler, 2004; Fauquet et al., 2005).  The genomic RNA is polyadenylated 
at the 3`-terminus and has a genome-linked protein (VPg) situated at the 
5`-terminus, as opposed to the 7-methyl guanosine cap structure often 
found on the genome of RNA viruses (Bedard and Semler, 2004).  The PV 
genome (7433 nt) is translated into a polypeptide of 2207 amino acids. 
This polyprotein is characteristically cleaved at three key positions 
followed by further cleavage to form 11 stable proteins (Figures 1.7 and 
1.8) (Moore et al., 1985) by 2 types of viral proteinases, the 3C and 2A 
proteinases. The number of proteinases involved in cleavage of the 
polyprotein precursor is dependent on the genus of the virus (Bedard and 
Semler, 2004).  
 
 
Figure 1.7.  Genome organization of a model picornavirus, PV.  The ultimate protein 
products of the proteolytic processing of P1 - P3 are colour coded according to their 
precursor origin.  VPg= genome-linked protein, ♣ = clover leaf RNA structure.  UTRs are 
represented by thick black horizontal lines (Adapted from Bedard and Semler, 2004).   
 
P1 P2 P3 
VP4 VP3 VP1 2A 2B 2C 3A 3C 3D 
♣VPg 5` 3` 
3B/VPg 
-AAAAA(A)nVP2 
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The polyprotein is initially cleaved into three precursor proteins simply 
labelled P1, P2 and P3 (Figure 1.7).  These three precursor proteins are 
cleaved into four, three and four end products respectively (Fauquet et al., 
2005) with the intermediates playing vital roles in the virus lifecycles 
before they are processed further (Aminev et al., 2003; Marcotte et al., 
2007). In members of the Apthovirus and Cardiovirus genera, a leader 
protein (L) exhibiting proteinase activity is translated from the very 5`-end 
of the polyprotein and is cleaved off the neighbouring P1 early in the 
polyprotein processing cascade (Strebel and Beck, 1986).  This protein 
serves to shut off host cell translation in infected cells (Devaney et al., 
1988).  Precursor P1 is the capsid intermediate and further cleavage 
results in the production of the three or four capsid proteins.  Cleavage 
products of P2 and P3 function in the shutting off of host cells translation, 
RNA replication (RNA-dependent RNA polymerase), protein processing, 
nuclear targeting of the viral genome, host cell membrane rearrangement 
(to increase permeability), the formation of virus-induced cytoplasmic 
vesicles and immune response interference (Bedard and Semler, 2004, 
Lee et al., 2006).   These proteins and cleavage intermediates will be 
discussed further, with particular reference to the role they play in genome 
replication and translation of the viral RNA.   
 
 
1.6.2. Polypeptide processing  
 
 
The post-translational processing of the picornavirus polyprotein is 
performed by one or more of the viral-encoded proteinases (reviewed in 
Bedard and Semler, 2004).  The first cleavage event of several 
picornaviruses is the cleavage at the junction of P1 and P2 precursors 
proteins, mediated by proteinase 2A, resulting in the production of the P2-
P3 precursor and the P1 region of the polyprotein.  The autocatalytic 
cleavage of the L protein from the N-terminus of the polyprotein varies in 
the order of processing from different protein intermediates between the 
genera of the Picornaviridae, yet its cleavage is universally mediated by 
the 3C proteinase (Bedard and Semler, 2004). The remaining secondary 
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cleavage events within the viral protein precursors are carried out by the 
3C viral proteinases (and its precursor, 3CD) (Bedard and Semler, 2004).  
Once 3C has self-cleaved it is responsible for the cleavage of the P2 and 
P3 proteins, as well as the cleavage of several host cell proteins involved 
in particularly mammalian cell transcription (Bedard and Semler, 2004).  A 
summary of this process and the function of the resultant cleavage 
products are represented in Figure 1.8. 
 
 
Figure 1.8.  Picornavirus polyprotein processing cascade.  The functions of mature 
and precursor proteins are highlighted and the proteinase responsible for each step 
shown (Taken from Bedard and Semler, 2004). 
 
 
During these cleavage events, a mature virion is formed from pentameric 
intermediates of capsid protein and finally matures into an infectious 
icosahedral particle (Rossmann and Tao, 1999).  Interestingly, picorna-like 
insect viruses have a completely different gene arrangement compared to 
mammalian picornaviruses (Rossmann and Tao, 1999).  The four 
structural proteins are typically positioned at the 3` terminus of the 
genome and form dimer intermediates during maturation of the virus 
particles (Rossmann and Tao, 1999).   
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1.6.3. Replication and translation of vRNA 
 
In picornaviruses the RdRp, named 3Dpol, is required for positive and 
negative strand RNA synthesis.  During viral replication, 3Dpol catalyzes 
chain elongation during viral synthesis and production of the protein 
primer, VPg-pU-pU, which is necessary for the initiation of viral RNA 
replication in a process described as VPg uridylylation (Lee et al., 1977).  
This is followed by the production of intermediate negative sense viral 
RNA, whereby the 3`-poly A tract acts as an initiation site.  The ratio of 
positive to negative sense RNA is almost always asymmetrical and tightly 
controlled during the replication process (Agol et al., 1999).  As is the case 
with other positive sense RNA genomes, the negative sense RNA in turn 
acts a template for the production of positive sense RNA, which is later 
packaged into virions (Bedard and Semler, 2004).   
 
Picornavirus genome replication is characterized as being primer-
dependent; in other words dependant on the uridylylated protein (VPg) 
linked to the 5`-end that initiates translation (Lee et al., 1977).  The VPg is 
cleaved off during the early stages of infection by an unknown host cellular 
protein.  This in turn uncovers the highly structured 5`-UTR that contains 
the IRES necessary for translation initiation (Bedard and Semler, 2004).  
This element also allows CAP- and eIF-4G-dependent modes of viral RNA 
replication while shutting off the host transcription processes (Aminev et 
al., 2003).  The IRES element of a picornavirus is a relatively long (300-
400 nt) and highly structured region of the RNA genome exhibiting a 
complex secondary and tertiary structure (Masoumi et al., 2003).   
 
The IRES elements of picornaviruses have been proposed to contain 
multiple protein binding domains, which act as RNA chaperones and 
regulate IRES activity via the modification of cellular proteins by virus-
encoded proteins (Belsham and Sonenberg, 2000).  It is unlikely that 
translation initiation in picornaviruses occurs by other means, such as the 
scanning mechanism or read-through stop signals (none of which have 
been discovered in this family), due to the presence of this cap-
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independent internal initiation of protein synthesis (Belsham and 
Sonenberg, 2000).   
 
Early in infection, the viral mRNAs have to compete with the host, not so 
much for ribosomes, but for the limited pool of eukaryotic initiation factors 
(eIFs) that mediate the recruitment of ribosomes to viral mRNAs.  The host 
protein, eIF4G, a component of eIF4F, is cleaved by the viral leader 
protein or 2A-like protease (depending on the virus), and used to form a 
pre-initiation complex together with tRNAMet, 40 S ribosome subunits and 
the translation initiation factors eIF2 and eIF3 (Belsham and Sonenberg, 
2000).  Picornavirus IRES elements bind intact or truncated forms of eIF-
4F which aid in the recruitment of 40 S ribosomal subunits allowing 
initiation and elongation of translation of the viral genome to occur (Bedard 
and Semler, 2004; Sarnow, 2003).  At least two types of IRES structures 
have been characterized in the picornaviruses, and the type of IRES will 
determine the host cell factors involved in the translation of the viral 
genome (Bedard and Semler, 2004).  Subsets of these factors have been 
shown to be involved in translation initiation, translation fidelity and 
quantity of the resultant viral translation product (Bedard and Semler, 
2004). 
 
1.6.4. Location and mechanisms of replication complexes  
 
Much of the replicative processing of PV has been unravelled because of 
the once medical significance of this particular picornavirus and, more 
recently, other members of the family such as FMDV (Ferrer-Orta et al., 
2004; 2006).  In general, picornaviruses have been shown to localize their 
replication complexes on the membranes of the Golgi body and E.R. i.e. 
derived from components of the cellular anterograde membrane traffic 
system (Rust et al., 2001).   
 
Once 3ABCD has been processed into 3AB by the 3C protease, it can 
functionally direct itself and the associated 3D to the cytoplasmic face of 
the ER, the location of the replication complex (Netherton et al., 2008).  
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2BC and 2C are also components of this complex and are targeted to 
membranes by individual hydrophobic domains (Netherton et al., 2008).  
With the number of viral proteins, precursor molecules and other RNA 
and/or protein interactions that occur during the lifecycle of a picornavirus, 
it is not surprising that the replication complex has yet to be fully dissected 
and described.   
 
The active genome replication of PV induces the rearrangement of 
intracellular membranes into characteristic vesicles which then assemble 
into an RNA replication complex (Egger et al., 2000).  Characterization of 
these vesicles revealed that ER membranes are initially used, followed by 
the incorporation of Golgi bodies into the complexes later in the infection 
process (Egger et al., 2000).  In addition, replicating RNA is required for 
the formation of a functional PV replication complex (Egger et al., 2000), 
which supports previous findings that the picornavirus genome must first 
be translated before it can be replicated (Novak et al., 1994).  In PV-
infected HeLa cells, de-capsidation is rapid and it is suspected that the 
viral genome, and not the entire capsid, is transported to the perinuclear 
regions for translation (Egger and Bienz, 2005).  Studies on this 
phenomenon in HeLa cells have revealed a series of molecular shuttling 
within PV-infected cells.  The viral genome undergoes extensive viral 
translation at the E.R within viral-induced vesicles (Egger and Bienz, 
2005).  All newly synthesized proteins and RNA not involved in the 
replication complexes are then rapidly shuttled towards the nucleus, 
following the anterograde membrane pathway to their final location:- the 
Golgi complex within the microtubule-organizing centre (MOTC), where 
particle assembly presumably occurs (Egger and Bienz, 2005).     
 
FMDV replication occurs next to the nucleus and close to the Golgi 
complex, but the membranes from this organelle are not part of the 
replication complex (Knox et al., 2005), suggesting that FMDV uses 
another source of intracellular membranes in order to anchor its replication 
complex. Alternatively, certain organelle-specific markers are extruded 
from these adapted membranes during the membrane rearrangement by 
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FMDV, explaining the lack of cross-reactivity with Golgi-specific markers 
and antibodies (Knox et al., 2005).  Research conducted by Moffat et al. 
(2005) reiterated the invasiveness of subcellular organization by the 
picornaviruses, a factor which is often the leading cause of cell death and 
cytopathology during infection (Egger et al., 2000).  FMDV precursor 
protein 2BC was shown to block the expression of cellular proteins on the 
cell surface, effectively disrupting the secretory pathway as a possible 
immune evasion strategy (Moffat et al., 2005), furthermore highlighting the 
multifunctional nature and importance of precursor proteins in the 
picornavirus lifecycle.   
 
Another picornavirus, Encephalomyocarditis virus (EMCV), a member of 
the genus Cardiovirus, employs a very different localization (Aminev et al., 
2003).  A distinct nuclear localization signal (NLS) present on the N-
terminal end of the 3DPOL is active, directing the RNA replication of the 
genome to the host nucleus (Aminev et al., 2003).  Additionally, it was 
found that the proteins, 2A and precursor, 3BCD, inhibited cellular mRNA 
transcription but not rRNA transcription (which is required for functional 
ribosome formation) and that the precursor, 3BCD, was localized to the 
nucleus before undergoing further proteolytic processing (Aminev et al., 
2003).   
 
Many small insect virus species have picornavirus-like biophysical 
properties (Moore et al., 1985), but their relationships with established 
members of the picorna-like virus lineage have only recently begun to be 
established (Wu et al., 2002; Wang et al., 2004).  The comparative 
biophysical and replication studies of viruses from different families and 
lineages is leading to a better understanding of the (co- and divergent) 
evolution of insect viruses and their respective modes of replication within 
the host cell, which are often highly adaptable to various changes within 
the host cell environment.   
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1.7. PROBLEM STATEMENT 
 
The discovery of Providence virus provided an opportunity to study 
tetravirus replication in vivo. Virtually nothing is known about the 
replication of tetraviruses nor the host and auxiliary viral factors involved in 
their life cycle.  The results achieved described in the accompanying 
chapters serve to shed light on some of these processes, further bridging 
the ever-narrowing knowledge gap between plant, animal and insect 
ssRNA viruses as well as the general viral replicative mechanisms within 
the context of a (+)ssRNA virus.   
 
 
1.8. AIM AND BROAD OBJECTIVES 
 
The overall aim of this work was to establish experimental systems for 
studying the replication biology of PrV.  The broad objectives were as 
follows: 
 
1. Bioinformatic analysis of the PrV genome and its translation products  
2. Creation of antiserum towards PrV translation products  
3. In vivo and in vitro analysis of PrV translation products  
4. Analysis of the distribution of PrV replication proteins and viral RNA in 
PrV-infected MG8 cells  
 
CHAPTER 2 
Bioinformatic analysis of the PrV genome and its 
translation products 
 
2.1. INTRODUCTION 
 
In 2003, Pringle et al. reported the discovery of a new betatetravirus, PrV in 
a Helicoverpa zea midgut cell line.  A partial cDNA of 704 nt was later 
annotated by Pringle to be part of a non-structural ORF of 2748 nt, the 
replicase gene following submission of the entire capsid protein precursor 
ORF sequence.  N-terminal sequencing of the major and minor capsid 
proteins of PrV revealed that, like TaV, the capsid protein precursor (p81) is 
cleaved twice:  it is processed at its N-terminus by a 2A-like processing 
signal, and at the C-terminus by the conserved autoproteolytic event that 
occurs during particle maturation (Pringle et al., 2003).    
 
A year later, the cDNA sequence of what is believed to be the entire PrV 
genome (6155 nt) had been determined.   Three 2A-like processing signals 
were discovered in the genome:  one in the N-terminal region of a large, 
unidentified ORF named p130 and the remaining two at the N-terminus of 
p81, the capsid protein precursor.  The discovery of an in-frame stop 
codon, proposed to be a read-through stop signal in the replicase coding 
sequence in all the cDNA clones, and an RdRp domain showing 
conservation with (+)ssRNA plant virus RdRps were some of the 
unpublished preliminary results obtained by Pringle during this period (F.M 
Pringle and L.A. Ball pers. comm., 2005).   The aim of the research 
described in this chapter was to confirm Pringle’s initial analysis of the PrV 
cDNA sequence and to use various bioinformatic tools to further annotate 
the genome, secondary RNA and predicted protein structures and 
translation modification signals associated with the individual ORFs.   
 
 
 
42 
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2.2. METHODS 
 
The nucleotide sequence of the p104 ORF of PrV was confirmed using the 
dideoxy sequencing method.  The procedure used and substitutions in the 
p104 sequence are described in Appendix 3.  The uniform resource 
identifiers (URIs) utilised in this Chapter and dates of when the webpages 
and links hosted at these locations were accessed, are listed in Appendix 
4.  The accession numbers of the nucleotide and amino acid sequences 
are referred to in text and listed in Appendix 5. 
 
Using the online National Centre for Biotechnology Information (NCBI) 
database, the three main ORFs of the PrV genome, namely the capsid 
precursor ORF (p81), the putative replicase ORF (p104) and p130 were 
submitted as both nucleotide and amino acid sequences and compared to 
other non-redundant sequences deposited in the database.  This was 
performed using the Basic Local Alignment Search Tool (BLAST) program 
(Altschul et al., 1997).  In the alignment of nucleotide and protein 
sequences, BLASTn and BLASTp programs, which align the query with 
‘somewhat similar sequences’ in the NCBI database, were each used 
respectively in the analysis of individual ORFs.   
 
Identification of amino acid residues that are potentially phosphorylated in 
vivo was conducted using the NetPhos V2 program, and by limiting the 
search to identify only candidate tyrosine, phenlyalanine and tryptophan 
residues in the p40/p104 coding sequence, with probability scores of over 
0.95 considered statistically relevant.  The online tool, TargetP was used to 
predict the subcellular localization of PrV peptides by identifying and 
assigning the probability of the following functional sequences:  chloroplast 
transit peptides, mitochondrial targeting peptides and secretory pathway 
signal peptides. 
 
The online programs, ClustalW v. 1.82 (Thompson et al., 1994) and 
phylogenetic tree viewer TreeView v. 1.6.6 9Page, 1996), were used to 
align amino acid sequences, measure phylogenetic distances and produce 
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phylograms based on this input sequence.  ClustalW is a multiple 
sequence alignment algorithm which generates enough information in the 
identities, similarities and divergence existing between sequences such 
that a phylogenetic relationship can be calculated (Pearson and Lipman, 
1988; Mackey et al., 2002).  The graphic interface version of ClustalW, 
ClustalX (Larkin et al., 1997), was used to predict bootstrap confidence 
values of the alignment files generated by ClustalW.  A total of 1000 
bootstrap trials were conducted on each submitted alignment file and 111 
used as a random number generator seed.    
 
In the phylogenetic analyses of capsid precursor proteins, the gap 
extension penalty was set at 2 and gap creation penalty set at 8, whereas 
in the analyses of RdRp sequences the gap penalty was increased to 2.5 
and the gap opening penalty decreased to 5.  The phylogram was 
generated from the aligned sequences using the neighbour-joining method 
(Saitou and Nei, 1987).  The Java-based program TreeView was used to 
produce an output phylogram based on sequence and parameters set in 
ClustalW.  The algorhythm, MFOLD and its server-supported graphic 
interface, were used to predict secondary structures of both the 5` and 3` 
UTRs of PrV.  The MFold program designed by Michael Zuker (Matthews 
et al., 1999; Zuker, 2003) is a widely used bioinformatic tool for predicting 
the most likely, energy-efficient folding of both DNA and RNA.  MFOLD has 
successfully been used in the accurate prediction of both viral (see Collier 
et al., 2002 and Baird et al., 2006 for examples) and cellular IRES 
structures because of the algorithms’ high rate of accuracy in determining 
the minimum free energy constraints and thus secondary structures 
(Matthews et aI., 1999).  This is achieved by the incorporation of, on 
average, 73% of all known base pair combinations in each of the most 
likely theoretical structures that are computed and not by an averaging of 
general base pairing combinations (Matthews et aI., 1999).  Nucleic acid 
sequences longer than 750 nt contain up to 86 % of known base pair 
combinations since the longer the sequence, the higher the level of 
confidence in structure prediction (Matthews et aI., 1999). The single 
strandedness of a molecule is also predicted on a statistical level in all 
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significant predicted structures, thus confirming the overall probability of the 
existence of such structures existing in nucleic acids and also the lack of 
any structured region under varying free energy values (Zuker, 2003).  
 
Furthermore, the minimum free energy difference (MFED) of each structure 
can easily be determined by subtracting the free energy calculated on 
randomly shuffled input sequence from the free energy predicted for the 
structure of the original sequence.  Values (expressed as a percentile of 
the original sequence) in the range of 15-20% are considered to represent 
accurate, sequence-specific secondary structures and not a randomised 
prediction on the natural folding properties of the RNA (Simmonds et al., 
2008).  In this study, the most likely secondary structures were predicted 
using the recommended default parameter settings and used in further 
interpretations.   
 
 
2.3. RESULTS AND DISCUSSION 
 
2.3.1. Genome organization and theoretical protein products 
 
The PrV cDNA sequence was obtained from Dr. Fiona M. Pringle and Prof. 
L. Andrew Ball (University of Alabama, Department of Microbiology, 
Birmingham, Alabama, USA).   Analysis of potential ORFs encoded by the 
PrV genome suggested the presence of 3 major ORFs, the first two 
overlapping extensively (Figure 2.1).  Nearest to the 5`-end of the genome, 
extending from nts 45 – 3708, is a large theoretical ORF of 3663 nt in 
length, the translation product of which has a theoretical molecular weight 
of 130 kDa, hereafter referred to as p130 in text.  The translational start of 
p130 could be at either of two downstream methionine (AUG) codons at nts 
139 - 141 or nts 354 - 356, which like the first AUG, are both in good 
context for translation. This was based on a comparison of its Kozak 
sequence with the invertebrate consensus sequence (Caverner, 1987; 
Kozak, 1987). The first AUG positioned at nts 45 - 47 has a Kozak 
sequence of acaaAUGg, whereas the second AUG positioned at nts 354 – 
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356 has a Kozak sequence of ggagAUGa.  The invertebrate consensus 
sequence from nts -4 to +4 is reported as:  ca(a/g)(c/g)AUG(g/a) (Caverner, 
1987).   
 
 
 
Figure 2.1.  Genome organization of PrV.  ORF and additional processing features of 
the PrV genome as originally annotated by Pringle et al. (F.M. Pringle, pers. comm.) 
included the p130, the replicase and capsid precursor ORF.  The three 2A-like processing 
sites are indicated by stars.  The in-frame stop codon within the replicase is indicated by 
the circle containing the strike-through.  The vertical dashed line in the capsid precursor 
ORF indicates the site of autoproteolytic cleavage of the capsid precursor protein.  The 
bent arrow indicates the start of subgenomic RNA transcription. 
 
 
 
Positioned at nts 1027 to 3775 is a second ORF (2748 nt) encoding a 
protein with a predicted molecular weight of 104 kDa in a +1 frame relative 
to p130 (Figure 2.1).  The p104 ORF (hereafter be referred to as p104 or 
the replicase coding sequence in text) has a Kozak sequence of 
uuguAUGu, which is not in a particularly good context for initiation of 
translation, compared to the optimal invertebrate Kozak consensus 
sequence stated above.  An in-frame UAG stop codon is present in the 
p104 ORF at position 2104 - 2107 nt, repeatedly detected during sequence 
analysis of different cDNA clones, confirming the presence of the UAG 
sequence (F.M. Pringle, pers. comm., 2005).  Termination of translation at 
this stop codon would produce a protein with a predicted molecular weight 
of 40 kDa (p40).  Lastly, the capsid precursor ORF begins just 4 nt after the 
end of the p104 ORF and is 2265 in length (3779 - 6044 nt) with a Kozak 
sequence of gaucAUGc.  This ORF is translated from a subgenomic copy 
of RNA into an 81 kDa capsid protein precursor protein (Pringle et al., 
2003).   
 
 
 
5` Capsid precursor 3` Replicase p130 
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 2.3.2. The read-through stop signal in p104 
 
The analysis of the reported in-frame stop codon, UAG, and the 6 
nucleotides downstream, revealed that PrV contains a read-through stop 
signal with the highly prevalent, conserved sequence of:  UAG CAA CUA 
typical of a group 1 set of sequences that constitute 80 % of the known 
stop signals (Harrel et al., 2002).  Group 1 is composed entirely of 
(+)ssRNA plant viruses belonging to the Tobamovirus, Benyivirus and 
Pomovirus genera and one unassigned potex-like virus, Botrytis virus F 
(Harrel et al., 2002).  Although the PrV stop signal is best categorized 
within group 1, it has a divergent C nucleotide at the start of the second 
codon (nt +4), making it the only member in group I with this sequence 
despite its otherwise perfect homology to the consensus sequence (UAG 
CAA UU/CA) (Harrel et al., 2002).   The effects of substituting this 
nucleotide with a C tested both in vivo and vitro did not affect the activity 
levels of the read-through stop signals in this particular group (Skuzeski et 
al., 1991; Harrel et al., 2002).  If this read-through stop signal in p104 was 
indeed functional, large amounts of a 40 kDa (p40) protein would be 
translated as well as small quantities (approximately one tenth to one 
twentieth relative to p40) of a read-through product with a predicted 
molecular weight of 104 kDa (p104).   
 
2.3.3.a.  Bioinformatic analysis of the PrV replicase ORF 
 
Based on the prediction that PrV replicates in the cytoplasm, a search was 
conducted for the consensus sequence of the enzymatic domains of a RNA 
helicase and guanylyl- and/or methyltransferase and proteases activities in 
the p104 amino acid sequence.   Only an RdRp catalytic domain in the C-
terminus of this coding sequence was positively identified.  Consensus 
sequences of the additional enzymatic domains normally associated with 
(+)ssRNA viruses that replicate in the host cytoplasm are apparently 
absent.  The carmo-like viruses of supergroup II are the only group of 
(+)ssRNA viruses that do not contain other additional motifs besides the 
essential RdRp (reviewed in van der Heijden and Bol, 2002).  By inference 
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PrV could be loosely classified within the carmo-like supergroup based on 
the lack of additional enzymatic domains within the replicase coding 
sequence.   These motifs are also absent in the replicases of two other 
betatetraviruses, namely TaV and EeV (Gorbalenya et al., 2002).   
 
2.3.3.b. Identification of the RdRp domain and its conserved motifs in   
p104  
 
Initial analysis of the PrV genome involved confirming the sequence of the 
replicase ORF and presence of motifs A - C encompassing the core RdRp 
domain as originally stipulated by Poch et al. (1989), as well as the semi-
conserved motif G (Koonin, 1991).  The core motifs were found to have the 
same permuted arrangement as discovered in two other members of the 
genus Betatetavirus, as well as in certain dsRNA viruses (Gorbalenya et 
al., 2002).  The core motif arrangement in the amino acid sequence of 
p104, the replicase, is as follows: C (721 - 723) - A (755 - 761) - B (774 - 
783), with the numbers in brackets corresponding to the amino acid 
position within the p104 coding sequence (Figure 2.2).  The D motif, if 
present in the RdRp domain of PrV, lacks a conserved sequence, and it 
has been reported that this motif is not always readily recognizable in RNA 
viruses (Gorbalenya et al., 2002).   
 
The putative G motif [547SDPETNLPIVAKG559] is not highly conserved and 
overlaps with the second of the two K residues (underlined in the sequence 
above) that usually flank this particular motif (Figure 2.2) (Gorbalenya et al., 
2002).  The putative motif found in the PrV RdRp domain, although 
divergent, is likely a G motif, since conservation of amino acids 
downstream of this stretch of amino acids is very similar to the two type 
members of the birnaviruses as annotated by Gorbalenya et al. (2002).  
Motif G in PrV is also situated an additional 35 amino acids upstream of the 
C motif, relative to the same motif positioning in the Birnaviruses, TaV and 
EeV (Figure 2.2) (Gorbalenaya et al., 2002), possibly leading to a new 
structural variant of the palm, fingers and thumb model of the RdRp protein 
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in its tertiary structure state or an evolutionary footprint, where the motif is 
not functional within the RdRp domain. 
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Figure 2.2.  The permuted motif arrangement in the PrV RdRp aligned to that of the 
tetraviruses EeV and TaV, the birnaviruses, IBDV and IPNV and the tombusviruses, 
TBSV and PCRPV.  The A – C and G motifs of EeV, TaV, IBDV and IPNV are indicated 
by the black boxes and the same motifs in PrV, using blue boxes.  Motifs A-C of TBSV 
have been boxed in green. The same motifs in PCRPV have not been labelled due to high 
sequence divergence in this virus and little literature to support the identification of the 
RdRp domain in this putative replicase ORF.  “*” refers to an exact match of amino acids in 
the alignment column; “:” refers to conserved substitutions in the column and “.” refers to 
semi-conserved substitutions in the column.  IPNV:  Infectious Pancreatic Necrosis virus.  
IBDV:  Infectious Bursal Disease virus.  The alignment was generated, under default 
parameters, using the ClustalW program.  
 
 
 
2.3.4. Evolutionary relationships between PrV and other tetraviruses 
 
BLASTn analysis of the nucleotide sequence of p130, p40 and full length 
p104 revealed no significant matches in the database.  The capsid 
precursor protein was analysed by submitting amino acid sequence starting 
at Pro123 (the proline residue after the second 2A-like processing site) of 
the p81 ORF and extending to the final amino acid of the coding sequence.  
BLASTp analysis of the capsid precursor sequence showed significant 
sequence homology with the other tetravirus capsid precursor ORFs, as 
was expected based on the results achieved by Pringle et al. (2003).  
Pringle et al. (2003) analysed the same stretch of protein using the GAP 
program within the GCG software package and a comparison of results in 
this study using BLASTp  vs. this earlier publication remain virtually 
unchanged.  The E-values and percentages calculated in this study are 
updated by the inclusion of the EeV and DpTV capsid precursor 
sequences.  Percentage identities recorded in descending order of 
significant homologies were:  DpTV (38 %); HaSV (36 %); NωV (35 %); 
TaV (26 %), NβV and EeV (25 %).   The accession numbers of the proteins 
used in this analysis are listed in Appendix 5.   
 
Although PrV is considered a betatetravirus based on its moncistronic 
genome, subgenomic copy of the capsid precursor and outer capsid 
particle appearance (Fauquet et al., 2005), its capsid precursor sequence 
has a higher percentage identity with the omegatetraviruses versus the 
betatetravirsuses (36.3 % vs. 25.3 %; n=3).  The implications of this 
ambiguous capsid precursor sequence conservation between species of 
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two genera are discussed later in light of phylogenetic analysis of these 
particular sequences.    
 
Analysis of the amino acid sequences of p130 and p40 using BLASTp 
revealed no significant similarity to any non-redundant amino acid 
sequence in the database.   Similar analysis of p104 revealed significant 
homologies with the replicase proteins of members of the (+)ssRNA virus 
families, Umbraviridae and Tombusviridae (Table 2.1).   
 
Table 2.1.  Comparison of the PrV p104 replicase amino acid sequence with the ten 
most homologous individual sequences (either replicases or putative replicases, 
and regions thereof) in the database   
 
Protein (and 
accession 
number) 
Virus species (and family) Percentage 
identity 
E-value Score 
(Bits) 
Replicase 
(YP05295.1) 
Pelargonium chlorotic ring 
pattern virus (tombusvirus) 
26 3 x10 -30 138 
RdRp 
(NP619714.1) 
Groundnut rosette virus 
(umbravirus) 
24 3 x10 -30 137 
RdRp 
(AAB81639.1) 
Carrot mottle mimic virus 
(umbravirus) 
26 4 x10 -30 137 
89K protein 
BAG13035.1 
Melon necrotic spot virus 
(tombusvirus) 
26 4 x10 -28 130 
P111 
(ACA57840.1) 
Maize chlorotic mottle virus 
(tombusvirus)  
26 1 x10 -27 129 
p84 -putative 
RdRp 
(NP619751.1 
Oat chlorotic stunt virus 
(tombusvirus) 
26 2 x10 -27 129 
RdRp 
(ABV66257.1) 
Opium poppy mosaic virus  
(umbravirus) 
25 2 x10 -27 128 
RdRp 
(NP733848.1) 
Tobacco bushy top virus 
(umbravirus) 
24 5 x10 -27 127 
Putative 
replicase 
(NP619718.1) 
Maize chlorotic mottle vein 
virus (tombusvirus) 
26 5 x10 -27 127 
RdRp 
(AAU20330.1) 
Pea enation mosaic virus-2 
(tombusvirus) 
26 1 x10 -26 126 
 
 
Interestingly, the first 100 significant identities originate from the sequence 
of replicase proteins belonging to (+)ssRNA plant viruses.  In particular, all 
of these plant viruses are grouped into the families Umbraviridae and 
Tombusviridae.  Regions of high conservation exist between the PrV 
replicase and these plant virus replicases, and the significance of the 
conservation is substantial with up to 500 amino acids of sequences 
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aligned to a significant percentage of similarity.  The RdRp region of p104 
showed significant conservation with the RdRp domains of all of the ten 
most similar sequences.  To measure the similarities of the amino acid 
sequence of only the RdRp domain of p104 PrV replicase with protein 
sequences in the database, the 292 amino acids of the RdRp sequence, 
located from amino acids 533 - 827 of the replicase protein was submitted 
to BLASTp for analysis (Table 2.2).   
 
Table 2.2.  Comparison of the PrV RdRp domain amino acid sequence with the five 
most homologous individual sequences in the database   
 
Protein (and 
accession 
number) 
Virus species (and family) Percentage 
identity 
E-value Score 
(Bits) 
p89 
(BAB82513.1) 
Melon necrotic spot virus 
(tombusvirus) 
28 2 x10 -19 100 
RdRp 
(AAB81639.1) 
Carrot mottle mimic virus 
(umbravirus) 
25 3 x10 -19 99.8 
87 kDa 
replicase 
protein 
(YP052925.1)  
Pelargonium chlorotic ring 
pattern virus (tombusvirus) 
27 1 x10 -18 97.6 
p84 
(NP862835.1) 
Pea stem necrosis virus 
(tombusvirus)  
27 3 x10 -18 96.3 
p87 
(ACF35783.1) 
Pelargonium line pattern 
virus (tombusvirus) 
26 5 x10 -18 95.5 
 
 
As observed in the BLASTp analysis of the whole protein, significant 
conservation between the PrV RdRp domain and sequences in the 
database was only observed with the RdRp domains and replicases (or 
predicted replicases) of other (+)ssRNA plant viruses belonging to the 
Umbraviridae and Tombusviridae.  Reshuffling of the PrV RdRp permuted 
sequence into a classical linear A-B-C motif arrangement, achieved by 
relocating amino acids 755 - 802 (motifs A and B) between amino acid 705 
and 706 (before the C motif), did not increase the bias of the amino acid 
homology between this RdRp domain and other insect or animal virus 
RdRp/replicase sequences in the database. Moreover, this reshuffling only 
decreased the score and E-value of the alignments with other plant virus 
RdRp domains, which is significant since the plant viruses showing 
greatest homology with the PrV RdRp domain do not exhibit motif 
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permutation as observed here in PrV and a select number of animal dsRNA 
viruses (Gorbalenya et al., 2002).  
 
 
2.3.5. Phylogenetic analysis of the RdRp domain and capsid 
precursor protein versus other related (+)ssRNA viruses  
 
The genetic diversity of PrV is so far very evident, based on factors such as 
a significant replicase sequence identity with both the full length replicases 
and RdRp domains of (+)ssRNA plant viruses, in particular the Tombus- 
and Umbraviridae (Tables 2.1 and 2.2) versus the minimal conservation 
observed with the homologous gene sequences of other beta- or 
omegatetraviruses.  To further characterise this apparent divergence, 
phylogenetic analyses of both the capsid precursor and replicase gene of 
PrV versus the analogous sequence in other tetraviruses and a proposed 
phylogenetic outlier, Cricket paralysis virus (CrPV), were conducted using 
ClustalW, and phylograms generated from these aligned sequences using 
the neighbour-joining tree builder, TreeView (Figure 2.3).   
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
Figure 2.3.  Phylogram of aligned tetravirus capsid precursor sequences.  The capsid 
precursor amino acid sequences of NωV, NβV, DpTV, PrV, TaV, EeV and structural protein of 
the genetic outlier, CrPV, were aligned in ClustalW and a phylogram generated by the 
progam, TreeView using a gap extension penalty of 2 and gap creation penalty of 8.   The 
phylogenetic distance of each sequence is represented next to the sequence name and the 
distance scale in the bottom left corner of the phylogram.  Bootstrap values are indicated at 
the nodes of each branch  The positon of PrV is indicated by the arrow. 
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The position of these viruses based on their phylogentic relationships 
suggested that PrV probably evolved as an ancestral offshoot from the 
omegatetraviruses.   It can be argued that the two betatetraviruses, EeV 
and TaV, co-evolved from a common unidentified ancestor, and that the 
two omegatetraviruses, NωV and DpTV, have only recently diverged from a 
comon ancestor ‘younger’ in phylogenetic terms than both HaSV and PrV.  
This data suggests that capsid precursor gene of PrV has not evolved as 
recently from an ancestor or intermediate relative to NωV and DpTV.    The 
bootstrap values generated from this particular phylogram do support this 
hypothesis, with the branch arrangement in Figure 2.3, the most probable 
genetic relationship between the capsid sequences used in this study 
under the stringencies stated.  This is reflected by the 100 % (1000 out of 
1000) confidence levels in the clustering predicted in this phylogram.  This 
data only represents a phylogenetic model of the evolutionary relationships 
of these six tetraviruses and does not take into account the divergence of 
other sequence information in these candidates or the possible 
relationships with other unsequenced tetraviruses.   
 
The RdRp domain, rather than the entire diverse replicase sequence of 
PrV, was analysed in a comparable manner.  Using the minimal RdRp 
sequence defined by Gorbalenya et al. (2002) to align and analyse TaV, 
EeV, IBDV and IPNV RdRp motifs, the 292 amino acids of RdRp domain 
located from amino acids 533 - 825 of PrV p104 were used to analyse the 
phylogenetic relationship of PrV relative to these other RdRp sequences.  
The RdRp sequences of HaSV and NβV were added to the alignment as 
well as an evolutionary outlier, CrPV.  The equivalent region of the 
replicase gene of Pelargonium chlorotic ring pattern virus (PCRPV) was 
also used in this phylogenetic analysis because of its known conservation 
with the RdRp sequence of PrV.  
 
Since the other RdRp sequences used in the analysis are not permuted, 
the A, B and C motifs were identified and an equal number of amino acids 
included upstream and downstream of the core domain resulting in a ~400 
amino acid RdRp-containing sequence.  The RdRp motif sequences of 
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IBDV, IPNV, TaV, EeV, PrV, PCRPV, HaSV, NβV and CrPV were aligned 
using ClustalW and the phylogram generated using TreeView and the 
neighbour-joining (N-J) method (Figure 2.4).  The phylogenetic relationship 
between the nine RdRp amino acid sequences revealed a complex 
relationship between the sequences, as well as some surprising 
implications on the evolutionary branches and distances between these 
viruses (Figure 2.4).   
    
 
 
Figure 2.4.  Phylogram of aligned RdRp sequences of tetraviruses, two 
birnaviruses, CrPV and the related PCRPV.  The RdRp amino acid sequences of HaSV, 
NβV, PrV, TaV, EeV, IPNV, IBDV, PCRPV and CrPV were aligned in ClustalW and a 
phylogam generated using the program, TreeView.   The phylogenetic distance of each 
sequence is represented next to the sequence name and the distance scale in the bottom 
left corner of the phylogram.  Bootsrap values are indicated at the nodes of each branch. 
The positon of PrV is indicated by the arrow.   
 
 
Based on this data, it appears that CrPV does indeed serve as a 
phylogenetic outlier as its position falls outside all smaller branches of the 
phylogram.  As previously predicted (Gorbalenya et al., 2002), the RdRp 
domains of TaV and EeV are phylogenetically closely related and have 
possibly diverged at the same time from a common ancestor.  When 
aligned with these particular nine sequences, IBDV and IPNV are also 
closely related, although IBDV is more similar to EeV and TaV, than IPNV 
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is.  Variations with the input data such as gap extensions and gap opening 
penalties, sequence length and number of sequences submitted produced 
very similar phylograms, adding confidence to these predictions and adding 
weight to the suggestion that IBDV might have an evolutionary intermediate 
and is ‘younger’ in evolutionary terms than the closely related IPNV (Figure 
2.4).  Bootstrap values generated for this phylogram support the clustering 
of each clade with high percentiles of confidence.  More information is 
required to accurately cluster the PrV and PCRPV vs. the permuted RdRp 
predecessor (which gave rise to EeV, TaV, IBDB and IPNV) since the 
confidence levels at this branching is only 65 %.  The lower bootstrap 
support value for this particular branch is most likely a result of the 
inclusion of a linear RdRp motif sequence showing high overall sequence 
similarity with PrV at the cost of large gap creations in the sequence.   This 
outcome could be the result of the specific sequences chosen in this 
alignment, since it does not consider the greater genetic variation in the 
p104 coding sequence and the rest of the PrV genome, nor the possibility 
of convergent evolution, with particular reference to the PrV/PCRPV 
relationship.  Importantly, this analysis shows that the RdRp regions of PrV 
and PCRPV are very similar and, relative to the other sequences submitted 
in this alignment, are ‘older’ in evolutionary terms than the more recently 
diverged TaV and EeV RdRp sequences.   
 
 
2.3.6. Post-translational modification and processing of PrV proteins 
 
Autoproteolytic cleavage 
 
The mechanism of autoproteolytic cleavage of the omegatetravirus capsid 
protein precursor into the large and small capsid proteins has been well 
characterized (Agrawal and Johnson, 1995; Gordon et al., 1999; Canady et 
al., 2000; Taylor et al., 2002).  The event occurs late in the virus lifecycle 
resulting in the maturation of the provirion into the mature virion following a 
decrease in the pH of the surrounding environment (Canady et al., 2000; 
Tomasicchio et al., 2007).  In PrV, the same autoproteolytic event occurs 
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within the p68 capsid protein to produce the large (p60) and small (p8) 
capsid proteins, between the amino acids Asn679 and Phe680, resulting in 
the 60 and 8 kDa major and minor PrV capsid proteins, respectively  
(Pringle et al., 2003).  Attempts to increase the relatively low percentage of 
autoproteolytic cleavage of the PrV capsid precursor protein in purified 
virus preparations by decreasing the pH of buffered particles did not result 
any increased cleavage activity (data not shown). 
   
2A-like co-translational processing 
 
Three 2A-like ‘cleavage’ sites were identified in the PrV genome (F.M. 
Pringle and L.A. Ball, unpublished data; Luke et al., 2008).  The first is 
between amino acids 123 - 131 of the N-terminal of p130; and the second 
and third between amino acids 46 - 53 and 115 – 122, respectively, of the 
N-terminal of p81. If these sites were active, the predicted p130 theoretical 
protein would be processed into 17 and 113 kDa peptides, and if both 
processing sites within p81 were active the capsid protein precursor would 
be cleaved into 5.8 (p6), 7.5 (p8) and 68 kDa (p68) proteins.  The 
identification of these co-translational processing signals was based on the 
minimum conserved signal of the six amino acids DxExNPG↓P, as initially 
defined in the picornavirus FMDV by Ryan & Drew (1994).  Table 2.3 lists 
the sequence of the 2A-like processing sites found in PrV and other 
tetraviruses, and their predicted activities in vitro (Donnelly  et al.,  2001b; 
Luke et al., 2008). 
 
Table 2.3.  2A-like processing sequences in tetraviruses  
 
Virus and ORF Annotation Sequence Activity 
 PrV – p130 PrV-2A1 123GDVESNPGP132 ~99 % 
PrV – p81 PrV-2A2 43GDIEKNPGP52 ~94 % 
PrV – p81 PrV-2A3 115GDVEKNPGP124 ~99 % 
TaV – p82 TaV-2A 148GDVEENPGP157 ~99 % 
EeV – p83 EeV-2A 142GDVEENPGP151 ~99 % 
Key:  Highly conserved nucleotides within the sequence are highlighted. The amino acid 
number in the coding sequence is noted in subscript for the first and last amino acids in 
the consensus sequence.   
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PEST-like sequences and rapidly degraded proteins 
 
The N-terminal 2A-like cleavage products of the capsid protein precursor, 
p81 (p6 and p8), contain a high percentage of Pro, Glu, Ser and Thr amino 
acids in a consolidated stretch, referred to as a PEST-like sequence 
(Rogers et al., 1986).  This entire non-structural coding sequence begins at 
the translational start of p81 and ends at the second 2A-like processing site 
(Gly123) found within the capsid protein precursor sequence.   This peptide 
stretch (p13) has a predicted molecular weight of 13.4 kDa because the 
first 2A-like cleavage site (PrV-2A2) in p81 has been shown to exhibit a 
lowered activity in vitro (Luke et al., 2008).  Thus instead of the p6, p8 and 
p68 proteins being processed, only a p13 and p68 protein are predicted to 
result from a single processing event arising from the PrV-2A3 sequence.    
p13 is located in a similar position on the PrV genome as are the PEST-like 
sequences found at the N-termini of the capsid precursor of certain 
tetraviruses (Hanzlik et al., 1995; Pringle et al., 1999).   
 
The N-terminal sections of the capsid protein precursor of HaSV and PrV, 
(and to a lesser extent, TaV and NωV) have high percentages of Pro, Glu, 
Ser and Thr amino acids relative to other amino acids in this peptide stretch 
(Hanzlik et al., 1995; Pringle et al., 1999; 2003).  It is proposed that 
peptides containing large numbers of these amino acids are labile and 
often rapidly degraded by proteolysis (Rogers et al., 1986; Reichsteiner 
and Rogers, 1996).  The online program, PESTfind (based on criteria set 
by Rogers et al., 1986) calculates the likelihood of “PEST-like proteins”.  
Analyses of the PEST-like sequences of DpTV, HaSV, NωV, TaV and PrV 
assigned PrV the highest score the five sequences (15.87 obtained for 
amino acids 23 – 34 of p13), and predicted a potential PEST-like sequence 
from amino acids 25 - 48 of this same peptide stretch, based on its score 
and amino acid composition.  Analyses of analogous peptide stretches of 
the capsid protein precursor of NωV, and the p17 peptides of HaSV, DpTV 
and TaV, predicted potential PEST-like sequences in HaSV and DpTV in 
similar positions to that found in PrV.  These PEST-like sequences attained 
scores of 7.16 and 15.14, respectively while analyses of NωV and TaV 
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were predicted to contain poor PEST-like sequences, attaining scores of 
just 1.66 and 0.95, respectively.   
 
According to comparisons of potential PEST-like sequences in other 
proteins, the scores achieved by the peptide stretches analysed in HaSV, 
and in particular, PrV, are considered to be significant.  A score of 15.87 
places the PrV peptide as one of the highest ranking PEST-containing 
sequences relative to other labile eukaryotic proteins, such as the 
transcription factor c-fos, calpain large subunits and the heavy subunit of 
the neurofilament to name a few (Carillo et al., 1996).   The functions of 
these PEST-like peptides in tetravirus biology are unknown, although 
Hanzlik et al. (1995) speculated that the PEST-like protein in HaSV (p17) 
might be a movement protein and play a regulatory role in the lifecycle of 
tetraviruses. 
 
Phosphorylation of replication proteins 
 
Based on other reports of functionally essential phosphorylation of 
tombusvirus auxiliary and replicase proteins in vivo, (Shapka et al., 2005; 
Jakubiec et al., 2006; Jakubiec and Jupin, 2007) the NetPhos program was 
used to predict regions within the amino acid sequence of  the p104 ORF 
showing a high probability (> 0.95) of being phosphorylated in the 
eukaryotic cellular environment.   
 
The analysis of possible sites of phosphorylation of the p40/p104 amino 
acid coding sequence showed two potential regions of phosphorylation – 
one region on the very N-terminal of the p40/p104 coding sequence, and 
the other situated over the RdRp domain of p104 (Figure 2.5).  It was 
predicted that a total of thirteen serine residues and one threonine residue 
in p104 are phosphorylated in vivo.  p40 alone contained seven of these 
serine residues predicted to be phosphorylated at probabilities greater than 
0.95, with four of these residues concentrated in a region spanning amino 
acids 6 - 33 of the p40/p104 coding sequence (Figure 2.5).  
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Figure 2.5.  Predicted phosphorylation sites for amino acids of the p40/p104 coding 
sequence.  Each site of phosphorylation is annotated by a single amino acid code letter 
and its amino acid number relative to the p104 coding sequence.  The region at the N-
terminus of p40 containing seven predicted phosphorylated serine residues is indicated by 
the horizontal green bar.  The A - C and G motifs of the RdRp are labelled on the p104 
coding sequence as a reference point.   
 
 
 
2.3.7. Identification of potential nuclear import/export signals, RNA 
binding motifs and subcellular localization and targeting 
signals on p104 
 
As discussed in Section 1.3.4 of the literature survey, all known RNA-
dependent RNA polymerases require host subcellular membranes to 
anchor themselves and efficiently replicate the viral genome (Buck, 1996; 
Ahlquist, 2002).  Based on this prediction, various online bioinformatic 
programs and algorithms were used to predict and search for potential sites 
required for subcellular localization and any potential membrane or 
organelle-targeting sequences.  Analysis of the predicted p104 amino acid 
sequence using TargetP v. 1.1 revealed no mitochondrial, chlorotic or 
secretory pathway signal peptide sequences and no predicted subcellular 
localization.  The same result was obtained using the program 
WoLFpSORT, which predicts and scores potential eukaryotic subcellular 
localization of peptides and proteins.  The program MitoProt II v1.101, 
which predicts mitochondrial targeting, was used to analyse the p104 
coding sequence for the prediction of targeting of this coding sequence, but 
no such targeting sequences were found.   
 
Next NetNES (v1.1), a program that identifies nuclear export signals was 
used in the analysis of p104.  No significant stretch of amino acids could be 
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found which would make up a probable nuclear export signal.  In case an 
artefact localization signal, such as a plant peroxisome targeting sequence 
(PTS) was present, the program ‘The PTS1 predictor’ was used.  No PTS 
signal and thus, no targeting of p104 to the peroxisome, was predicted 
using this program.    
 
The presence of potential RNA binding motifs within p104 was investigated.  
All tombusviruses have an RNA binding motif, termed the RPR motif that is 
highly conserved amongst members of the family (Panviene et al., 2003).  
The sequence of this arginine/proline rich motif is Rx3Px2Rx2Rx2Rx3P 
(Rajendran and Nagy, 2003) with the number of arginine residues (stated in 
superscript) in this sequence found to be optimal for tombusvirus genome 
replication (Panaviene et al., 2003).  No such RNA binding domain was 
found in the predicted amino acid sequence of p104.  This adds motivation 
for the experimental testing for any internal replication elements such as 
RNA or auxiliary recognition elements PrV p104. 
 
2.3.8. Identification of transmembrane helices in p104 and p130 
 
Although initial analyses of p40 and p104 did not reveal any obvious 
membrane or organelle targeting signal, the prediction of transmembrane 
helices within the secondary structure of these protein sequences could 
indirectly signify a subcellular localization as well reinforcing the theory that 
these replication-related proteins are both intimately associated with a 
(subcellular) membrane. 
 
Two different online programs were used in the analysis of p40/p104 for the 
presence of transmembrane helices.  The first program, SOSUI engine v. 
1.11 (Hirokawa et al., 1998), predicted two such transmembrane helices.  
The first transmembrane helix present in p40/p104 is 23 amino acids in 
length and spans from amino acids 225 - 247 of p40/p104 (Figure 2.6).  
The second such transmembrane sequence is 22 amino acids in length 
and lies in the C-terminal half of the read-through portion of p104 spanning 
amino acids 644 - 665 of p104.   The prediction implies that p40 is 
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membrane-associated and that the N-terminal half of the protein is 
cytoplasmic, while the C-terminal section should be located on the other 
side of the theoretical membrane and is hydrophilic (Figure 2.6).   
 
 
 
 
Figure 2.6.  Position of the predicted hydrophilic and hydrophobic domains of 
p40/p104 in relation to probable sites of phosphorylation.  The diagram shows the 
relative position of stretches of the p40/p104 protein relative to a theoretical lipid bilayer.  
The amino acid stretch of each transmembrane helix is annotated at either side of the lipid 
bilayer and the length of each stretch is represented to scale.  The A - C and G motifs of 
the RdRp are labelled on the protein sequence as points of reference for the RdRp. The 
annotation of the phosphorylation sites remains unchanged from Figure 2.5.  RTSS refers 
to the Read Through Stop Signal.   
 
If the N-terminus of p104 membrane-spanning sequences are indeed 
functional, then this region of p104 will theoretically be membrane-
associated.  An internal hydrophobic loop from amino acids 248 to 643 is 
predicted to be situated on the other side of the theoretical membrane and 
the remaining 259 amino acids (656 - 915 of p104) resurface into the 
cytoplasm (Figure 2.6).  This suggests that a C-terminal third of p40 is 
membrane-associated while more than 40 % of p104 is membrane 
associated, although the RdRp domain at the C-terminal is exposed to the 
cytoplasm as to be expected.  The putative G motif would be positioned 
within the lumen of the theoretical organelle raising questions regarding the 
annotation of the G motif in this sequence since the motifs of an RdRp 
interact in close proximity with each other and presumably not across a 
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lipid bilayer.  The predictions of these two transmembrane stretches within 
p40/p104 were confirmed using the program TMPred (Hoffman and Stoffel, 
1993).  The scores calculated for these two transmembrane stretches using 
the TMPred programme were 2068 (a.a 225-247) and 1638 (a.a. 644-655) 
where a score of over 500 is considered statically relevant.   Analysis of 
p130 using both programs revealed that the protein is predicted to be 
completely hydrophilic and thus soluble in the cellular environment, 
containing no transmembrane helices in its amino acid sequence.    
 
 
2.3.9. Secondary structure of the 5`- and 3`-UTR of the PrV 
genome 
 
Secondary structure in vRNA has been shown to play essential, varying 
roles in the replication and recognition of replication-related proteins.  
Gordon et al. (1999) demonstrated that the 3`-UTR region is folded into a 
clover-leaf tRNA-like structure in both NβV and HaSV, and even went on to 
suggest that the sequences play a telomeric role and conserve critical 
information on the terminal sequence by protecting it from exonuclease 
activity.   PrV lacks a tRNA-like cloverleaf secondary structure of its 3`-UTR 
and does not contain a poly-A sequence (F.M. Pringle and A. Ball pers. 
comm., 2005).  To confirm this apparent lack of significant secondary 
structure formed by the PrV 3`-UTR, the folding of the nucleotide sequence 
of this region was analysed using the MFold program.  The program was 
used to predict the secondary viral RNA structure of the 3`-UTR of PrV (nts 
6043-6155).  Using the default parameters suggested by the program 
creators found to produce optimal secondary RNA structures, the following 
structure (Figure 2.7) was predicted to be the most energy-efficient natural 
form of this region.  
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Figure 2.7.  The predicted secondary structure of the PrV 3`-UTR.  This structure was 
generated using the MFold program with parameters set at predicting a structure requiring 
the least amount of energy - a Gibbs free energy (dG) value of -30.64 kcal/mol.   
 
 
The structure of the 3`-UTR predicted by MFold measured a degree of 
secondary structure in this particular region.  However, these structures 
were not analogous to the tRNA-like conserved structures of the 3`-UTR 
present in both RNA1 and RNA2 of HaSV (Gordon et al., 1995; Hanzlik et 
al., 1995) or NβV (Gordon et al., 1999).  Furthermore the loop regions 
generated by MFold show no homology to the conserved sequences of 
HaSV and NωV originally by Gordon et al. (1995), nor with the later addition 
of supporting data within the same region of NβV (Gordon et al., 1999).  
The large loop structures shown in the bottom left (nts 80 – 121 of 3`-UTR 
sequence), and to a lesser extent, the top right (nts 5 – 116) are not small 
or structurally stable enough to fold into the tRNA-like structures detected 
in particular tetraviruses although the two smaller loops (nts 6 - 17 and 57 – 
64) could be considered as hairpin-like structures (Figure 2.7). 
 
The PrV genome is unusual in that the first functionally identifiable ORF 
(p104) starts more than 1000 nts from the start of the genome.  Although 
the p130 ORF is predicted to be translated at the most 5` ORF, its 
presence and role has yet to confirmed in PrV.  The first 1026 nts were 
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analysed using the MFold program, for secondary structures that might 
indicate the presence of an IRES.  Again, the suggested default 
parameters were used and the overall secondary structure predicted in this 
region is displayed in Figure 2.8, panel A.   
       
 
 
Figure 2.8.  IRES secondary structures in the 5`-UTR of (+)ssRNA viruses. (A):  
Prediction of the secondary structure of the first 1026 nucleotides of the PrV genome This 
structure was predicted, using the MFold program with parameters set at a structure 
requiring the least amount of energy - a Gibbs free energy (dG) value of -95.36 kcal/mol. 
The p104 and p130 translational starts are indicated by arrows leading on from nt 1036 
and 44, respectively.  (B):  A simplified diagram of the HCV IRES secondary structure 
(taken from Collier et al., 2002).  Sequence and secondary structure of the HCV IRES 
within nucleotides 1 - 362 of HCV genotype 1a.  The number and orientation of these 
stem-loop structures are found in both HCV and Cholera swine fever virus (CSFV) and can 
be related to other viral IRES structures (Baird et al., 2006).  The large box shows the 
predicted binding site of eIF3, while the smaller rectangle is positioned over a conserved 
bulge structure that is essential for initiation of translation mediated by an IRES (Collier et 
al., 2002).    
 
 
Again, this particular stretch of nucleotide sequence exhibited a degree of 
secondary structure.  When compared to the secondary structures often 
associated with IRES such as the well-characterized IRES of Hepatitis C 
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Virus (HCV) (Figure 2.8, panel A vs. B), it is evident that this entire stretch 
of sequence does not contain the finer stem-loop structures and bulges 
associated with an IRES.  Also, the basic pattern of stem-loop structures 
often modelled from viral IRES sequences is absent.  The IRES sequences 
in members of the Dicistroviridae are divergent in both sequence and 
structure relative to other viral IRES sequences, although functionally 
important similarities do exist (Sasaki and Nakashima, 1999; reviewed in 
Sarnow, 2003).  Using the MFold program, no obvious IRES-like secondary 
structure was predicted in the first 1026 nt of the PrV genome. This 
prediction, due to the length of the PrV 5`UTR has a theoretical level of 
confidence of approximately 86 %, based on all known base pairing 
combinations recognized by the MFOLD algorhythm.  Further 
characterization of the viral translation products would need to be 
performed in order to indirectly analyse the mechanism of translation 
initiation in this region of the PrV genome and also increase the level of 
confidence in the prediction of the secondary structure in this region.   
 
 
2.4. CONCLUSION 
 
Bioinformatic analysis of PrV has uncovered new information regarding 
sequence homologies, protein processing and modification, RNA structures 
of the long pre-p104 5-` and 3`-UTR, predicted membrane-association and 
finally a preliminary phylogenetic analysis of the replication and capsid 
proteins.  Analysis of the non-structural p130 ORF, yielded little information 
on its predicted function, potential subcellular localization and any post-
translational modification.  Due to the very short leader sequence before 
the proposed translational start of this ORF, no IRES signal is predicted to 
be present at the 5`-UTR.  This is unsurprising since one of the two 
methionine residues with good invertebrate Kozak sequences (Caverner, 
1987; Kozak, 1987), present at the start of the p130 coding sequence, are 
the most likely source of the translational start by the scanning ribosome 
mechanism.   
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The replicase (p40/p104) 
 
The sequence of the predicted replicase protein, p104, showed no 
significant homology with sequences from the database and the RdRp 
motif displayed a permuted motif arrangement as characterized in TaV and 
EeV as well as two birnaviruses.  This permutation was, in itself, unusual in 
that the G motif is not as highly conserved, relative to the consensus found 
in the other permuted domains.  The location of this putatively identified 
motif is more than 163 amino acids upstream of the C motif which differs 
from the ~128 nt of the other analyzed tetraviruses with permuted RdRp 
domains, TaV and EeV.  Also, the transmembrane helices prediction on 
p104 place this motif in the luminal cavity making unlikely that is motif is 
functional since this is dependent on proximal positioning to the other 
motifs of the RdRp.  The significance in the overall tertiary structure and 
thus activity of the PrV replicase, modelled on the identification of the RdRp 
domains, remains to be shown and will be encompassed in future research 
of this protein.  Based on the lack of any identifiable 
guanylyl/methyltransferase or helicase domains, and conservation of the 
RdRp amino acid sequence with (+)ssRNA viruses belonging to the carmo-
like supergroup, the PrV RdRp should be categorized in the carmo-like 
virus supergroup. 
 
In terms of the predicted subcellular localization of p40 and p104, no 
obvious subcellular targeting or import/export signal could be detected 
using available programs.  Two transmembrane helices were predicted to 
occur within p104, one of which is located in p40, suggesting that both 
might be intrinsically anchored to a subcellular membrane.  This 
characteristic has been experimentally proven for many tombusvirus 
auxiliary and replicase proteins (Rubino and Russo, 1998; Navarro et al., 
2004).  The predicted hydrophobic region of p104 potentially situated in the 
lumen of an organelle is quite large and it is surprising that p40 has only 
one transmembrane helix since two tombusviruses, Cymbidium ringspot 
(CymRSV) and Carnation Italian ringspot viruses (CIRV) have two helices 
(Rubino and Russo, 1998).   In the case of CymRSV, only 7 kDa of the 
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auxiliary protein is anchored into the peroxisomal membrane (Navarro et 
al., 2004).  The lack of any obvious subcellular targeting signal has also 
been found in the analyses of various tombusvirus replication proteins, in 
particular CymRSV and CIRV (Rubino and Russo, 1998).   
 
Localization of the replication proteins of tombusviruses involves a 
multistep process with the interaction of the auxiliary proteins, replicase, 
viral RNA and host proteins before targeting of a pre-replication complex to 
a membrane (Rajendran and Nagy, 2006; reviewed by Nagy and Pogany, 
2006).  It is these auxiliary/replicase interaction domains which are also 
thought to play a role in targeting of Tombuvirus replication proteins to 
organelles, although a transmembrane sequence within the CNV p33 
amino acid sequence is also essential for the targeting of p33 (yet not p92) 
to the site of replication (Panavas et al., 2005a).  Due to the complexity of 
the assembly and targeting of the replication complex, one cannot rule out 
the multifunctional nature of these domains and thus the overall effect they 
may have on the functionality and therefore targeting of a pre-replication 
complex to the site of replication. 
 
Although no RNA binding domains were detected within the p104 
sequence, a number of amino acids were predicted to have a high 
probability of being phosphorylated, a well-characterized post-translational 
modification in replication-related viral proteins.   Two regions within the 
p104 sequence were predicted to be phosphorylated – the very N-terminus 
of p40 and the RdRp domain of p104.   Further experimental analysis of 
p40 needs to be performed in order to confirm the phosphorylation of p40 
and possibly p104.  The two are predicted to act together as replication 
proteins in the course of PrV infection, although differences in sequence 
motifs and post-translational modification do exist between p40/p104 and 
other plant virus replication proteins.  It is also predicted that p104 is 
translated by the standard ribosomal scanning mechanism and not by an 
IRES signal located in the 5` region upstream of the p104 translational 
start.   
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The capsid precursor  
 
Much of the sequence identity of the capsid precursor protein of PrV when 
compared to other tetraviral proteins remains unchanged from Pringle’s 
initial assessment (Pringle et al., 2003). The discovery and sequencing of 
the DpTV capsid precursor protein does, however, alter these findings on a 
phylogenetic level.  The capsid precursor protein of PrV shares more 
sequence identity with other omegatetraviruses and is phylogenetically 
most closely related to NωV and DpTV.  Phylogenetically, PrV is positioned 
between the outlier, CrPV and the omegatetraviruses, ultimately showing 
more similarity to the omegatetraviruses than the betatetravirus, in terms of 
its capsid precursor protein sequence.   
 
The analyses reported here have shed light on the potential function of 
many of the predicted proteins translated by PrV, revealing the interesting 
evolutionary history of the replicase (p104).  These results also confirmed 
the greater sequence similarity that the capsid precursor protein has, 
relative to the analogous sequence of omegatetraviruses versus that of 
other betatetraviruses.  In terms of its relatedness to the betatetraviruses, 
the genome organization of PrV, position and size of its RdRp domain as 
well as the presence of a third potential ORF suggest a substantial 
divergence from other members in this genus.  The differences between 
PrV and other members of the betatetraviruses are evident with particular 
reference to the type member, NβV, as well as EeV and TaV, despite the 
presence of a permuted RdRp and 2A-like processing sequence at the N-
termini of the capsid protein precursor ORFs of these two viruses (Figure 
2.9). 
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Figure 2.9.  Genome organization of the betatetraviruses, NβV, TaV and EeV 
compared to PrV.   The 2A-like processing sites are indicated by stars.  The in-frame 
stop codon within the replicase ORF is indicated by the circle containing the strike-through.  
The boxed cylinder in the replicase ORF indicates the RdRp domain, drawn to scale. The 
dashed vertical line in the capsid precursor ORF indicates the site of autoproteolytic 
cleavage of the capsid precursor protein.  The bent arrow indicates the start of 
subgenomic RNA transcription.  The ORFs and UTRs are represented to scale. 
 
 
The initial classification of PrV into the Tetraviridae was based on physical 
characteristics of the capsid, as well as the significant amino acid homology 
of the capsid precursor amino acid sequence with that of other tetraviruses 
(Pringle et al., 2003).  These results add significant weight to the two 
hypotheses that PrV a) has a replication mechanism that utilises an 
auxiliary and full length replicase protein as observed in many (+)ssRNA 
plant virus families and b) is a unique tetravirus in terms of both sequence 
homology and replication mechanisms.  
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CHAPTER 3 
Production of antibodies for the detection of PrV 
translation products 
 
 
3.1. INTRODUCTION 
 
Bioinformatic analysis of the PrV cDNA sequence identified the presence of 
three major ORFs in the PrV genome:  (1) p130, a large ORF of unknown 
function, (2) p104, predicted to be the viral replicase based on the 
presence of a putative RdRp domain and (3) p81, the virus capsid protein 
precursor.  The presence of a read-through stop signal in p104 and 2A-like 
processing sequences in p130 and p81, suggested that PrV might employ 
a unique strategy for regulating the expression of viral gene products.  In 
addition, phylogenetic analysis of the replicase coding sequences raised 
the possibility that the replication of PrV might be different to that of other 
betatetraviruses and the Tetraviridae in general.  The first objective of the 
research described in this thesis was to confirm the annotation of the PrV 
genome and to investigate the co-translational regulation of viral gene 
expression focussing on the viral replicase.   
 
This chapter describes the production of anti-p104 polyclonal antiserum 
using peptides derived from the p104 coding sequence expressed in 
Escherichia coli.   
 
3.2. MATERIALS AND METHODS 
3.2.1. General recombinant methods and bacterial strains   
 
Unless otherwise stated, all gene manipulation methods were performed 
according to Sambrook et al. (1989) and protein analysis as described by 
Laemmli (1970).  Crude extracts and purified proteins were quantified by 
Bradford’s assay (Bradford, 1976) to within 99% accuracy relative to a 
broad range standard linear curve of concentrations of bovine serum 
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albumin fraction V (BSA) and equimolar quantities of protein analysed by 
SDS-PAGE and Western analysis.  Primer sequences used in the PCR 
amplification of sequences are listed in Appendix 1.  The cloning strain of 
Escherichia coli (E. coli) DH5α (Hanahan, 1983) was used for plasmid 
propagation and strain E. coli BL21 (DE3) (B F–ompT hsdS(rB–mB–) dcm+ 
Tetr gal (DE3) endA Hte) (Stratagene) was used for the overexpression of 
the peptides.  The integrity of all PCR amplification products was confirmed 
by DNA sequencing.    
 
3.2.2. Construction of the 6xhis-p104(644-915) bacterial expression 
plasmid pCW21 
 
The bacterial expression plasmid, pCW20 was created by ligating the 
double stranded oligonucleotide AI11 (Figure 3.1 C) into the pT7-7 derived 
vector pRD107R, which had been digested with Xba I and Nde I.  pCW20 
contained an inducible T7 RNA polymerase promoter, ribosome binding 
site (RBS) and a 6xhistidine sequence followed by a methionine residue 
(Figure 3.1 A).  This plasmid also contained the coding sequence for the 
yeast UGA3 gene fused to the 3` end of the 6xhistidine tag.   
 
Amino acids 644 - 915 of the p104 coding sequence were selected for 
overexpression in the E. coli BL21 (DE3) heterologous system.  This 
peptide stretch located at the C-terminus of the p104 protein also contains 
most of the RdRp domain (amino acids 533 – 825). The coding sequence 
was amplified from the cDNA clone of the PrV genome (pFLM1) using the 
primers CW5 and CW6, which introduces a partial Csp451 at the 5` end 
and a Hind III site at the 3` end of the PCR fragment, respectively.    Due to 
the use of a Taq polymerase that created 5` single A nucleotide-overhangs 
in the amplification of a nucleotide sequence, the Csp451 restriction site 
was reconstituted following ligation of the amplicon into the vector pGEM-T 
Easy (Promega). The resulting plasmid, pCW19, was digested with Csp451 
and Hind III and ligated into the pCW20 vector backbone digested with 
Csp451 and Hind III, to create the bacterial expression vector pCW21 
(Figure 3.1 B).   
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Figure 3.1.  Two-step cloning strategy used in the construction of the expression 
vector, pCW21.  Step A:  Creation of pCW20.  Step B:  Creation of pCW21.  OriR:  origin 
of replication, AmpR:  β-lactamase, UGA3p:  yeast UGA3 coding sequence, p27:  p104(644-
915).   C:  Sequence and annotation of the ds oligonucleotide, AI11.  RBS:  ribosome 
binding site.  
 
 
3.2.3. Overexpression and purification of the 6xhis-p104(644-915) 
peptide (p27) 
 
pCW21 was transformed into chemically competent E. coli BL21 (DE3) 
cells. A volume of 2.5 ml of log phase culture was inoculated into 50 ml 
Luria-Bertani (LB) broth in the presence of ampicillin (125 µg/ml) and grown 
with agitation at 37 ºC to an OD600 nm of 0.4. These cultures were induced 
with IPTG to a final concentration of 1 mM for 4 hours at 37 ºC, after which 
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the OD600 nm of 1 ml of culture was recorded and the cells harvested by 
centrifugation at 10 000 g for 5 minutes at 4 ºC.    
 
The cells were resuspended in 1 ml of  ice-cold phosphate buffered saline 
(PBS: 140 mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 1.8 mM KH2PO4) and 
sonicated using a hand-held 3 mm probe (Vibra Cell™) for 20 x 10 second 
bursts, at 20 % power at 4 ºC.  Soluble and insoluble fractions were 
obtained from these crude lysates by centrifugation of sonicated extracts at 
10 000 g for 10 minutes at 4 ºC.  All samples were analysed by SDS-PAGE 
(4% stacking/12 % resolving discontinuous glycine/polyacrylamide gels) 
and protein bands visualised by Coomassie staining of the resolving gel.   
  
3.2.4. Purification of bacterially overexpressed p27 
3.2.4a. Denaturing nickel affinity purification of p27 
 
Denaturing nickel affinity purification using the Qiagen Nickel NTA columns 
was tested on expressed heterologous p27 from the clarified supernatant of 
resuspended, sonicated extracts of induced E. coli BL21 (DE3) transformed 
with pCW21 according to the manufacturers’ instructions. Protein was 
eluted into two fractions of 100 µl each from the spin column using elution 
buffer containing 8 M urea, and then further dialyzed against native 
purification buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 
8) using 10 kDa cut-off dialysis tubing.   
 
3.2.4b. Acrylamide gel peptide purification of p27  
  
Due to insolubility of the peptide, a different protein purification protocol (Dr 
Sharon Braunagel, Department of Biochemistry and Biophysics, Texas A & 
M University, College Station, Texas, USA. pers. comm., 2005) was used 
to gel-purify p27 following SDS-PAGE analysis.  Ten OD600 nm units of E. 
coli BL21 (DE3) cellular pellets containing overexpressed protein were 
heated at 100 ºC in SDS-PAGE sample buffer (10 % glycerol; 125 mM Tris-
Cl pH 6.8; 4 % SDS; 10 % β-mercaptoethanol; 0.01 % bromophenol blue) 
for 5 minutes.  Samples were centrifuged at 14 000 g for 10 minutes at 
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room temperature, the supernatant aspirated from the insoluble pellet and 
analysed by SDS-PAGE analysis (4% stacking/12 % discontinuous 
glycine/polyacrylamide gels).  The samples were electrophoresed for an 
appropriate duration of time and the resolving gel incubated in 100 ml of a 
100 mM solution of ice cold KCl.  After 5 minutes, the localized white bands 
representing the 27 kDa 6xhis-p104(644-915) was excised from the resolving 
gel, finely diced and incubated with agitation at 4 °C overnight in 1 X PBS 
(pH 7.4).   
 
To elute the protein, this supernatant was passed through a 1 ml syringe 
fitted with a 25 gauge needle and a small glass wool plug inserted into the 
neck of the syringe to filter out the acrylamide.  The resultant protein was 
further concentrated and the SDS removed by ethanol precipitation as 
follows: a 1.6 volume of ice-cold ethanol (95 %) was slowly added to the 
filtered suspension in order to further concentrate the protein and remove 
the SDS.  The mixture was allowed to incubate on ice for 1 hour with 
occasional mixing, after which the protein was pelleted by centrifugation at 
10 000 g for 10 minutes at 4 ºC.  The protein pellet was dried and 
resuspended in PBS, pH 7.4 then analysed by SDS-PAGE and detected by 
Western analysis using a monoclonal anti-6xhistidine antibody (Roche 
Applied Science) before quantification by Bradford’s assay (Bradford, 
1976).  For Western analysis, proteins were transferred onto nitrocellulose 
membrane (GE Healthcare) using the Biorad® Mini Trans-blot 
electrophoretic transfer cell system according to the manufacture’s 
instructions.  The membrane was incubated with a 1 in 2 500 dilution of 
monoclonal anti-6Xhistidine antibodies prepared in TBST buffer [Tris-
buffered saline (150 mM NaCl and 50 mM Tris-Cl pH 7.6)] containing 1 % 
BSA and 0.1 % Tween-20.  The membrane was then probed using goat 
anti-rabbit alkaline phosphatase-conjugated IgG, followed by addition of 
substrate according to the manufacturers’ specifications (Roche 
Biosciences) The resultant chemiluminescence was documented by 
exposure to X-ray film. 
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3.2.5. Construction of GST-p104(644-915) 
 
Difficulties with the solubility of the 6xhis-p104(644-915) peptide prompted the 
use of an alternative affinity purification system based on the glutathione S 
transferase (GST) protein.  The fusion protein was created by re-amplifying 
the p27 sequence from the plasmid pCW19 with the oligonucleotides  CW7 
and CW6 which create a Bam HI site and Hind III site on the 5` and 3` of 
this sequence, respectively. The Hind III site was included in the 3` end of 
the selected sequence in order to create an in-frame stop codon 
downstream of the coding sequence.   This amplicon was ligated into 
pGEM-T Easy and the recombinant plasmid (pCW22) sequenced and upon 
confirmation of the insert sequence, digested with Bam HI and Sal I to 
release the p27 coding sequence.  The expression vector pGEX-4T-2 (GE 
Healthcare) (Figure 3.2) was also digested with Bam HI and Sal I and the 
backbone ligated with the Bam HI/Sal I p104(644-915) fragment of pCW22.   
 
 
Figure 3.2.  Cloning strategy used in the construction of the expression vector, 
pCW24.  OriR:  origin of replication, AmpR:  β-lactamase, lacIq:  lactose repressor gene, 
MCS:  multiple cloning site, B-lac:  β-lactamase promoter, p27/RdRp stretch of PrV:  
p104(644-915). 
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This new bacterial expression vector, pCW24, contained the IPTG-
inducible hybrid bacterial promoter, Tac (tryp-lac hybrid), followed by GST 
fused to the N-terminal p104(644-915) coding sequence (Figure 3.2).  The 
sequence of the insert in this expression vector was confirmed.   
 
3.2.6. Overexpression and affinity purification of GST-p104(644-915) 
 
pGEX-4T-2 (GST alone) and pCW24 (GST-p104(644-915)) were transformed 
into E. coli BL21 (DE3) cells and expression of the proteins induced by 
IPTG, as described in Section 3.2.1.  Soluble fractions of induced cell-free 
extracts were analysed by SDS-PAGE.  A 1 ml GSTrap™FF column and 
the AKTA UPC 900/PJ 920 fast performance liquid chromatography (FPLC) 
model and fractionator were used for affinity purification of soluble GST and 
GST-p104(644-915), according to the manufacturer’s instructions (GE 
Healthcare).   
 
3.2.7. Production of anti-p104(644-915) rabbit polyclonal antiserum 
 
A total of 500 µg of purified 6xhis-p104(644-915) protein was used to generate 
anti-p104 polyclonal rabbit antiserum. Antigen complex preparation and 
antibody production was performed by Prof. D. U Bellstedt, Department of 
Biochemistry, University of Stellenbosch, Stellenbosch, Western Cape, 
South Africa as follows: acid-treated naked bacteria (NB) were prepared 
from Salmonella minnesota R595 as described (Bellstedt et al., 1988). A 
fine suspension of NB in water (2 mg/ml) was prepared using an 
homogenizer with a loosely fitting Teflon plunger. A 400 µg amount of the 
antigen, 6xhis-p104(644-915), in a solution of PBS pH 7.4,  was mixed with the 
NB suspension so that the ratio by dry mass of protein to NB was 1 to 5 
(Bellstedt et al., 1987). These mixtures were placed in small pear-shaped 
flasks and taken to dryness by rotary evaporation. The complexes thus 
formed were resuspended at a concentration of 240 µg / 0.5 ml PBS (0.15 
M, pH 7.2) for immunization purposes. 
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The 6xhis-p104(644-915)-antigen NB complexes were used to immunize 
rabbits intravenously into the marginal ear vein (125 - 240 µg per 
immunization). Rabbits were immunized on days 1, 4, 7, followed by 
booster series on days 14, 18 and 21, and again on days 28, 32 and 35. A 
2 ml blood sample was collected on days 1 (as a negative control of all 
subsequent assays) and 28 (as a test bleed to check antibody titres) 
followed by a large bleed on day 42 at which time most antigens elicit a 
strong immune response using this method.   
To test the specificity of the antiserum generated against the 6xhis-
p104(644-915) peptide (referred to here as anti-p104 antiserum), cell free 
extracts of the PrV-infected H. zea midgut cell line MG8 (MG8); the H. zea 
fat body cell line FB33 (FB33) and Spodoptera frugiperda ovarian cell line 9 
(Sf9) were generated and quantified by Bradford’s assay (Bradford, 1976).  
Details on the maintenance of each cell line are given in Appendix 2.  In 
order to generate cell-free extracts from these cell lines, whole cells were 
dislodged from the culture flask, pelleted by centrifugation (5 000 g for 2 
minutes at room temperature), resuspended in PBS pH 7.4 and disrupted 
by passing through a 22 gauge needle 20 times.  Cell-free extracts were 
stored in the presence of the protease inhibitor, 100 µM 
phenylmethylsulphonyl fluoride (PMSF) dissolved in 70 % isopropanol at    
-80 ºC.  Varying amounts of quantified cell-free extracts were analysed by 
SDS-PAGE (4% stacking/12 % discontinuous glycine/polyacrylamide gels) 
and the resolved proteins analysed by Western analysis.   An optimal 
dilution of 1 in 150 000 anti-p104 antiserum in 1 % BSA and 0.1 % Tween-
20 in TBS buffer (Section 3.2.4b) was used. 
 
To eliminate non-specific antibodies, the antiserum was pre-absorbed with 
a cell-free extract of uninfected FB33 cells.  Approximately 300 µg (in 250 
µl) of cell-free extract was mixed with 540 µg (in 250 µl) of anti-p104 
antiserum and incubated with agitation, at 4 ºC overnight.  The mixture was 
then centrifuged at 10 000 g for 30 minutes at 4 ºC and the supernatant 
carefully aspirated into a fresh microfuge tube, discarding the last 
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approximate 50 µl of antibody-protein precipitate.  This pre-absorbed 
antiserum was used at a dilution of 1 in 50 000 in further Western analyses. 
 
 
3.2.8. Baculovirus-mediated expression of 6xhis-p104(1-207) peptide in 
Spodoptera frugiperda (Sf9) insect cells 
 
A recombinant baculovirus was created for the expression of 6xhistidine-
tagged p27 in Spodoptera frugiperda ovarian cell line 9 (Sf9).  The 
insect/bacterial shuttle vector, pCW30, used for the transposition and 
subsequent generation of recombinant viruses was constructed using the 
following multicloning strategy (Figure 3.3):  The primers, CW9 and CW10, 
were created to amplify a 619 nt stretch of the PrV genome (amino acids 1 
- 207 of p104) and in the process introduce NdeI and Hind III restriction 
sites on the 5` and 3` of the fragment, respectively.  This fragment was 
ligated into the commercial vector pGEM-T Easy, sequenced and named 
pCW26.  pCW26 was digested with NdeI and Hind III and the 619 bp insert 
ligated into the NdeI/Hind III-digested backbone of pCW20.  Although the 
resulting plasmid, pCW27, is a complete bacterial expression vector that 
could potentially be used in the expression of this PrV coding stretch, it was 
constructed in order to create a 5`-coding sequence which contained the  
SD – methionine – 6xhistidine cassette originally introduced into the vector 
by insertion of dsDNA oligonucleotide, AI11 (Section 3.2.1.).  A region of 
599 nt (nt 2-661) from pCW27 was amplified using the primers CW11 and 
CW10.  CW10, the complementary primer, was an exact match of the very 
3` sequence of the coding stretch in pCW27, whereas the forward primer 
CW11 introduced a BglII site into the sequence before the translational 
start of the optimized cloning cassette.  This amplicon was ligated into the 
commercial vector pGEM-T Easy, sequenced and named pCW28.  Finally, 
the commercial insect/bacterial shuttle vector pFB DUAL, [containing the 
baculoviral polH and p10 promoters in a bi-directional arrangement 
(Invitrogen™ Life Technologies)] was digested with Bam HI and SacI and 
the backbone ligated with a BglII/SacI insert originating from digested 
pCW28  (Figure 3.3).   
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Figure 3.3.  Multiple step cloning strategy used in the construction of the insect 
expression plasmid, pCW30.  OriR:  origin of replication, AmpR:  β-lactamase, GentR:  
gentamicin resistance gene, HSVtk polyA:  Herpes Simplex virus thymidine kinase poly A 
sequence, p10:  p10 promoter, Polh:  polH promoter, SV40 PolyA:  Simian vacuolating 
virus 40 poly A sequence, B-lac:  β-lactamase promoter, p27: p104(644-915).   
 
The resultant plasmid, pCW30, contained a 6xhistidine-tagged N-terminal 
207 amino acids of p104 under the control of the polH promoter (Figure 
.3.3).  The transformation of pCW30 into E. coli DH10BAC™ cells and the 
subsequent isolation of recombinant bacmid DNA was carried out as 
described in the instruction manual for the Bac-to-Bac® Baculovirus 
Expression Systems from GibcoBRl (Invitrogen™ Life Technologies).  
Confirmation of inserted sequence within recombinant bacmid DNA was 
performed by PCR analysis. The primers, pucF and pucR, were used to 
PCR amplify and confirm the presence of a 273 bp region in unmodified, 
transposed bacmid DNA, a 1980 bp fragment of transposed bacmid DNA 
containing only pFB DUAL and finally, a 2689 bp fragment of bacmid DNA 
containing transposed pCW30. The amplification reactions were prepared 
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using 1 µl of template bacmid DNA and Taq DNA polymerase (Bioline) 
following the manufacturer’s instructions.   The reactions were cycled using 
an annealing temperature of 55 °C and an extension time of 5.5 minutes 
over 30 cycles.  Recombinant bacmid DNA was transfected into Sf9 cells 
and the recombinant baculovirus passaged four times in Sf9 cells following 
the initial transfection of confirmed, recombinant bacmid DNA.   
 
In order to confirm that these viral passages continued to produce active 
recombinant baculoviruses containing the transposed pCW30 cassette, 
PCR analysis was performed on extracted DNA from passage IV.  A total 
volume of 6 ml of high titre recombinant virus was centrifuged at 12 000 g 
for 15 minutes at 4 °C and the pellet resuspended in 100 µl of virus 
disruption buffer (10 mM Tris pH 7.6, 10 mM EDTA and 0.25 % SDS).  
Proteinase K was added to a final concentration of 500 µg/ml and the 
sample incubated at 37 °C until the resuspended pellet appeared 
translucent.   The resuspended pellet was extracted with equal volumes of 
phenol, phenol:chloroform:isoamyl alcohol [P.C.I (25:24:1)], and 
chloroform:isoamyl alcohol [C.I (24:1)].  The first organic phase from the 
phenol extraction was back-extracted in equal volumes of TE buffer (10 
mM Tris-Cl and 1 mM EDTA, pH 8).  The baculovirus DNA was precipitated 
in 205 µl of 3 M sodium acetate (pH 5.2) and 410 µl of ice-cold 96 % 
ethanol.   The DNA was left to precipitate overnight at -20 °C and then 
centrifuged at 12 000 g for 16 minutes at 4°C.  The pellet was washed 
twice with 200 µl of ice-cold 70% ethanol, resuspended in 25 µl TE buffer 
and stored at 4 °C.   
 
PCR analysis of extracted recombinant baculovirus DNA was performed 
using the primers CWF3, which anneals 4583 - 4607 bp and polR, which 
anneals to 5390 - 5415 bp of pCW30.   PCR amplification would produce a 
883 bp fragment from the recombinant baculovirus genomic DNA, while 
control bacmid DNA containing unmodified, transposed pFB DUAL would 
produce a 172 bp PCR fragment.  The PCR reactions were carried out as 
described in the instruction manual for the Bac-to-Bac® Baculovirus 
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Expression Systems from GibcoBRl (Invitrogen™ Life Technologies) and 
O’Reilly et al. (1992) using 3 µl of baculovirus DNA and Expand High 
Fidelity DNA Polymerase (Roche Applied Science).  An annealing 
temperature of 47 °C and extension time of 1 minute (plus an additional, 
cumulative 5 seconds after each cycle) for 30 cycles was used in the PCR 
amplification of these inserts.   
 
The virus titre of the supernatant of viral passage 3 stocks containing 
baculovirus-mediated expression of pCW30 was determined using the 
tissue culture infectious dose 50 % (TCID50) assay described by O’ Reilly et 
al. (1992).  Eight duplicate wells of a 96-well microtitre plate were each 
seeded with 2x104 Sf9 cells and the plate incubated at room temperature 
for 1 hour.  A ten-fold dilution series of supernatant from virus passage 3 
was made up to a final dilution of 10-12 in 50 µl of serum-free TC100 
medium. Following attachment of the cells to the wells, the 10-8 to 10-12 
dilutions were added to the cells in each of the 8 duplicate wells and 
incubated at 28 °C for 10 days.  After 5 days of incubation, each well was 
fed with 10 µl of complete TC100 medium and after 10 days each well was 
scored for cytopathic effects.  The TCID50 of virus passage 3 of 
recombinant baculoviruses containing transposed pCW30 was calculated 
and a T25 (25 cm3) flask of 100 % confluent Sf9 cells infected with 
recombinant baculoviruses at a multiplicity of infection (MOI) of 5, 
according to the instruction manual for the Bac-to-Bac® Baculovirus 
Expression Systems from GibcoBRl (Invitrogen™ Life Technologies).  After 
5 days of infection, both supernatant and cell lysates (prepared as 
described in Section 3.2.7) were analysed by SDS-PAGE.  
 
3.3.1. Bacterial expression and purification of a system GST-p104(248-
331) peptide 
Based on the identification of hydrophilic and antigenic domains in p104 
using Kyte & Doolittle hydropathy plots (Kyte and Doolittle, 1982) and the 
Jameson-Wolf antigenic index (Jameson and Wolf, 1988), a peptide 
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corresponding to amino acids 248 - 331 of the p40/p104 coding sequence 
(~10 kDa and referred to as GST-p104(248-331)) was selected for 
overexpression in a bacterial expression system.   The hydropathy plots 
were generated by online submission of the p104 amino acid sequence to 
the ProtScale program (Gasteiger et al., 2005) hosted by the Expert Protein 
Analysis System (ExPASy), and selecting the Kyte and Doolittle 
hydropathicity scale.   The URI and date on which this online tool was 
accessed are referenced in Appendix 4.   
The nucleotide sequence encoding p104 amino acids 248 – 331 was 
amplified from the plasmid pFLM1, using the primers CW23 (binding at nts 
1756 - 1779 of the PrV cDNA) and CW24 (binding at nts 1986 - 2013), with 
CW23 introducing a Bam HI site at the 5` end of the sequence and CW24, 
a Hind III and an in-frame stop codon at the 3` end.   This amplified product 
was ligated into the commercial vector, pGEM-T Easy, the insert sequence 
confirmed and the recombinant plasmid (pCW52) digested with Bam HI 
and Eco RI.  The Bam HI/Eco RI fragment containing the p104 fragment 
was ligated into pGEX-4T-2 (GE Healthcare) and digested with Bam HI and 
Eco RI (Figure 3.4.).  The resultant plasmid, pCW53 contained the 
inducible tac promoter upstream of a GST-p104(248-331) peptide fusion.  
Expression of the GST-p104(248-331) fusion peptide was induced in E. coli 
BL21 (DE3) cells transformed with pCW53 as described in Section 3.2.3.  
Following induction, equivalent amounts of cell-free extracts were analysed 
by SDS-PAGE and the proteins visualised by Coomassie staining.   
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Figure 3.4. Cloning strategy used in the construction of the expression vector, 
pCW53.  OriR:  origin of replication, AmpR:  β-lactamase, tac promoter: hybrid bacterial 
promoter, lacIq:  lactose repressor gene, MCS:  multiple cloning site, B-lac:  β-lactamase 
promoter, p10:  GST-p104(248-331). 
 
 
 
3.3.2. Purification of the GST-p104(248-331) peptide fusion protein by 
affinity purification and FPLC  
 
E. coli BL21 (DE3) cells expressing the GST-p104(248-331) fusion protein 
were harvested by centrifugation at 10 000 g for 5 minutes at 4 °C and the 
pellet resuspended in 1 ml of binding buffer (10 mM DTT in PBS, pH 7.4).  
The suspension was sonicated using a hand-held 3 mm probe [Vibra 
Cell™]) for 20 x 10 second bursts at 20 % power at 4 °C, and the cell lysate 
centrifuged at 10 000 g for 10 minutes at 4 °C.  The supernatant (soluble 
fraction) was filtered through a 0.45 µm filter to remove any remaining 
whole cells and large/viscous cellular debris.  This filtrate was passed 
through a GSTrap™FF 1 ml column using the AKTA UPC 900/PJ 920 
FPLC model and fractionator following the manufacturers’ instructions (GE 
Healthcare).  Eluted fractions (500 µl) were collected for SDS-PAGE 
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analysis followed by consolidation of fractions containing the eluted protein, 
and the existing buffer exchanged with PBS (pH 7.4) using centrifugal 
filtration tubes (Amicon Ultra 10 kDa cut-off centrifugal filter devices, 
Millipore).  The pooled purified protein was quantified by Bradford’s assay 
(Bradford, 1976) and approximately 640 µg of this purified protein used to 
raise rabbit polyclonal anti-p40 antiserum (performed by Prof. D. U 
Bellstedt, Department of Biochemistry, University of Stellenbosch, 
Stellenbosch, Western Cape, South Africa as described in Section 3.2.7).  
 
3.3.3. Testing of rabbit polyclonal anti-GST-p104(248-331) antiserum   
To test the specificity of the antiserum generated against GST-p104(248-331) 
fusion protein (referred to here as anti-p40 antiserum), cell free extracts of 
the MG8, FB33, Baby Hamster Kidney 21 (BHK), HeLa S3 immortalised 
cervical cancer cells (HeLa) and Sf9 cell lines were generated and 
preserved as described in Section 3.2.7 and quantified by Bradford’s assay 
(Bradford, 1976).  4 µg of each cell-free extract was analysed by SDS-
PAGE (4% stacking/12 % discontinuous glycine/polyacrylamide gels) 
followed by Western analysis using dilutions of the anti-p40 antiserum.  An 
optimal dilution of 1 in 200 000 in 1 % BSA and 0.1 % Tween-20 in TBS 
buffer was selected for the use of this antiserum in Western analyses.  
 
  
3.4. RESULTS AND DISCUSSION 
 
Based on the bioinformatic analysis of the p104 coding sequence 
discussed in Chapter 2, the only enzymatic domain positively identified in 
this replicase ORF was the RdRp domain.  This domain was mapped on 
the C-terminus of the p104 ORF based on the positions of motifs A - C and 
G.  The RdRp domain was positioned at amino acids 533 – 825 of p104 
(Figure 3.5) and as an essential domain in an RNA virus, was predicted to 
fold correctly following transcription and translation of the p104 coding 
sequence.  Antibodies raised towards this peptide stretch would recognize 
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the entire p104 protein and therefore, in order to produce antibodies 
specifically towards the p40 pre-read through N-terminus of this protein, a 
peptide stretch positioned at amino acids 248 - 331 was also selected for 
overexpression based on its antigenicity and hydrophilic nature (Figure 
3.5). 
   
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5.  Hydropathy plots of the two peptide regions of p104, p104(248-331) and 
p104(644-915), selected for overexpression in either a bacterial or eukaryotic 
expression system.  The p104(248-331) and p104(644-915) peptide stretches are represented, 
drawn to scale relative to p104, as blue rectangles and positioned below the pp40/104 
coding sequence.  The baseline (0 score) is highlighted in each hydropathy plot by a thick 
horizontal line.  The GDD (C) motif is indicated on the p104 coding sequence as a point of 
reference. 
 
 
 
3.4.1. Overexpression in E. coli and purification of 6xhis-p104(644-915) 
 
With the ultimate aim of generating antibodies towards p104, the 
expression of the RdRp domain was selected first because this antiserum 
could be used to identify and detect the essential PrV replicase protein.   
Initial SDS-PAGE analysis of crude extracts derived from E. coli cells 
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expressing 6xhis-p104(644-915) showed the overexpression of a 27 kDa 
protein corresponding to the predicted size of the his-tagged peptide 
(Figure 3.6).  However, the peptide appeared to be mostly insoluble since 
no dominant 27 kDa protein was visible in the soluble fraction (Figure 3.6, 
lane 5 vs. 6).  In an attempt to improve the solubility of the 6xhis-p104(644-
915) peptide, the induction temperature was lowered from 37 to 30 ºC and 
the concentration of IPTG was decreased to 0.5 mM.  These measures did 
not significantly improve the amount of soluble protein present (data not 
shown).   
 
 
                          
Figure 3.6.  Overexpression of the 6xhis-p104(644-915)) peptide in E. coli BL21 (DE3).  
SDS-PAGE analysis of protein fractions collected from E. coli BL21 (DE3) cells 
transformed with pCW21.  Lanes 1 – 3:  extracts derived from cells harvested after 0, 2 
and 4 hours’ induction with IPTG, respectively.   Lane 4:  sonicated extract (SE) after 4 
hours induction; Lane 5:  Soluble (S) fraction; Lane 6:  insoluble (P) fraction.  The 
molecular weight standards are indicated on the left of the gel in kDa, while the arrow on 
the right indicates the p27 expression product, 6xhis-p104(644-915).   
 
 
Attempts at native purification of 6xhisp104(644-915) were unsuccessful, so it 
was decided to proceed with denaturing nickel affinity purification of this 
peptide.  Fractions collected during this procedure were collected and 
analysed by SDS-PAGE (Figure 3.7).   
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Figure 3.7.  Denaturing nickel affinity purification of 6xhisp104(644-915) peptide 
expressed in E. coli BL21 (DE3).  SDS-PAGE analysis of fractions collected during 
denaturing nickel affinity purification of 6xhisp104(644-915) from E. coli BL21 (DE3) cells 
transformed with pCW21.  Lane 1:  sonicated crude extract (SE).  Lane 2: flow-through 
(FT).  Lanes 3 and 4: wash 1 and 2 (W1/W2).  Lanes 5 and 6:  elution 1 and 2 (E1/2).  The 
molecular weight standards are indicated on the left of the gel in kDa, while the arrow on 
the right indicates the 27 kDa protein corresponding in size to the 6xhisp104(644-915) 
peptide. 
 
The denaturing affinity purification of 6xhisp104(644-915) from overexpressed 
E. coli BL21 (DE3) (Figure 3.7) was more efficient than the native nickel 
affinity protocol (data not shown).  However, while sufficient quantities of 
peptide were purified using the denaturing protocol (Figure 3.7 lanes 5 and 
6), the purified product only remained soluble in the presence of 8 M urea, 
making the use of this protein unsuitable in a mammalian immunization 
schedule.  Attempts to re-fold the peptide in a less physiologically toxic 
buffer by both dialysis and centrifuge column buffer exchange led to the 
precipitation of the peptide.   
 
3.4.2. Expression in E. coli and purification of the GST-p104(644-915) 
peptide 
 
Since the 6xhisp104(644-915) peptide appeared to be insoluble, it was 
decided to replace the 6xhist tag with the GST protein in the hope that this 
would lead to the expression of a soluble fusion peptide.  Analysis of crude 
extracts derived from E. coli cells transformed with pCW24 revealed that 
this peptide was only marginally soluble (Figure 3.8 lane 7), with the 
majority of the fusion peptide (~50kDa) remaining in the insoluble pellet 
(Figure 3.8 lane 8).   
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Figure 3.8.  Overexpression of GST-p104(644-914)  peptide in E. coli Bl21 (DE3).   SDS-
PAGE analysis of protein fractions collected E. coli BL21 (DE3) cells transformed with 
pCW24.  Lanes 1 – 5:  extracts derived from cells harvested after 0, 1, 2, 3 and 4 hours 
induction with IPTG, respectively. Lane 6:  sonicated extract (SE) after 4 hours induction. 
Lane 7:   soluble supernatant (S) after 4 hours induction.  Lane 8:  insoluble fraction (P) 
after 4 hours induction.   The molecular weight standards are indicated on the left of the 
gel in kDa, while the arrow on the right indicates the 50 kDa protein, corresponding to the 
predicted molecular weight of the GST-p104(644-915) fusion peptide.  
 
 
 
3.4.3   Baculovirus-mediated expression of p104 peptides in insect 
cell culture 
                       
With little success in expressing soluble p104(644-915) despite the fusion of 
the peptide with GST, it was decided to attempt to express the first 204 
amino acids of p104 using a recombinant baculovirus expression system.  
This system was selected because the (over)expression of p40, the N-
terminal section of p104, proved unsuccessful in a bacterial heterologous 
expression system (F. M Pringle, pers. comm., 2005). Recombinant 
baculoviruses expressing 6xhis-p104(1-207), under the control of the polH 
baculovirus promoter (pCW30) were used to transfect Sf9 cells.  SDS-
PAGE analysis and Coomassie staining of cell-free extracts obtained from 
cells infected with the recombinant virus showed no observable expression 
of the peptide.   Furthermore, modified native affinity purification using 
Nickel-NTA spin columns (Qiagen) and subsequent Western analysis of 
eluted fractions using monoclonal anti-histidine antibodies did not detect 
the 6xhisp104(1-207)  peptide (data not shown). 
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3.4.4. Gel purification and solubilisation of the 6xhis-p104(644-915) 
peptide expressed in E. coli.   
 
Isolation of soluble 6xhis p104(644-915) protein by acrylamide gel fragment 
purification proved to be successful with large amounts of soluble protein 
isolated  (Figure 3.9 panel A).  This purified protein presented the 
6xhistidine tag sufficiently for detection of this protein by Western analysis, 
using monoclonal anti-histidine antibodies (Figure 3.9 panel B).   This 
protein was used to raise anti-p104 anti-serum.  Mass spectroscopy (MS) 
analysis was not performed on this peptide due to financial constraints and 
the undoubted presence of other 27 kDa proteins that would have been co-
excised with the overexpressed 6xhis p104(644-915) peptide during the 
purification procedure.   
 
                                   
Figure 3.9.   Gel purification, solubilization and detection of the 6xhis p104(644-915) 
peptide expressed in E. coli Bl21(DE3).   (A) SDS-PAGE analysis of 6xhis p104(644-915) 
peptide and (B) Western analysis of the purified protein using monoclonal anti-
hexahistidine antibodies.  The molecular weight standards are indicated on the left of the 
gel and are represented in kDa, while the arrow on the right indicates a purified, soluble 
protein migrating at approximately 27 kDa corresponding to the predicted molecular weight 
of the 6xhis p104(644-915) peptide.  
 
 
3.4.5. Validation of rabbit anti-p104 polyclonal antiserum 
 
During the optimisation of the heterologous expression of p40 and peptide 
stretches of p40, the sensitivity and specificity of the rabbit polyclonal anti-
p104 antiserum generated in this study was examined.  This antiserum was 
analysed by Western analysis using cell-free extracts prepared from a 
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number of insect cell lines available at the time of these experiments 
(Figure 3.10).  
 
 
 
Figure 3.10.  Specificity of 6xhis-p104(644-915) antiserum tested with cell-free extracts 
derived from insect cell lines.  (A):  Western analysis of varying quantities of MG8 cell-
free extracts (lanes 1 to 4) using anti-p104 antiserum at a dilution of 1 in 50 000. Lane 5:  
50 ng of purified 6xhis-p104(644-915).  (B):  Western analysis of varying quantities of FB33 
(lanes 1 – 2) and Sf9 cell-free extract (lanes 3 - 4) tested with anti-p104 antiserum.  The 
amount of each cell-free extract (in µg) probed are indicated above the relevant lane.  The 
molecular weight standards are indicated on the left of the gel in kDa, while the arrows on 
the right of the image in panel A represent distinct proteins detected by Western analysis 
of MG8 extracts. 
 
Although purified 6xhis-p104(644-915) peptide was detected, the antiserum 
also cross-reacted with numerous cellular protein in all three tested cell 
lines (Figure 3.10 panel A and B).  In particular, five distinctive proteins 
were detected in the PrV-infected MG8 cell line (125, 104, 86, 65 and 60 
kDa) (Figure 3.10 panel A).  Only the 104 kDa protein potentially 
corresponds to the predicted molecular weight of the p104 coding 
sequence.  Importantly, a 40 kDa protein corresponding to p40 was not 
detected (Figure 3.10 panel A, lanes 1 - 4), as was to be expected since 
the region chosen for the production of this antiserum is not represented on 
the p40 protein amino acid sequence.   
 
When the anti-p104 antiserum was also tested against cell-free extracts of 
FB33 (Figure 3.10 panel B, lanes 1 & 2) and Sf9 (Figure 3.10 panel B, 
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lanes 3- 4) proteins, numerous non-specific proteins were detected.  
Besides  a couple of dominant proteins of various molecular weights 
depending on the cell line being detected in both cell types, this antiserum 
also cross-reacted with other cellular proteins of a wide range of molecular 
weights (Figure 3.10 panel B, lane 1 - 4).  Pre-absorption of the anti-p104 
anti-serum with FB33 cell-free extract was performed in an attempt to 
precipitate out antibodies binding non-specifically to H. zea cellular 
proteins.   
The Western analysis of the three cell-free extracts (in varying 
concentrations) was repeated using the pre-absorbed antiserum, but no 
decrease in the non-specific binding of this antiserum to cellular proteins 
was observed when tested in all thee of the cell-free extracts (data not 
shown).  The pre-absorption step did not eliminate the non-specific binding 
of the antiserum to what appears to be at least three or four cellular 
proteins in the MG8 extract, nor the one or two dominant proteins detected 
in the FB33 and Sf9 cell-free extracts.   It is likely that the purified peptide 
described in Section 3.4.5 did not re-fold during the purification and 
precipitation steps leading to the generation of anti-serum to co-purified 27 
kDa cellular proteins as well as a small proportion of antibodies generated 
towards correctly re-folded 6xhisp104(644-915). 
 
3.5.1. Expression of a peptide stretch within the p40 coding sequence 
in a bacterial heterologous expression system 
Since the anti-p104 antiserum generated in this study was non-specific, it 
was decided to focus on another potentially antigenic region in the N-
terminal half of p104, immediately upstream of the read-through stop 
signal.  It was elected to express the p104(248-331) fragment with GST fused 
to its N-terminus to increase the likelihood of both the expression and 
purification of a soluble fusion protein. 
The expression plasmid, pCW53, was created for the IPTG-inducible 
overexpression of a GST-p40 peptide fusion protein.  The p40 peptide is an 
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83 amino acid stretch located at the C-terminal half of the entire coding 
sequence of p40, and was selected for fusion to GST because this region 
appeared to be highly antigenic and hydrophilic nature according to 
hydropathy plots (Figure 3.5) and antigenic indices.  Crude extracts derived 
from E. coli BL21 (DE3) cells transformed with pCW53 were induced with 
IPTG and crude cell extracts analysed by SDS-PAGE (Figure 3.11). 
               
                               
 
Figure 3.11.   Expression and solubility studies on protein extracts from E. coli BL21 
(DE3) expressing GST-p104(248-331).  SDS-PAGE analysis of protein fractions collected 
from E. coli BL21 (DE3) cells transformed with pCW53.  Lanes 1 - 2: crude extracts of 
pT7-7 and pGEX-4T-2 samples 1 hour post induction with IPTG.  Lanes 3 – 6:  crude 
extracts of pGEX-4T-2 samples taken 1, 2, 3 and 4 hours post-induction with IPTG.  Lanes 
7 and 8: crude extracts of pT7-7 and pGEX-4T-2 samples 4 hours post induction with 
IPTG. Lanes 9:  sonicated extract (SE) after 4 hours induction.  Lane 10:  soluble 
supernatant (S) after 4 hours’ induction.  Lane 11:  insoluble fraction (P) after 4 hours’ 
induction.  The molecular weight standards are indicated on the left of the gel in kDa, while 
the arrows on the right indicate the expression products, GST-p104(248-331)  and GST.   
 
 
 
The expression of pCW53-transformed cells, and subsequent SDS-PAGE 
analysis of samples taken at hourly time intervals during the induction, 
clearly showed the presence of a 37 kDa protein corresponding to the 
predicted molecular weight of GST-p104(248-331) (Figure 3.11, lanes 3-6).   
This protein was not visible in cell-free extracts of E. coli BL21 (DE3) 
transformed with the expression vector pT7-7 (Figure 3.11, lanes 1 and 7), 
whereas a noticeable 26 kDa band corresponding to the GST protein is 
visible in cell-free extracts of E. coli BL21(DE3) transformed with the GST 
expression vector, pGEX-4T-2 (Figure 3.11, lanes 2 and 8).  A band 
migrating at the same size as GST is also visible in the protein samples 
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derived from cells transformed with pCW53 (Figure 3.11, lanes 3 - 6).  This 
is likely a result of C-terminal truncated translation products occurring at the 
fusion point between GST and the p40 peptide.   Solubility studies 
performed on cell-free extracts expressing the GST-p104(248-331) fusion 
peptide sampled after four hours post-induction showed that the fusion 
peptide was soluble (Figure 3.11, lane 9 - 11) and expressed in sufficient 
quantities for affinity purification (Figure 3.11, lane 10).  Following this 
positive result, native affinity purification of this fusion protein was 
performed using FPLC and the resultant fractions analysed by SDS-PAGE 
(Figure 3.12). 
                 
 
 
Figure 3.12.  Native affinity purification of GST-p104(248-331) fusion peptide.  SDS-
PAGE analysis of fractions collected following the native affinity chromatography using 
FPLC.  Lanes 1 - 2: Alternate flow-through (FT) fractions collected following addition of the 
sample and post-void volume release.  Lanes 3 – 5:  wash fractions 1 – 3 (W 1 - 3) 
collected following the addition of wash buffer.  Lanes 6 – 11:  elution fractions  (E1 – E6), 
collected following the addition of reduced glutathione.  Lanes 12 – 13:  purified, pooled 
GST-p104(248-331) protein (P1 and P2).  The molecular weight standards are indicated on 
the left of the gel in kDa, while the arrows on the right indicate the expression product, 
GST-p104(248-331).   
 
 
 
FPLC affinity purification of GST-p40 protein resulted in the purification of 
sufficient quantities of fusion protein purified from soluble supernatant 
derived from cell-free extracts of E. coli BL21 (DE3) cells transformed with 
pCW53 and induced with IPTG (Figure 3.12).  Purified and concentrated 
fusion protein in PBS buffer was further analyzed by SDS-PAGE (Figure 
3.12, lanes 12 and 13).  The resultant purified fusion protein was co-eluted 
and purified with GST and a larger protein of approximately 39 - 40 kDa, 
but due to its low concentration and the option of being able to remove 
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contaminating antibodies by pre-absorption, it was decided that the purified 
protein was sufficiently pure and of a high enough concentration for 
antiserum production.  Since the expression of p40 alone has previously 
demonstrated to be unsuccessful and considering the overall insoluble 
nature of p104 peptides expressed without fusion to a tag, thrombin 
cleavage at the GST-p40 fusion point was not performed post purification in 
order to maintain the stability and solubility for further studies.  MS analysis 
was not performed on this purified fusion peptide due to financial 
constraints. 
 
 
3.5.2. Validation of rabbit anti- p104(248-331) antiserum 
 
As described in Section 3.4.6, the rabbit anti-p104(248-331), referred to from 
here on as anti-p40 polyclonal antiserum was tested for its specificity in 
Western analysis using cell-free extracts of both insect and mammalian cell 
lines (Figure 3.13).  The degree of non-specific interactions detected by the 
tested anti-p40 antiserum appeared much less in comparison to the degree 
of non-specific binding shown by the anti-p104 antibody (compare Figure 
3.13 with 3.10).    
                                       
 
Figure 3.13.  Specificity of GST-p104(248-331) antiserum tested with cell-free extracts 
derived from insect cell lines.  A total of 4 µg of each cell-free extract was probed with a 
1 in 200 000 dilution of anti-p40 serum.  Lane 1:  FB33. Lane 2:  HeLa.  Lane 3:  MG8.  
Lane 4:  Sf9.  Lane 5:  BHK.   Molecular weight standards are indicated on the left of the 
gel, in kDa.  The arrow on the right indicates a ~40 kDa protein in the MG8 sample 
corresponding in size to the replication protein, p40.   
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The MG8 cell-free extract contained two (suspected viral) proteins which 
cross-reacted with the anti-p40 antiserum (Figure 3.13, lane 3).  These 
proteins had estimated molecular weights of 42 and 68 kDa and it is likely 
that the approximately 42 kDa protein represents the hypothesized auxiliary 
protein, p40 originating from PrV.  When the anti-p40 antiserum was tested 
on resolved proteins of an FB33 extract, no non-specific interactions were 
detected (Figure 3.13, lane 1) while the HeLa, MG8, Sf9 and BHK extracts 
(Figure 3.13, lanes 2 - 5 respectively) showed cross-reactivity with single 
cellular proteins.  These proteins are most likely cellular GST proteins 
cross-reacting with the antibodies raised against the GST portion of the 
fusion protein.  Interestingly, the endogenous GST from the FB33 and MG8 
cell-free extract was not detected, while the suspected GST in the Sf9 cell-
free extract was detectable using this antiserum (Figure 3.13 lane 4).  Anti-
GST antiserum was not available at the time of these experiments to prove 
this cross-reactivity in the HeLa, Sf9 and BHK cell lines.   It was concluded 
from these results that the anti-p40 antiserum would be suitable for use in 
Western analysis to examine the translation products of PrV.    
 
 
3.6. CONCLUSION 
 
The expression of sections of p40 and p104 coding sequences were not 
very successful and when the C-terminal (amino acids 644 - 915) region of 
p104 was successfully produced in the bacterial heterologous expression 
system, the protein proved to be insoluble.  Although the peptide was 
eventually solubilized following gel purification, the resulting antibodies 
raised against this peptide did not appear to cross-react with the native 
protein expressed in the MG8 cells suggesting that it was likely misfolded.  
Expression of the N-terminal 207 amino acids of p40/p104 was also 
unsuccessful in both bacterial and insect heterologous expression systems 
for reasons unknown, although difficulties in expressing peptides in this 
region have been observed before (F.M. Pringle, pers. comm., 2005).  
Figure 3.14 below summarises the peptide stretches of p40/p104 that were 
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selected for overexpression, the heterologous system used and the 
outcome of the expression study. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14.  Peptide stretches of p40/p104 selected for overexpression in this 
study.  The first column shows the p40/p104 coding sequence drawn to scale.  The 
second column describes the name of each peptide (and its fusion partner) and the third 
column summarizes the system used and result of expression.  The rectangles in the 
second column are drawn to scale and coloured black if no expression/insoluble protein 
was observed or green for successful purification.   
 
 
A hydrophilic and antigenic region at the C-terminal of p40 (fused to the C-
terminal of GST) proved to be soluble in the E. coli expression system and 
was used to raise rabbit polyclonal antibodies.  This anti-p40 antiserum 
was proven to be both sensitive and specific, detecting an approximately 
40 kDa protein in cell-free extracts of PrV-infected MG8 cells, indicating 
that these antibodies would be suitable for further studies on the 
expression of PrV proteins in vivo.  Future experiments would ideally 
involve testing of this antiserum against uninfected MG8 cell lines in order 
to confirm no cross-reactivity between endogenous GST and the antiserum 
or perhaps GST pull down from the MG8 cell-free extracts followed by 
Western analysis of clarified extracts using anti-p40 antiserum.   
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 CHAPTER 4  
Characterization of the PrV translation products  
 
 
4.1. INTRODUCTION 
 
PrV was initially identified as a new tetravirus based on its capsid structure, 
monopartite genome and the amino acid sequence of the capsid protein 
precursor gene (Pringle et al., 2003).  However, further analysis of the 
cDNA sequence has revealed that PrV might not be a typical betatetravirus 
(Chapter 2).  As in the betatetraviruses, the PrV genome encodes a viral 
replicase (p104) and the capsid precursor gene (p81).  However, unlike 
other members of this family, the 5` end of the genome encodes an 
additional large ORF (p130) of unknown function.  The replicase ORF is 
unique in that it contains a read-through stop signal, which would result in 
the translation of two products from the p104 ORF: p40 (the auxiliary 
replication protein) and p104 (the replicase protein).  In addition, the PrV 
genome encodes three 2A-like ‘cleavage’ sequences, one at the N-
terminus of p130 and two at the N-terminus of p81.  The presence of p130 
and the co-translational processing signals suggest that PrV might employ 
a unique strategy for regulating expression of its viral gene products in 
infected host cells.    
 
The objective of the research described in this chapter was to confirm the 
annotation of the PrV genome and to uncover more information about the 
co-translational processing of its gene products, both in vivo and in vitro. 
 
 
4.2. METHODS AND MATERIALS 
 
Unless otherwise stated, all gene manipulation methods were performed 
according to Sambrook et al. (1989) and protein analysis as described by 
Laemmli (1970).  Primer sequences used in the construction of the 
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expression vectors pSTA1 – 5, 7 and 8, are described in Table 4.1 and 
listed in Appendix 1.  
 
4.2.1. Metabolic labelling of PrV translation products in vivo 
 
The methodology used for the in vivo labelling of PrV translation products 
in the PrV-infected MG8 cell line was performed according to Pringle et al. 
(2003).    Successful inhibition of cellular transcription by Actinomycin D 
treatment was confirmed using the following protocol:  the ExCell 420 
medium from a T25 (25 cm3) flask containing a near-confluent (80 %) 
monolayer of MG8 cells was removed and replaced with 6 ml of pre-
warmed ExCell 420 medium containing different concentrations (and 
optimized at 20 µg/ml) of Actinomycin D.  The cells were resuspended and 
aliquoted in 5 X 1 ml quantities into single wells of a 24-well cell culture 
plate.  One millilitre of medium and cells was removed from a single well 
and collected for further analysis after 6, 12, 25, 36 and 48 hours.  The cell 
suspensions were microfuged at 5 000 g for 2 minutes at room temperature 
and the pellet resuspended in RIPA buffer (150 mM NaCl, 1 % Nonidet® 
NP40, 0.5 % sodium deoxycholate (Na-DOC), 0.1 % SDS and 50 mM Tris-
Cl, pH 8.0) by passing the cells through a 22 gauge needle four times 
before being stored in the presence of 100 µM PMSF at -80 ºC.  The cell 
free extracts were quantified by Bradford’s assay (Bradford, 1976) in order 
to ensure equal loading of protein extracts during SDS-PAGE analysis.  
Cell-free extracts were analysed by SDS-PAGE (4% stacking/12 % 
resolving glycine/polyacrylamide gels) and subjected to Western analysis 
using monoclonal antibodies towards VDAC and the PrV capsid protein as 
described in Chapter 3 (Section 3.2.4b).   The nitrocellulose membranes 
were probed with a 1 in 500 dilution of monoclonal anti-VDAC antibodies 
(Santa Cruz Biotechnology) and a 1 in 2 000 dilution of polyclonal anti-PrV 
capsid antiserum, respectively.  Antiserum and monoclonal antibodies were 
diluted accordingly in 1 % BSA and 0.1 % Tween-20 in Tris-buffered saline 
(150 mM NaCl and 50 mM Tris-Cl pH 7.6).   
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MG8 cells were allowed to grow to 90 % confluence in complete ExCell 420 
medium in a T25 (25 cm3) flask.  The media was removed and replaced 
with 20 mg/ml of Actinomycin D in media deficient in the amino acid 
methionine.  The cells were incubated at 28 ºC for 30 minutes after which 
the media was removed and the cells gently rinsed twice with 1 ml of 
methionine-free medium.  Three millilitres of methionine-free medium 
containing 60 µg of Actinomycin D and 5.55 MBq of [35-S]-methionine 
(Amersham Biosciences), was added to the rinsed cells and the flask 
incubated at 28 ºC for 24 hours.  Whole cells were then dislodged from the 
flasks, harvested by centrifugation (5 000 g for 2 minutes at room 
temperature), resuspended in 400 µl of RIPA buffer and lysed by passing 
through a 22 gauge needle six times.  Cell-free extracts were stored in the 
presence of 100 µM PMSF at -80 ºC subsequent to quantification by 
Bradford’s assay (Bradford, 1976).      A total of 10 µg of cell-free extract 
was analysed by SDS-PAGE (4% stacking/12 % resolving 
glycine/polyacrylamide gels), the resolved proteins fixed with 0.25 % 
Coomassie brilliant blue in 50 % methanol and 10 % acetic acid for 1 hour, 
destained in 50 % methanol and 10 % acetic acid for 1 hour and finally 
destained in 7 % methanol and 5 % acetic acid overnight.  The fixed gels 
were dried under vacuum at 80 ºC and exposed to hyperfilm (GE 
Healthcare) for an appropriate duration of time. 
  
 
4.2.2. Isolation of tetraviruses from the FB33 cell line 
 
To confirm the uninfected status of the FB33 cell line, a virus purification 
procedure was performed as described by Pringle et al. (2003).  The small 
pellet derived from sucrose cushion ultracentrifugation of FB33 cell-free 
extract was resuspended in 10 µl of 50 mM sodium phosphate buffer, pH 
7.2.  5 µl of this resuspension was adsorbed onto a carbon coated copper 
grid prepared as described by Dong et al. (1998) and examined using a 
Phillips JEOL 1210 Transmission Electron Microscope. 
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4.2.3. In vitro transcription/translation experiments 
4.2.3a. Plasmid construction for in vitro transcription/translation 
 
A total of seven expression plasmids were constructed for in vitro 
transcription and translation assays to characterize the PrV ORFs.  The 
vector, pBiEX-3 (Novagen) was digested with NcoI, the overhangs from this 
restriction site filled in using the Klenow fragment of DNA polymerase I and 
the vector then further digested with Not I.   Each ORF was PCR amplified 
from the PrV cDNA (using the plasmid pFLM1), digested with Not I and 
ligated into the expression vector, pBiEX-3 (Figure 4.1).   
 
 
                          
Figure 4.1.  Restriction map of the expression plasmid, pBiEX-3.  AmpR – β-
lactamase gene; lacI – lactose repressor gene; hr enhancer – baculovirus promoter 
enhancer element; IE promoter – immediate early cytomegalovirus promoter; T7 RNA 
polymerase  - bacterial promoter and T7 terminator – terminator sequence.   
 
 
The individual plasmids, each containing the unmodified or altered version 
of a (predicted) PrV coding sequence, are described below (Figure 4.2, 
Table 4).    The p130 ORF was PCR amplified using the primers CW01 and 
CW02 and ligated into pBiEX-3 to construct pSTA1.  pSTA2 was 
constructed by amplifying a truncated version of the p130 ORF (with the 
coding sequence starting from an artificial translational start directly 
downstream of the 2A-like processing site) using the primers CW03 and 
CW02 and the amplicon ligated into pBiEX-3.  pSTA3 was constructed by 
pBiEX-3
5373 bp
AmpR
hr enhancer
IE promoter
T7 RNA polymerase
lacI
T7 terminator
Nco I (1178)
Not I (1268)
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amplifying another truncated version of the p130 ORF starting from a 
second possible translational start of p130 at nt 309 (amino acid 103) and 
ending at the same stop codon as the extended version of p130 expressed 
in pSTA1.  The primers, CW01b and CW02 were used to amplify this 
truncated version of the p130 ORF and the amplicon ligated into pBiEX-3.   
 
    
 
 
 
 
Figure 4.2.  Restriction maps of the expression plasmids, pSTA1 – 5, 7 and 8 used 
for in vitro expression of the three major ORFs identified in the PrV genome.  pSTA1 
contains the coding sequence of p130.  pSTA2 contains the coding sequence of a post-
2A-like processing signal of the p130 ORF.  pSTA3 contains the coding sequence of p130 
starting from the second in-frame methionine.  pSTA4 contains the p40 coding sequence 
and pSTA5 contains the entire p104 coding sequence.  pSTA7 contains the capsid 
precursor protein (p81) coding sequence and pSTA8 contains the capsid protein α (p68) 
coding sequence.  AmpR – β-lactamase gene, lacI – lactose repressor gene, hr enhancer 
– baculovirus promoter enhancer element, IE promoter – immediate early cytomegalovirus 
promoter, T7 RNA polymerase  - bacterial promoter and T7 terminator – terminator 
sequence.  
pSTA1
8950 bp
p130
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase promoter
T7 terminator
Nco I (4404)Nco I (4475)
pSTA2
8563 bp
p117
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase promoter
T7 terminator Nco I (4017)
Nco I (4088)
pSTA3
8597 bp
p130
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase promoter
T7 terminator Nco I (4051)
Nco I (4122)
p12  
pSTA4
6381 bp
p40
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase
T7 terminator
Not I (2264)
pSTA5
8035 bp
p104
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase 
T7 terminator
pSTA7
7549 bp
p81
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase 
T7 terminator
Nco I (1733)
pSTA8
7200 bp
p68
IE promoter
hr enhancer
AmpR
lacI
T7 RNA polymerase
T7 terminator
Nco I (1370)
Not I (3083)
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Table 4.1.  Description on the coding sequences cloned into pSTA1 5, 7 and 8, primers used to amplify these coding sequencesp and the 
molecular weight of the predicted expression product.   
 
Plasmid name Primer combination used to amplify coding sequence ORF Predicted MW of translation 
products 
pSTA1 CW01:       5`GCTGTGAACACTTCAGGTAAAAC‘3  
CW02:   5`TATATAGCGGCCGCTTACACTGCTCCGTTGGCGAAATG`3 
p130  117 and 13 kDa 
pSTA2 CW03:        5`CCCATCGGCTCTTGGCTTCGAGGA`3  
CW02:    5`TATATAGCGGCCGCTTACACTGCTCCGTTGGCGAAATG`3 
p130 (a.a. 130 – 1221) 117 kDa 
pSTA3 CW01b:       5` AAGGAGTCTAATAGTGGTTACG`3  
CW02:    5`TATATAGCGGCCGCTTACACTGCTCCGTTGGCGAAATG`3 
p130(a.a.103-1221 117 and 6 kDa 
pSTA4 CW04:        5`TGCGAGCCTTTAAGTTTACGC’3  
CW05:      5`TATATAGCGGCCGCTTACTTTGTCGGGATTGTTCTTCC`3  
p40 40 kDa 
pSTA5 CW04:         5`TGCGAGCCTTTAAGTTTACGC’3 
CW06:        5`TATATAGCGGCCGCTCAATACCCTGACGGCCAGTCAATATC`3 
p104 40 kDa and 104 kDa 
pSTA7 CW09 :       5`CAGAATTTACCAGTACCCAATG`3 
CW10:   5`TATATAGCGGCCGCTTACTTGGCTCGTCTAGCGCGG`3 
p81 68, 8 and 7 kDa 
pSTA8 CW11:        5`CCCCAGATGACCCGCGAGAATAAAG`3  
CW10:   5`TATATAGCGGCCGCTTACTTGGCTCGTCTAGCGCGG`3 
p81(a.a.122-754)  68 kDa 
Key:  The Not I site is underlined and in bold and the mutated nucleotides are represented in lower case, in bold. 
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pSTA4 contains the p40 ORF and a functional stop codon (a.a 1 – 360 of 
p104) situated directly after the last coding triplet amplified using the 
primers, CW04 and CW05.  A legitimate stop codon (UGA) was introduced 
at the end of the coding sequence to ensure the termination of translation 
in the in vitro system.   pSTA5 was constructed by the amplification of the 
entire p104 ORF including the read-through stop signal using the primers 
CW04 and CW06.    Finally pSTA7 and 8 were constructed by amplifying 
the capsid precursor ORF and a truncated version excluding the N-terminal 
2A-like cleavage (first 121 amino acids) using the primers CW09 and, 
CW10 and for the truncated version, using the primers, CW11 and CW10. 
 
4.2.3.b. Coupled in vitro transcription/translation using rabbit 
reticulocyte lysates 
 
Coupled in vitro transcription/translation reactions were performed using 
rabbit reticulocyte lysates (TnT® T7 system, Promega).  High quality 
plasmid DNA used in these reactions was extracted using Qiaprep Spin 
Miniprep columns (Qiagen). Translation reactions were performed by 
charging 5 µl in vitro rabbit reticulocyte master mix with 100 ng of the 
plasmids DNA; 0.25 µl double distilled water and 0.5 µl (0.925 MBq) of    
[35-S]-methionine to a final volume of 6.25 µl.  This mixture was gently 
mixed and incubated at 30 ºC for 1.5 hours.  5 µl of each radiolabelled 
translation reaction was analysed by SDS-PAGE and the labelled proteins 
detected by autoradiography using a phosphoimager.    
 
Due to the low levels of p104 translation products, immunoprecipitation 
was used to concentrate the in vitro translation products of p104 (and p40), 
after which these precipitates were probed using anti-p40 antiserum.  100 
µl of protein A/G beads (Santa Cruz Biotechnology, Inc.) was rinsed three 
times with 1 ml of PBS (pH 7.4) and the slurry microfuged at 13, 300 g for 
12 seconds to precipitate the beads.    50 µl of anti-p40 antiserum was 
then added to the washed beads (100 µl) and the mixture incubated with 
agitation at 4 ºC for 2 hours.  The bead/antibody conjugate was then 
washed four times with 1 ml PBS containing 0.1 % v/v Nonidet® NP40 and 
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centrifuged at 13 300 g for 20 seconds.  In the final wash, BSA was added 
to a final concentration of 10 mg/ml and the slurry incubated with moderate 
agitation for 30 minutes at room temperature.   The beads were briefly 
centrifuged and resuspended in 50 µl of PBS (pH 7.4) containing 10 mg/ml 
BSA.  Next, 20 µl of the prepared beads were added to 7 µl of rabbit 
reticulocyte lysate as well as 1 ml of binding buffer (150 mM NaCl; 20 mM 
Tris-Cl pH 7.4; 1 mM DTT; 0.05 % v/v Nonidet® NP40 and 10 mg/ml BSA).  
This mixture was incubated with to incubate at 4 ºC with moderate 
agitation for 30 minutes.  The bead/protein conjugate was microfuged at 13 
300 g for 20 seconds, the supernatant carefully removed and the beads 
washed by the addition of 1 ml of binding buffer.  The resuspended 
bead/protein conjugate was microfuged at 13 300 g for 20 seconds.  This 
was step was repeated a total of five times.  
 
The pelleted beads were resuspended in 10 µl of SDS-PAGE sample 
buffer (10 % glycerol; 125 mM Tris-Cl pH 6.8; 4 % SDS; 10 % β-
mercaptoethanol; 0.01 % bromophenol blue) and analysed by SDS-PAGE 
followed by Western analysis of the resolved proteins.    The anti-PrV 
capsid antiserum used in this particular Western analysis was a recently 
generated rabbit polyclonal antiserum generated from approximately 500 
µg of PrV purified according to Pringle et al. (2003) (Performed by Prof. D. 
U Bellstedt, Department of Biochemistry, University of Stellenbosch, 
Stellenbosch, Western Cape, South Africa and described in Section 3.2.7). 
 
 
4.2.3.c. Coupled in vitro transcription/translation using wheat germ 
extract 
 
Coupled in vitro transcription/translation reactions were carried out by 
adding 12.5 µl of wheat germ extract (Promega); 1 µl TnT® reaction buffer, 
0.5 µl TnT® T7 RNA polymerase, 0.5 µl amino acid mix minus methionine, 
1.85 MBq of [35-S]-methionine, 0.5 µl RNAsin® ribonuclease inhibitor and 
500 ng of DNA template, to a final volume of 25 µl. The reactions were 
gently mixed and incubated at 30 ºC for 90 minutes. 10 µl of each reaction 
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was analysed by SDS-PAGE (4 % stacking/7.5 % resolving 
glycine/polyacrylamide gels) and the resolving gels fixed followed by 
detection of the radiolabelled translation products by autoradiography as 
described in Sections 4.2.3.b.   
 
 
4.3. RESULTS AND DISCUSSION 
 
4.3.1. Optimization of [35-S]-methionine metabolic labelling of MG8 
cells 
 
The first step towards characterizing the translation products of PrV was to 
determine whether proteins corresponding to the ORFs identified in the 
cDNA sequence were present in the persistently infected MG8 cells.  Since 
there was no anti-p130 antiserum available, it was decided to use 
metabolic labelling with [35-S]-methionine to identify the viral translation 
products in the MG8 cells. To differentiate between host and viral proteins, 
the cells were treated with Actinomycin D, which inhibits host transcription 
and therefore the translation of cellular proteins.  Since virus replication is 
not sensitive to Actinomycin D, one is able to differentially label viral 
proteins by growing the cells in medium containing [35-S]-methionine.   
 
MG8 cells were treated with varying concentrations of Actinomycin D for up 
to 48 hours, the rate of cell growth monitored and cell-free extracts 
assayed to determine the optimal concentration and incubation time to halt 
cellular transcription and thus translation.  Both adhered and lifted cells 
were collected at each time point, pelleted and lysed into cell-free extracts.  
Quantification of the total protein of these cell-free extracts by Bradford’s 
assay (Bradford, 1976) indicated that a concentration of 20 µg/ml 
Actinomycin D efficiently inhibited transcription/translation, without wide-
spread cell death, for up to 36 hours.  This was attained by the 
confirmation of a plateau in total protein concentration 36 hours post-
treatment.   
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The voltage-dependent anion channel (VDAC) transporter protein is a 
ubiquitous eukaryotic protein found in the outer membranes of 
mitochondria that plays an essential role in many mitochondrion-related 
signalling pathways and in small molecule or anion transport across the 
outer membrane (Brown, 1992).  This protein has a relatively long half-life 
and a commercial monoclonal anti-mouse VDAC antibody was able to 
detect endogenous insect VDAC protein.  It was decided to use this protein 
as a control to confirm Actinomycin D inhibition of cellular transcription in 
MG8 cells (Figure 4.3 panel A).  Anti-PrV capsid antiserum was used to 
detect capsid protein in the Actinomycin D-treated MG8 cells and to 
confirm that the presence of the inhibitor did not affect the amount of 
detectable capsid protein over at least a 24 hour period following 
commencement of treatment (Figure 4.3 panel B).  In both experiments, 
the total protein was quantified by Bradford’s assay (Bradford, 1976) and 
standardised for each sample in order to ensure equalised loading of total 
protein.   
 
 
 
Figure 4.3.  Detection of VDAC and PrV VCAP in MG8 cell-free extracts treated with 
Actinomycin D.  (A):  Western analysis of MG8 cell-free extracts cultured with (+) or 
without (-) Actinomycin D and probed with anti-VDAC antibodies.   Cells harvested after 
zero hours (lanes 1, 2); 12 hours (lanes 3, 4) and 24 hours (lanes 5, 6).  (B):  Western 
analysis of cell-free extracts probed with anti-PrV capsid antiserum.  Lanes 1 – 3:  Cells 
cultured for 0, 12 and 24 hours following treatment with Actinomycin D.  Lanes 4 – 6:  
Cells cultured for 0, 12 and 24 hours in the absence of Actinomycin D.   Key:  “+” and “-” – 
cells treated with and without Actinomycin D.  The molecular weight standards are 
indicated on the left of the blot and are represented in kDa, while the arrows on the right 
either indicate cellular VDAC (30 kDa) or virus capsid proteins (p60 and p68). 
 
 
 
Western analysis of the MG8 cell-free extract using the anti-VDAC 
antibodies resulted in the detection of VDAC protein (30 kDa) in all of the 
samples taken over a 24 hour period.  (Figure 4.3 panel A).  Cells grown in 
A 
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the presence of Actinomycin D showed a significant decrease in the 
amount of detectable VDAC protein (Figure 4.3 panel A, lanes 1, 3 and 5).  
This is most likely explained by the increasing number of dying cells (cells 
began to lift from the bottom of the well after 12 hours).  The reduction in 
VDAC would therefore be expected to result from inhibition of cellular 
transcription even though the total protein was equilibrated in each sample.   
Cells growing in the absence of Actinomycin D showed increasing levels of 
VDAC as is to be expected during normal cellular proliferation (Figure 4.3 
panel A, lanes 2, 4 and 6) although it is uncertain why the initial quantity of 
VDAC detected was lower (Figure 4.3 panel A, lane 2) than that detected 
in the equivalent time period grown in the presence of Actinomycin D 
(Figure 4.3 panel A, lane 2 vs. lane 1).   
 
An equivalent amount of PrV capsid protein was present in the cells after 
12 hours incubation in the presence or absence of Actinomycin D (Figure 
4.3 panel B).  The resolution of the chemiluminescence signal in panel B, 
lane 6 was unfortunately affected by a technical problem during signal 
capture.  Although these results do no conclusively confirm the inhibition of 
cellular transcription, it was decided to proceed with in vivo metabolic 
labelling experiments since the inhibitory concentration of Actinomycin D 
was the same that was used by Pringle et al. (2003) for in vivo labelling of 
viral RNAs in the same cell line.   
 
 
4.3.2. Metabolic radiolabelling of PrV translation products in MG8 
cells 
 
At least seven radiolabelled proteins were detected in the MG8 cells 
treated with Actinomycin D (Figure 4.4).  The relative molecular weights of 
these proteins were estimated to be:  128, 104, 85, 68, 63, 61 and 41 kDa.  
The largest protein of 128 kDa (and also the most dominant in terms of 
signal detection), corresponds closely in terms of molecular weight to the 
predicted p130 protein product which contains ten methionine residues in 
its coding sequence.  The 104 kDa protein corresponds in molecular 
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weight to the replicase protein, p104, with thirty one methionine residues.   
If these two proteins are the translation products of p130 and p104, then 
the relative intensity of the two bands suggests that p104 is expressed at a 
substantially lower rate than p130.  A 41 kDa protein potentially represents 
p40, the potential auxiliary replication protein that contains ten methionine 
residues in its coding sequence.  A comparison of the putative p104 band 
with that corresponding to p40 suggests that p40 may be expressed at 
substantially higher levels than p104 (Figure 4.4).   
 
 
                                     
 
Figure 4.4.  Detection of [35-S]-methionine-metabolically labelled viral translation 
products in MG8 cells treated with Actinomycin D.  Ten micrograms of total cellular 
protein of Actinomycin D-treated MG8 cells grown in the presence of [35-S]-methionine for 
24 hours, was analysed by SDS-PAGE followed by autoradiography.  The molecular 
weight standards are indicated on the left of the autoradiograph and are represented in 
kDa, while the arrows on the right indicate seven dominant radiolabelled proteins and their 
molecular weight.   
 
 
 
The 85 kDa protein that was detected in this experiment could represent 
the translated p81 capsid protein precursor translation product, which has 
a predicted molecular weight of 81 kDa.  A putative capsid precursor 
protein of 68 kDa, which contains 14 methionine residues, was also 
1
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detected.  Two proteins of approximately 61 and 63 kDa were detected, 
either of which might represent the cleaved major capsid protein of PrV 
(p60).  The detection of proteins corresponding in size to the capsid protein 
precursor, p81 and the major capsid protein, p60, was to be expected 
based on the results of Western analysis by Pringle et al. (2003) and in this 
study (Figure 4.3).  No band corresponding to p13, which would be 
translated at the N-terminus of p81, was detected using this method.  This 
could suggest that this peptide was unstable or marked for proteolysis in 
this cellular environment as has been documented with peptides containing 
PEST-like sequences.  The predicted ORF of this protein contains four 
methionine residues.  The minor capsid protein (p8), produced after 
autoproteolytic cleavage during capsid maturation, does not contain any 
methionine residues and thus would not be detected using this 
experimental approach, explaining its absence in the autoradiograph.   
 
Since the MG8 cell line is persistently infected and an uninfected cell line is 
therefore not available, it was not possible to compare the profile of 
labelled proteins in infected vs. uninfected cells. A similar metabolic 
labelling experiment could not be conducted using PrV-infected and 
uninfected FB33 cells because of the low infection rate of this cell line by 
PrV (Pringle et al., 2003).  The Se1 cell line was also shown to be 
permissive to PrV infection but at a lower rate of infection (Pringle et al., 
2003), was not available in the laboratory.  Nevertheless, based on the 
detection of proteins corresponding to within 5 % of the predicted 
molecular weights of all the identified PrV ORFs, the next objective was to 
confirm the identity of some of these proteins by Western analysis of the 
PrV-infected MG8 cells.  Although antibodies recognizing the p130 protein 
were not available during the course of this work, antisera raised against 
PrV virus particles and p40/p104 were used in the subsequent 
experiments.   
 
 
 
 
                               Chapter 4 – Characterization of PrV translation products  
 
112
4.3.3. Western analysis of PrV proteins in MG8 cells 
 
Analysis of cell-free extracts probed with anti-capsid antiserum detected 
the presence of the capsid protein precursor (p68) and the major capsid 
protein (p60) in MG8 cell-free extracts (Figure 4.5 panel A, lane 1).  The 
minor capsid protein (p8) was not detectable under these conditions 
because of the percentage resolving gel used in the SDS-PAGE analysis 
of MG8 cell-free extracts.  The faint bands of non-specific proteins between 
15 - 30 kDa region (Figure 4.5 panel A, lane 1) were attributed to degraded 
capsid proteins commonly observed with purified PrV particles and crude 
preparations containing PrV.  The same antiserum detected a faint cross-
reacting protein in the FB33 cell-free extract with an approximate molecular 
weight of 60 kDa, (Figure 4.5 panel A, lane 2), which appears to be a 
cross-reacting protein from the tissue culture medium used to culture FB33 
cells.  This cross-reactivity was repeatedly observed in other experiments 
and was attributed to a protein present in the foetal calf serum that is 
added to the cell culture medium used for the FB33 cell line.  The MG8 cell 
line does not require foetal calf serum for growth – this cell line cannot 
survive in FCS-supplemented medium. 
    
        
Figure 4.5.  Detection of the VCAP and p40/p104 proteins in PrV-infected MG8 cells.   
(A):  Western analysis of 2 µg of MG8 and FB33 cell-free extract using anti-PrV 
antiserum.  The anti-PrV antiserum was diluted 1 in 100 000.  (B):  Western analysis of 5 
µg of MG8 and FB33 cell-free extract using anti-p40 antiserum (diluted 1 in 100 000).  
Key:  MG8 – MG8 cell-free extract; FB33 – FB33 cell-free extract.  The molecular weight 
standards are indicated on the left of the Western blot and are represented in kDa, while 
the arrows on the right indicate cross-reacting proteins and their respective molecular 
weights. 
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Western analysis of MG8 cell-free extracts using anti-p40 antiserum 
detected a protein migrating at approximately 41 kDa (p40) and a higher 
molecular weight protein of approximately 100 kDa, which may represent 
p104 (Figure 4.5 panel B, lane 1).  Based upon the intensities of their 
chemiluminescent signals, it appeared that p40 was present in much 
higher concentrations than p104.  This result is consistent with relative 
levels of expression of the 41 and 104 kDa proteins observed in metabolic 
labelling experiments (Figure 4.4).  Two cross-reacting proteins migrating 
at 52 and 35 kDa were detected in the FB33 cell-free extract (Figure 4.5 
panel B, lane 2), which appeared to be present in very low concentrations.  
To eliminate the possibility that these protein bands might represent a 
tetravirus infection in the FB33 cell line, a tetravirus extraction protocol was 
performed on the FB33 cells.  No virus particles were detected by T.E.M 
analysis of a sucrose pellet.   This result suggested that the FB33 cell line 
is unlikely to be infected with a tetravirus and that the bands observed in 
the Western blot were most likely the result of non-specific binding to 
cellular proteins.   
 
 
4.3.4. In vitro detection of individual PrV translation products 
 
The previous section described the detection of seven radiolabelled 
proteins in vivo that were attributed to the PrV viral translation products of 
the three ORFs p130, p104 and p81.   Western analysis using anti-PrV 
capsid and anti-p40/p104 antisera identified 4 proteins of 68 and 60 kDa 
(detected by the anti-PrV capsid antiserum) and 40 and 104 kDa (detected 
by the anti-40/p104 antiserum).   While a protein of approximately 128 kDa 
was detected in the in vivo radiolabelling experiments, the absence of anti-
p130 antibodies precluded Western analysis to confirm the presence of 
this protein in MG8 cells.  Thus the data suggested that at least two ORFS, 
(p81 and p104) in the PrV genome were translated in vitro.  The N-terminal 
of p81, which comprises the PEST-like protein p13, was not detected using 
this form of labelling, possibly due to its unstable nature, as is usually 
predicted for PEST-containing peptides.  Coupled in vitro 
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transcription/translation of constructs expressing each of the three PrV 
ORFs was conducted to characterize the translation initiation sites, the 
read-through activity of the stop signal found in p104, as well as the co-
translational processing of the three 2A-like cleavage sites in p130 and 
p81.   
 
Rabbit reticulocyte lysate coupled in vitro transcription/translation of the 
p130 ORF 
 
Expression vectors were constructed, that would allow for the analysis of 
the translation of each of the three ORFs identified on the PrV cDNA 
sequence.  Three variants of the p130 theoretical ORF were analysed 
initially using the rabbit reticulocyte lysate system.  The plasmid pSTA1 
contained the full-length version of p130, while pSTA2 contained a 
truncated ORF starting immediately after the 2A-like processing site (a.a. 
130 – 1221).  The p130 ORF in pSTA3 was also truncated, starting from 
the second potential translation start at Met103.  SDS-PAGE analysis was 
conducted on the protein extracts originating from lysate charged with each 
of the three constructs and the [35-S]-methionine-labelled translation 
products were visualized by autoradiography (Figure 4.6). 
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Figure 4.6.  Detection of coupled in vitro transcription/translation products of 
constructs expressing p130 in rabbit reticulocyte lysates.  Autoradiograph of SDS-
PAGE analysis of rabbit reticulocyte lysates charged with pSTA1-pSTA3.  Lane 1:  control 
reaction with no input plasmid DNA.  Lane 2:  pSTA1 (p130).  Lane 3:  pSTA2 (p130130-
1221).  Lane 4:  pSTA3 (p130103-1221).  The molecular weight standards are indicated on the 
left of the autoradiograph and are represented in kDa, while the arrows on the right 
indicate radiolabelled proteins and their molecular weights. 
 
 
A translation product of 127 kDa was detected in lysates charged with all 
three coding sequence variants; pSTA1, pSTA2 and pSTA3 (Figure 4.6 
lanes 2 - 4).  The size of this protein was calculated and confirmed using 
marker bands as standards.  This 127 kDa protein was not present in 
rabbit reticulocyte lysates that were not charged with plasmid DNA (Figure 
4.6 lane 1).  The full length version of p130 (pSTA1), predicted to start at 
the first methionine (which is in an good context for initiation of translation), 
would be translated into proteins with a predicted size of 117 and 13 kDa 
protein, if the 2A-like processing site at the N-terminal of this coding 
sequence was functional.  The 2A-like cleavage site did not appear to be 
functional in this particular in vitro translation system (Figure 4.6 lane 2).  
The truncated version of the coding sequence (pSTA2), translated from a 
start codon after the 2A-like sequence (PrV-2A1), was predicted to 
translate a protein of 117 kDa.  This was not detected and instead, a 
protein of 127 kDa was detected as the dominant translation product 
(Figure 4.6. lane 3).  A 10 kDa difference between the theoretical 117 and 
127 kDa proteins seen on the autoradiograph should have been detectable 
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using this method.  It is not certain why the translation product of the 
truncated ORF has a larger than expected molecular weight.  This 
phenomenon was repeatedly recorded in both the wheat germ extracts and 
rabbit reticulocyte lysates charged with this expression plasmid.   SDS-
PAGE analysis using high percentage acrylamide ratios were used in the 
analysis of these translation products with the aim of detected the 17 kDa 
protein.  No labelled proteins were detected using this method.   
 
The possibility that translation of these p130 coding sequences is being 
initiated at an out of frame methionine relative to the frame of the p130 
ORF, resulting in this larger than expected protein product was considered.  
However, the first eight AUG codons (at least one of which is positioned in 
one of the two other reading frames) would not be translated into a protein 
of a significant molecular weight nor do they exhibit better Kozak 
sequences for the initiation of translation.  The coding sequence starting at 
the second in-frame methionine residue was predicted to be translated into 
117 and 6 kDa proteins and yet no detectable difference using this 
technique could be established between the observed 127 kDa peptide 
and the other two p130-derived products.  The possibility also exists that 
the p130 frame is translated beyond the first in-frame stop codon, UAA (nts 
3661 – 3663) since a methionine residue is the next codon directly after 
this stop codon.  The extension of the p130 coding sequence beyond the 
first and even a second downstream stop codon only increases the 
molecular weight of this translation product to 132 and 137 kDa, 
respectively making this possibility unlikely for the increase of 10 kDa in 
translation products produced from both pSTA2 and pSTA3.   
 
A protein of 139 kDa was detected at low levels in all three of the in vitro 
translation reactions charged with the p130 constructs, but its significance 
and relatedness to the p130 coding sequence is unknown as C-terminal 
extension of this coding sequence is unlikely because of the in-frame stop 
codons in the adjacent downstream sequence.   Another possibility is that 
the molecular weights of these three products are larger than predicted 
and that the product translated from the full-length ORF is the larger of the 
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two potential products resulting from processing at the 2A-like site and thus 
of a similar  molecular weight as the two other truncated translation 
products.  The smaller of the two resultant processing products, with a 
predicted molecular weight of 17 kDa, might be labile explaining its 
absence using this method of detection.  
 
Rabbit reticulocyte lysate coupled in vitro transcription/translation of the 
p104 ORF 
 
The coding sequences of p40 (pSTA4) and p104 (pSTA5) were analysed 
by radiolabelling of translation products using the rabbit reticulocyte lysate 
in vitro coupled transcription/translation system.  SDS-PAGE analysis was 
performed on immunopreciptated protein extracts originating from lysate 
charged with pSTA4 and pSTA5, followed by either autoradiography of the 
dried resolving gel and Western analysis of lysates using anti-p40 
antiserum.  A 40 kDa protein was expressed from pSTA4 (Figure 4.7 panel 
A, lane 2) and a corresponding 40 kDa protein also detected by Western 
analysis of immunoprecipitated translation products using anti-p40 
antiserum (Figure 4.7 panel B, lane 1).  A 104 kDa protein was the 
dominant translation product of pSTA5 (containing the native p104 ORF), 
although a faint 40 kDa band corresponding to p40 was also detected 
(Figure 4.7 panel A, lane 3). The relative levels of p40 vs. p104 were not 
equivalent to those seen in the metabolically labelled translation products 
analysed in MG8 cells. Perhaps this is a consequence of the animal in vitro 
transcription/translation system used.   Both the 104 kDa and 40 kDa 
proteins were detected by Western analysis of immunoprecipitated 
translation products using anti-p40 antiserum (Figure 4.7 panel B, lane 2). 
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Figure 4.7.  Detection of coupled in vitro transcription/translation products of 
constructs expressing p40/p104 in rabbit reticulocyte lysates.  (A): Autoradiograph of 
SDS-PAGE analysis of rabbit reticulocyte lysates charged with pSTA4 and 5.  Lane 1: 
control reaction with no input plasmid DNA (-ve).  Lane 2:  pSTA4 (p40).  Lane 3:  pSTA5 
(p104).  (B):  Western analysis of immunoprecipitated protein (anti-p40 antiserum) in 
lysate charged with pSTA4 (lane 2) and pSTA5 (lane 3) using anti-p40 antiserum (1 in 
50 000 dilution).  The asterisks (*) indicate cross-reacting rabbit IgG heavy and light 
chains present as a result of the immunoprecipitation step.  The molecular weight 
standards are indicated on the left of the autoradiograph and Western blot and are 
represented in kDa, while the arrows on the right indicate the molecular weights of 
radiolabelled proteins and immunoreactive proteins, respectively.   
 
 
Since immunoprecipitation of these translation products was required prior 
to Western analysis (the sensitivity of the anti-p40 serum was not 
particularly high when probed against pSTA5-charged lysate alone), cross-
reacting rabbit immunoglobulin heavy and light chains were also detected.  
These cross-reacting proteins of approximately 50 and 110 kDa did not 
interfere with the signals detected for p104 and p40.   
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Rabbit reticulocyte lysate coupled in vitro transcription/translation of the 
p81 ORF 
 
                 
              
Figure 4.8.  Detection of coupled in vitro transcription/translation products of 
constructs expressing p81 in rabbit reticulocyte lysates.  (A): Autoradiograph of SDS-
PAGE analysis of rabbit reticulocyte lysates charged with pSTA7 and pSTA8.  Lane 1: 
control reaction with no input plasmid DNA (-ve).  Lane 2: pSTA8 (p81122-754).  Lane 3:  
(p81).   (B):  Western analysis of lysates charged with pSTA7 and pSTA8 by Western 
analysis using anti-PrV capsid antiserum.  Lane 1: pSTA7 (p81).  Lane 2:  pSTA7 (p81122-
754).  The molecular weight standards are indicated on the left of the autoradiograph and 
Western blot and are represented in kDa, while the arrows on the right indicate the 
molecular weights of radiolabelled and immunoreactive proteins, respectively.   
 
 
 
Expression plasmids carrying the coding sequences of the virus capsid 
protein precursor (p81) (pSTA7) and a truncated version, where the start of 
translation occurs after the second 2A-like processing (pSTA8 – p81aa121-
754), were analysed using the rabbit reticulocyte lysate coupled in vitro 
transcription/translation system (Figure 4.8).   A 68 kDa translation product 
corresponding to the processed capsid protein precursor (p68) was 
detected in lysates charged with both pSTA7 and pSTA8 (Figure 4.8 panel 
A, lanes 2 & 3 and panel B, lanes 1 & 2).  The bands in panel B, although 
over exposed, are distinct.  The reason for this overexposure was to 
confirm that no 15 kDa protein cross-reacted with the anti-PrV antiserum.  
The amount of capsid protein originating from the truncated version of the 
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coding sequence (pSTA8) was much less than that of the equivalent 
translation product of the full length version of the p81 coding sequence 
(pSTA7).  In addition, a translation product migrating at approximately 15 
kDa was detected in the lysates charged with the plasmid expressing the 
wild-type p81 ORF (Figure 4.8. panel A, lane 3).  If the co-translational 
processing of the p81 capsid precursor ORF occurs, a 13 kDa protein 
would be produced during translation of p81 in addition to the 68 kDa 
capsid protein precursor.  A single dominant protein of 68 kDa and two 
dominant proteins of 68 and 15 kDa were detected in lysates charged with 
the plasmid pSTA8, expressing p81122-754, and pSTA7, expressing p81 
(Figure 4.8 panel A, lane 3), respectively. Thus, this result confirms that the 
second 2A-like cleavage site on the p81 coding sequence (PrV-2A3) is 
active in the rabbit reticulocyte lysates and that this sequence results in the 
capsid precursor protein processing mechanism employed by PrV.  This 
co-translational processing also follows the same sequential order and 
mechanism described in the capsid precursor processing of the 
betatetravirus, TaV (Pringle et al., 2001; Donnelly et al., 2001b).  The 15 
kDa translation product resulting from pSTA7 (Figure 4. 8 panel A, lane 3) 
is not immunoreactive to anti-PrV capsid anti-serum, suggesting that this 
peptide may not be present in PrV virion (Figure 4.8 panel B, lane 2).  No 
mature capsid protein (p60) was detected, indicating that no particle 
maturation had occurred.  It is likely that this is due to inefficient assembly 
in vitro of the capsid protein precursor into the provirion in this cell lysate 
environment which is buffered and will therefore not decrease in pH over 
the course of infection.  It is this decrease in pH (possibly the result of 
apoptosis that typically results in the particle maturation of tetraviruses in 
the host cellular environment.  Another possibility is that, in the reticulocyte 
lysate environment, processing of the capsid precursor into mature capsid 
proteins takes longer than the 1.5 hour time allowed for translation of 
proteins in this system.  This explanation of a sub-optimal protein 
processing system would also explain the large percentage of p68 present 
in purified PrV and in the in vivo labelling system.   
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Wheat germ extract coupled in vitro transcription/translation of PrV 
translation products  
 
The results of bioinformatic analysis of the PrV replicase suggested a close 
phylogenetic relationship with the tombus- and umbraviruses (Chapter 2, 
Sections 2.3.2 and 2.3.5), which are both plant virus families.  It was 
therefore decided to also examine the translation products and co-
translational processing of the PrV ORFs in a wheat germ extract coupled 
in vitro transcription/translation system.   Plasmid constructs expressing 
the three ORFs were therefore used to charge a wheat germ extract 
system, and the [35-S]-methionine-labelled translation products were 
analysed by SDS-PAGE, followed by autoradiography (Figure 4.9).     
 
 
 
     
 
Figure 4.9.  Detection of coupled in vitro transcription/translation products of 
constructs expressing p130, p40/p104 and p81 in wheat germ extracts.    (A): 
Autoradiograph of SDS-PAGE analysis of wheat germ extracts charged with pSTA1 – 3.  
Lane 1: pSTA1 (p130). Lane 2:  pSTA2 (p130130-1221). Lane 3: pSTA3 (p130103-1221) extract 
charged with pSTA3.  (B):  Autoradiograph of SDS-PAGE analysis of wheat germ extracts 
charged with pSTA4 and pSTA5.  Lane 4: pSTA4 (p40).  Lane 5:  pSTA5 (p104). (C):  
Autoradiograph of SDS-PAGE analysis of wheat germ extracts charged with pSTA7 and 
8.    Lane 6:  pSTA7 (p81).  Lane 7:  pSTA8 (p81122-754).  The molecular weight standards 
are indicated on the left of the autoradiographs and are represented in kDa, while the 
arrows on the right indicate the molecular weights of radiolabelled proteins. 
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As was observed in the rabbit reticulocyte system, the three plasmids 
expressing the p130 coding sequence (pSTA1), a truncated version 
translated from after the 2A-like processing site (pSTA2) and a third variant 
where the coding sequence starts at an alterative translation start (pSTA3), 
produced a radiolabelled protein of approximately 127 kDa (Figure 4.9 
panel A, lanes 1 – 3).  The absence of a 17 kDa protein from translated 
pSTA1 and pSTA3 indicated that no co-translational processing of the 
p130 was occurring at the PrV-2A1 site.  This indicated that the 2A-like 
cleavage site was not active under these in vitro experimental conditions.  
 
Wheat germ lysates charged with pSTA4, containing the p40 ORF 
produced a radiolabelled protein of 40 kDa corresponding to p40 (Figure 
4.9 panel B, lane 4).  In the case of the constructs expressing the p104 
ORF (pSTA5), a 40 kDa and a 104 kDa protein, corresponding to p40 and 
p104, respectively, were detected in the wheat germ extracts (Figure 4.9 
panel B, lane 5).  However, unlike the rabbit reticulocyte system, p40 was 
expressed at significantly higher levels relative to p104 in the wheat germ 
system suggesting that the suppression of the read-through stop signal 
was less efficient in the plant system.  The levels of p40 relative to p104 in 
the wheat germ system were similar to those observed in PrV-infected 
MG8 cells (Figure 4.5 panel B, lane 1).   p40 (pSTA4) was translated at 
high levels in this system and the smaller protein of about 32 kDa detected 
with this product and other products translated at moderate to high levels 
(Figure 4. 9 lanes 4 - 7), is most likely an endogenous protein resulting 
from residual aminoacyl tRNAs - an artefact often observed when using 
this in vitro system.  p104 (pSTA5) was translated into a 104 kDa protein 
and high levels of a 40 kDa protein (Figure 4.9, lane 5).   
 
The two plasmids expressing the capsid precursor ORF, as well as a 
truncated version starting immediately after the 2A-like cleavage site 
(pSTA7 and 8), resulted in the detection of a 68 kDa translation product 
consistent with the size of the capsid protein precursor following 2A-like 
processing (Figure 4.9 panel C, lanes 1 and 2).  A second protein of 15 
kDa was detected in wheat germ lysates charged with pSTA7 (expressing 
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the full p81 ORF), attributed to ‘p13’, the peptide resulting from 2A-like 
processing of p81 since this protein was not produced by pSTA8.   Thus, 
as observed in the rabbit reticulocyte system, the PrV-2A3 processing 
sequence appeared to be active, while no PrV-2A2 activity was observed.   
 
 
4.4. CONCLUSION 
 
In vivo labelling of viral translation products in the persistently PrV-infected 
MG8 cells detected the presence of seven radiolabelled proteins, of which 
six corresponded to the predicted molecular weight of the translation 
products of p130, p104/p40 and p81 (p68 and p60), originating from the 
predicted ORFs.  Western analysis confirmed the presence of proteins 
corresponding to p40 and p104, indicating that the read-through stop 
codon identified in the p104 ORF is functional in vivo.   The capsid protein 
precursor (p68) and major capsid protein (p60) were also detected, 
confirming the results of Pringle et al. (2003).  However, the three peptides 
predicted to result from 2A-like processing at the N-terminus of p81 to 
produce p68 were not detected and instead a single small 15 kDa protein 
and the capsid precursor protein of 68 kDa were observed in both systems.   
 
The expression of p130 in virus-infected cells remains to be confirmed and 
is dependent on the availability of p130-specific antibodies.  Also, a future 
experiment should involve the isolation of (over)expressed p130 followed 
by the MS analysis of this peptide to confirm its amino acid sequence and 
thus translational origins.  The results of the in vitro coupled 
transcription/translation systems showed that p130, p104 and p81 were 
translated in both animal and plant systems.  In addition, it was 
demonstrated that the read-through stop codon present in p104 was 
functional, since the presence of p104 and p40 was detected.  However, it 
appeared that the read-through activity of this stop codon was different in 
the two translation systems, with more p104 produced in the rabbit 
reticulocyte system.  The levels of p40 relative to p104 in the wheat germ 
translation system corresponded to the levels of both proteins detected in 
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PrV-infected cells, supporting the bioinformatic data that the read-through 
signal could have originated from a plant virus.  Only one of the three 2A-
like sequences, PrV-2A3, appears to be active in vitro.  This contradicts the 
data of Luke et al. (2008), who reported that both PrV-2A1 and PrV-2A2 
were active in vitro, although not tested in the context of the wild-type 
surrounding coding sequence on either side of these processing signals.  
An interesting experiment to perform would be to measure the activities of 
these processing sites using a reporter system in the context of the wild-
type sequence.   
CHAPTER 5  
Establishing a system for studying the subcellular 
distribution of p40 and viral RNA in MG8 cells  
 
 
5.1. INTRODUCTION 
 
The replicase proteins of (+)ssRNA viruses are known to encode at least 
an RNA-dependent RNA polymerase catalytic core.  This domain 
associates itself with a subcellular membrane within the host cell and 
makes up a critical component of the viral replication complex (Ahlquist et 
al., 2003).  This association with a subcellular membrane that usually 
originates from an organelle, is thought to be important in: (1) physically 
shielding the newly produced viral RNA from host defences such as RNAi 
(Jonczyk et al., 2007), (2) providing a physical anchor for the replication 
complex to provide the essential membrane lipids required for 
polymerization and (3) as a means of concentrating these components into 
small areas within the host cellular environment (Lee et al., 2006).  The 
subcellular localization and thus the variety of organelles used for this 
purpose vary substantially, even between viruses of the same genus 
(Ahlquist et al., 2003).     
 
Another important morphological structure, which has been observed at the 
site of some replicating viruses, is the aggresome (Wileman, 2006; 
Netherton et al., 2008).  Aggresomes act as a component-concentrating 
subcellular structure and, although well-characterized in terms of their role 
in the replication of large dsDNA viruses (Wileman, 2006), little is known 
about their biological importance and frequency of occurrence during the 
infection of a cell by certain ssRNA viruses.   The aggresome is surrounded 
by filaments of vimentin and these complexes have been shown to recruit 
chaperones, proteasomes and mitochondria, most likely to facilitate as a 
site for protein folding and degradation (Wileman, 2006).  The default 
protein degradation pathway in these structures must be altered in order to 
125
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keep the replication complex intact (Wileman, 2006).   Pausing this cellular 
pathway might entail halting the entry of autophagosomes into the 
aggresome and/or subsequent fusion of the complex with lysosomes 
(reviewed in Wileman, 2006).  
 
The presence of either structurally altered subcellular organelles or 
aggresomes during virus infection are two key subcellular structures 
indicating the presence of replicating viral RNA (Netherton et al., 2008).  
Information on these structures, as well as knowledge on the site of 
replication of related viruses, is used in predicting this site within a virus-
infected host cell (reviewed in Netherton et al., 2008).  Data analyzed and 
discussed in Chapters 2 and 4 has revealed that PrV may employ a unique 
replication strategy compared to other members of the Tetraviridae family.  
Like the tombusviruses, PrV might be utilizing an auxiliary protein and a 
full- length replicase protein for replication of its viral genome.  Based on 
prior reports of the co-localization of the auxiliary and replicase proteins at 
the site of tombusvirus replication (Scholthof et al., 1995; Weber-Lotfi et al., 
2002; Pantaleo et al., 2004), it is hypothesized that PrV p40 recruits and 
then co-localizes with other p40 molecules, p104, specific host proteins and 
viral RNA to a membrane-associated subcellular site of replication within 
the PrV-infected cells. 
 
Based on this hypothesis, this chapter serves to investigate the subcellular 
distribution of p40 both in transiently expressing cells and within the PrV-
infected MG8 cell line.  Fluorescence microscopy and biochemical 
fractionation techniques were developed to investigate the distribution of 
transiently expressed p40 fused to enhanced green fluorescent protein 
(eGFP) in Sf9 cells and ‘endogenous’ p40 (and p104) in persistently 
infected H. zea MG8 cells.  The distribution of viral RNA in the infected 
MG8 cell line was also examined and compared with the subcellular 
distribution of p40/p104.   
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5.2. MATERIALS AND METHODS 
 
Unless otherwise stated, all gene manipulation methods were performed 
according to Sambrook et al. (1989) and protein analysis as described by 
Laemmli (1970).  The cloning strain of E. coli (DH5α) (Hanahan, 1983) was 
used to propagate and clone all plasmids described below.   Primers 
sequences are listed in Appendix 1 and additional montages of confocal 
images are shown in Appendix 7. 
 
5.2.1. Expression plasmid design and construction 
 
The plasmid pA1 (generously supplied by Prof. Vernon Ward, Department 
of Microbiology and Immunology, School of Medical Sciences, University of 
Otago, Dunedin, New Zealand) contains the kanamycin resistance and 
ampicillin resistance genes, the SV40 origin of replication and the 
baculoviral AcMNPV polH promoter.  The coding sequence of eGFP was 
cloned into this vector by digesting pA1 and the commercial mammalian 
expression vector, pEGFP-N1 (Clontech), with Hind III and Not I.  The 779 
bp Hind III/Not I fragment containing the eGFP ORF from pEGFP-N1 was 
ligated into the Hind III/Not I backbone of pA1.  The resultant construct, 
pCW31, contains the eGFP coding sequence immediately downstream of 
the AcMNPV polH promoter (Figure 5.1).   
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Figure 5.1.  Cloning strategy used in the construction of the expression plasmid, 
pCW31.  AmpR:  β-lactamase gene; pUC oriR:  bacterial origin of replication; SV40 Ori:  
Simian vacuolating virus 40 origin of replication; SV40 poly A signal: Simian vacuolating 
virus 40 poly-A sequence; Kan/NeoR:  kanamycin/neomycin phosphotransferase, P-CMV: 
cytomegalovirus promoter; f1 Ori:  F1 bacteriophage origin or replication.   
 
 
The p40 coding sequence was amplified from pFLM1 (containing the entire 
PrV genome) using the primers CW9 (which introduces a Nde I site at the 
5`-end of the p40 coding sequence) and CW13 (which creates a Bcl I site 
in place of the read-through stop codon).  The 1085 bp amplicon was 
ligated into the commercial vector pGEM-T Easy (Promega) to produce 
pCW35.  pCW35 was then digested with Sac II and Bcl I and the insert 
containing the p40 coding sequence minus the UAG stop codon was 
ligated into the Sac II/Bam HI-digested backbone of pCW31 (Figure 5.2).  
The final construct, pCW39, is therefore an insect expression vector driving 
the expression of p40-eGFP under the control of the AcMNPV promoter.    
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Figure 5.2.  Cloning strategy used in the construction of the expression plasmid, 
pCW39.  AmpR: β-lactamase gene; pUC oriR:  bacterial origin of replication; SV40 Ori:  
Simian vacuolating virus 40 origin of replication; SV40 poly-A signal: Simian vacuolating 
virus 40 poly-A sequence; Kan/NeoR:  kanamycin/neomycin phosphotransferase.   
 
An expression vector, expressing the p40-eGFP fusion protein under the 
control of an enhanced promoter, was derived from the expression vector 
phrA1GFP (generously supplied by Vernon Ward, Department of 
Microbiology and Immunology, School of Medical Sciences, University of 
Otago, New Zealand), which carries an enhancer-promoter fusion – 
hr/AcMNPV. The enhancer element comprises nine small 150-800 bp of 
repeated sequences derived from the genome of the baculovirus, 
AcMNPV.  These nine repeats, referred to as homologous regions (hrs) 
(Ayers et al., 1994), have each been found to act as early transcriptional 
enhancers (Guarino et al., 1986; Guarino and Summers, 1986).  These 
repeats have been engineered into insect expression promoters due to the 
marked increase these enhancers confer on insect virus promoter activity 
(Lo et al., 2002).    The enhanced baculovirus promoter (hr/AcMNPV) was 
PCR amplified from phrA1GFP using primers CW19 (introducing an Aat II 
restriction site at the start of the enhanced promoter sequence) and CW20 
(introducing a Hind III restriction site at the 3`-end of the enhanced 
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promoter sequence).   The 1211 bp amplification product was directly 
ligated into pGEM-T Easy vector and the resultant plasmid (pCW44) 
sequenced.  Amplicons that had ligated into pGEM-T Easy vector in the 
correct orientation (pCW44R) were used in the subsequent sub-cloning 
experiments, whereby the AcMNPV promoter in pCW39 was substituted for 
the enhanced version, hr/AcMNPV.  The expression plasmid, pCW55, was 
constructed by digesting pCW44R with Aat II and Sac II, and the resultant 
1222 bp fragment containing the enhanced promoter ligated into the Aat 
II/Sac II backbone of pCW39 (Figure 5.3).  The plasmid, pCW55, contained 
the hr/AcMNPV promoter driving the expression of p40 fused to the N-
terminus of eGFP.  
 
 
 
Figure 5.3.  Cloning strategy used in the construction of the expression construct, 
pCW55.  AmpR: β-lactamase gene; pUC oriR:  bacterial origin of replication; SV40 Ori:  
Simian vacuolating virus 40 origin of replication; SV40 poly-A signal: Simian vacuolating 
virus 40 poly A sequence; Kan/NeoR:  kanamycin/neomycin phosphotransferase. 
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In order to construct an expression construct with the p40 coding sequence 
fused to the C-terminus of eGFP, the Aat II/Sac II fragment of pCW44R, 
containing the enhanced promoter, was ligated into the Aat II/Sac II-
digested backbone of pCW31.  The resultant insect expression plasmid, 
pCW56, contained the enhanced promoter (hr/AcMNPV) driving the 
expression of eGFP (Figure 5.4). 
 
 
 
Figure 5.4.  Cloning strategy used in the construction of the expression plasmid, 
pCW56.  AmpR: β-lactamase gene; pUC oriR:  bacterial origin of replication; SV40 Ori:  
Simian vacuolating virus 40 origin of replication; SV40 poly-A signal: Simian vacuolating 
virus 40 poly A sequence; Kan/NeoR:  kanamycin/neomycin phosphotransferase.   
 
 
The commercial mammalian expression vector, pEGFP-C1 (Clontech), was 
linearized with Eco RI.  pCW35 was digested with Eco RI, and a 1103 bp 
fragment (containing the p40 coding sequence) was ligated into the 
linearized pEGFP-C1 to  construct pCW54 – a mammalian expression 
vector driving the expression of the eGFP-p40 fusion protein.  Using the 
existing eGFP-p40 fusion within the plasmid pCW54, this fragment was 
excised by digestion of pCW54 with AgeI/Nsi I and the 2832 bp fragment 
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ligated into the AgeI/Nsi I backbone of pCW56, thus substituting the eGFP 
in pCW56 with the eGFP-p40 fusion removed from the vector, pCW54.  
The resultant insect expression plasmid, pCW57, contained the enhanced 
promoter immediately upstream of the eGFP-p40 fusion (Figure 5.5). 
 
 
 
Figure 5.5.  Cloning strategy used in the construction of the expression construct, 
pCW57.  AmpR: β-lactamase gene; pUC oriR:  bacterial origin of replication; SV40 Ori:  
Simian vacuolating virus 40 origin of replication; SV40 poly A signal: Simian vacuolating 
virus 40 poly A sequence; Kan/NeoR:  kanamycin/neomycin phosphotransferase, P-CMV: 
cytomegalovirus promoter.   
 
 
The leader sequences, invertebrate Kozak sequences (Caverner, 1987, 
Sano et al., 2002), of each expression vector as well as the correct stop 
codon at the end of each fusion protein were confirmed by sequence 
analysis.  Due to the presence of the promoter enhancer element in the two 
expression vectors, pCW55 and pCW57, these two plasmids were selected 
for the expression of large quantities of p40-eGFP and eGFP-40 protein, 
respectively, in transfected insect cells.   
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5.2.2. Transfection of insect cell lines 
 
Sf9 monolayers were transfected using a method obtained from Prof, 
Vernon Ward (Department of Microbiology and Immunology, School of 
Medical Sciences, University of Otago, Dunedin, New Zealand, pers. 
comm., 2006).  Single glass coverslips were added to single wells of a 24-
well cell culture plate.  1 ml of complete TC100 medium was added to the 
coverslip followed by the addition of approximately 1.8 X 105 Sf9 cells 
resuspended in fresh, complete medium.  The plate was gently agitated in 
order to disperse the cells evenly on the coverslip and then incubated at 28 
ºC until the cell monolayer reached 50 % confluence. 1 µg of plasmid DNA 
(prepared using Qiaprep Spin Miniprep columns by Qiagen®) was added 
along with 4 µl of Fugene® HD (Roche Applied Science) to serum-free 
medium to make up a final volume of 100 µl.  This transfection mixture was 
incubated at room temperature for 45 minutes after which it was added 
drop-wise to the Sf9 cells growing onto the coverslip. The transfection 
mixture was left at 28 ºC for 4 hours, after which a further 1 ml of complete 
medium was added and the cells incubated at 28 ºC for 3 days or until each 
monolayer had reached complete confluence.  The medium was removed 
from the well and rinsed once with 400 µl of phosphate-buffered saline 
(PBS) (pH 7.4).  To fix the cells on the coverslips, 400 µl of 
paraformaldehyde (4 % w/v in PBS pH 7.4) was added to each well and 
incubated at room temperature for 20 minutes.  Each coverslip was rinsed 
twice in 400 µl of PBS for 10 minutes at room temperature, with gentle 
agitation.  Following the first two washes in PBS, the nuclear stain, 4', 6-
diamidino-2-phenylindole (DAPI), was added to a final concentration of 5 
µg/ml in 400 µl of PBS for 5 minutes and the coverslip rinsed once more in 
PBS.   Finally, the coverslips were rinsed in triple-distilled water, the 
reverse side of the slip dried and the side containing the cells mounted face 
down into ~2.5 µl of mounting medium (Dako Cytomation) and placed in 
the centre of a glass slide. 
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5.2.3. Biochemical fractionation to determine subcellular 
distribution of p40 in insect cell lines 
 
The following protocol, which is based on a modified protocol obtained from 
Prof. Tom Wileman (School of Medicine, Health Policy and Practise, 
University of East Anglia, Norwich, England), was used to obtain 
subcellular fractions of insect cells transiently expressing p40-eGFP 
fusions.  The protocol was validated using the mitochondrial membrane 
protein, VDAC, (a known membrane-associated 30 kDa protein) as a 
marker in subsequent Western analyses.  Western analysis of VDAC 
protein using anti-VDAC antibodies (Santa Cruz Biotechnology) detected 
the 30 kDa mitochondrial protein in the post-nuclear and membrane 
fractions. 
   
To fractionate membrane-associated proteins from insoluble protein and 
aggregates, a 100 % confluent monolayer of transfected Sf9 cells in a 24-
well cell culture plate, transfected with pCW55 or pCW57, was 
resuspended in the existing growth medium.  The cells  were pelleted by 
centrifugation at 5 000 g for 2 minutes at room temperature and the cellular 
pellet resuspended in 1 ml of chilled buffer (50 mM Tris-Cl, pH 7.4; 1 mM 
EDTA; 8 % (w/v) sucrose and one Complete™ EDTA-free protease 
inhibitor cocktail tablet per 50 ml of buffer (Roche Applied Science).  The 
suspended cells were disrupted by passing through a 25 gauge needle 
twenty times.  These lysates were then centrifuged at 3 300 g for 2 minutes 
at 4 ºC, the supernatant transferred to a fresh microfuge tube and the pellet 
re-extracted as described above.  The pooled supernatant, referred to as 
the post-nuclear fraction due to the absence of the nuclei, was further 
fractionated to obtain a solubilized membrane fraction and an 
aggregates/insoluble protein fraction. 
 
The post-nuclear fraction was centrifuged at 17 000 g for 20 minutes at 4 
ºC and the resultant pellet resuspended in 500 µl of chilled IPB buffer (see 
Appendix 6) containing 2 % v/v Triton X-100.  The resuspended extract 
was centrifuged at 17 000 g for 20 minutes at 4 ºC and the supernatant 
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(solubilized membrane fraction) transferred to a new microfuge tube.  The 
pellet was resuspended in 500 µl of chilled IPB buffer containing 2 % v/v 
Triton X-100, centrifuged at 17 000 g for 20 minutes at 4 ºC and the 
supernatant added to the solubilized membrane fraction.  The pellet was 
resuspended (and solubilized for further analysis) in 500 µl of 50 mM 
HEPES buffer pH 7.4 containing 1 % v/v SDS.  The protein concentration in 
these fractions was quantified by Bradford’s assay (Bradford, 1976), then 
concentrated by ethanol precipitation, if necessary (Chapter 3, Section 
3.2.2) and resolved by SDS-PAGE followed by Western analysis.  A total of 
2 µg from each fraction was electrophoresed, in duplicate, in 12 % 
glycine/acrylamide resolving gels, transferred to nitrocellulose membrane 
and subjected to Western analysis using polyclonal anti-p40 antiserum as 
described in Chapter 3, Section 3.2.2.   
 
The MG8 cell line was subjected to the same subcellular fractionation 
protocol described above.  Additionally, total membrane and cytoplasmic 
fractions were obtained by halving the post-nuclear fraction and subjecting 
one half to the procedure described above.  The remaining half was 
fractionated as follows:  the post-nuclear fraction was centrifuged at 17 000 
g for 20 minutes at 4 ºC, the supernatant made up to 1 ml in 50 mM 
HEPES, pH 7.4 and the pellet resuspended in 1 ml of HEPES buffer.  Both 
supernatant and pellet were centrifuged at 17 000 g for 20 minutes at 4 ºC, 
the supernatants pooled and made up to 4 ml in HEPES buffer followed by 
a final centrifugation at 17 000 g for 20 minutes at 4 ºC.  The supernatant 
(cytoplasmic fraction) was transferred to a fresh microfuge tube while the 
resultant pellet (membrane fraction) was resuspended in 1 X IPB 
containing 2 % Triton X-100 (v/v).  The protein concentration in subcellular 
fractions of MG8 cells was quantified and analysed as above and subjected 
to Western analyses using polyclonal anti-PrV and anti-p40 antisera as 
described in Chapter 4, Section 4.2.2.   
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5.2.4. Bromouridine labelling of viral RNA in the MG8 cells 
 
The protocol for bromouridine labelling of viral RNA was carried out 
according to a protocol modified from Wansink et al., 1993 and Dr. D. J 
Miller (Department of Medicine and the Department of Microbiology and 
Immunology, University of Michigan Medical School, Ann Arbour, Michigan, 
USA, pers. comm., 2006).  Single glass coverslips were added to wells of a 
24-well cell culture plate.  Approximately 5 X 105 MG8 cells resuspended in 
fresh, complete ExCell 420 medium were added to the coverslip to obtain 
80 – 90 % confluence.  The plate was gently agitated in order to disperse 
the cells evenly on the coverslip.  Once settled, the cells were treated with 
a 20 µg/ml concentration of Actinomycin D as described in Chapter 4, 
Section 4.2.1, with the exception that complete medium was used during 
the addition of Actinomycin D.  The labelling/transfection mixture was made 
up as follows:  5.1 µl of Fugene® HD (Roche Applied Science); 8.5 µl of 5` 
bromouridine 5` triphosphate sodium salt (BrUTP) (10 mM final 
concentration); 3.4 µl of Actinomycin D (20 µg/ml final concentration); and 
68 µl of complete medium (to a final volume of 85 µl), gently mixed and 
allowed to equilibrate to room temperature for 15 minutes.  Following the 
pre-treatment with Actinomycin D and equilibration of the 
labelling/transfection mixture, the existing medium over the monolayer of 
cells was removed and 85 µl of equilibrated mixture added drop-wise to 
each well.  Following the observation by Pringle et al. (2003) that sufficient 
RNA synthesis was detected after 3 hours of [3H]-uridine metabolic 
radiolabelling, MG8 cells were incubated in the presence of 20 µg/ml 
Actinomycin D for 3 hours at 28 ºC.  After bromouridine incorporation, the 
MG8 cells were fixed as described above and subjected to 
immunofluorescence as described below.   
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5.2.5. Fluorescence microscopy 
 
Visualization of p40-eGFP in transfected Sf9 cells 
 
The expression plasmids, pCW55 and pCW57, were used to individually 
transfect Sf9 cells.  After an appropriate period of time, the cells were fixed, 
stained with DAPI, mounted onto a glass slide and imaged by confocal 
microscopy.  In all experiments, a Zeiss LSM 5-Meta inverted confocal 
laser scanning microscope (Carl Zeiss Optics®) was used to view 
transfected or labelled cells under a 63 X oil objective and images captured 
directly by the detector system.  A dual track sequential line by line mode 
was set to scan and image 1 µm optical slices of cells at a resolution of 
1768 x 1768 pixels unless otherwise stated.  The helium/neon and argon 
lasers were set at excitation wavelengths of 488 (GFP) and 405 (DAPI) nm 
and attenuated to 2 - 10 % and 2 % laser power, respectively, during the 
imaging of cells in Figures 5.2 and 5.3 below.   Two filter channels were set 
to detect wavelength emissions at 420 nm and 505 - 530 nm in order to 
visualize the eGFP and DAPI staining, respectively.   All images were 
analyzed using the Zeiss LSM 5 Image Browser software program v 4.2.0.   
 
Immunofluorescence and fixing of bromouridine- labelled MG8 cells 
 
Following labelling, the medium was removed from each well containing a 
cell monolayer and rinsed once with 400 µl of PBS (pH 7.4).  To fix the 
cells, 400 µl of paraformaldehyde (4 % w/v in PBS pH 7.4) was added to 
each well and incubated at room temperature for 20 minutes.  Each well 
was rinsed once with 400 µl of PBS and the cells equilibrated in 400 µl of 
permeabilization buffer (1 % Triton X-100; 10 % sucrose; 5 % goat serum 
in PBS) for 20 minutes at room temperature, with gentle agitation.  A 1 in 
50 dilution of mouse monoclonal anti-BrUTP primary antibody (Sigma®) in 
a total of 400 µl of permeabilization buffer was added to each well and 
incubated for 90 minutes at room temperature with gentle agitation.   
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Following incubation in primary antibody, each well was rinsed three times 
in 400 µl of PBS-Tween (1 % v/v Tween-20) for 10 minutes at room 
temperature with gentle agitation.  Next, the secondary antibody, anti-
mouse antibody conjugated to Texas Red (sulphur rhodamine) (Invitrogen 
Molecular probes™) was diluted in 400 µl of permeabilization buffer, added 
to each well and incubated for 30 minutes at room temperature with gentle 
agitation.  Each well was then rinsed three times in 400 µl of PBS-Tween 
for 10 minutes at room temperature, with gentle agitation.  In the second of 
the three washes, DAPI was added to a final concentration of 5 µg/ml.  The 
coverslips were rinsed in dddH20 and mounted on glass slides as described 
in Section 5.2.2.  The primary and secondary antibody dilutions were 
optimized and the fixed cells visualized as described in Section 5.2.5 using 
confocal laser scanning microscopy.  The fluorophore, Texas Red, was 
excited using a helium/neon laser attenuated to 30-40 % and the 
fluorescence subsequently detected at 546 nm.   The Texas Red 
fluorophore combined with the filter sets and lasers did not produce an 
optimal signal output but the use of this particular secondary antibody 
conjugate was unavoidable at the time of experimentation. 
 
 
5.2.6. Immunofluorescence of p40 (and p104) in MG8 cells. 
 
Immunofluorescence was used for the detection of p40/p104 in the MG8 
cell line as described in Section 5.2.5.  Primary rabbit anti-p40 antiserum 
(Chapter 3) and secondary antibody [goat anti-rabbit antiserum conjugated 
to fluorescein isothiocyanate (FITC) (Zymax™ by Zymed] dilutions were 
optimized and fixed cells visualized as described in Section 5.3.3, using 
confocal laser scanning microscopy.  FITC was excited using argon laser 
attenuated to 1 - 10 % and the fluorescence subsequently detected at a 
wavelength of 488 nm.   The MG8 cells were directly probed with anti-p40 
antiserum (1 in 100 dilution) followed by the addition of the secondary 
antibody, goat anti-rabbit FITC conjugate (1 in 400 dilution).   
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Co-localization of PrV p40 and vRNA in MG8 cells 
 
Due to a high degree of both green/yellow auto-fluorescence as well as low 
levels of p40 production in all the MG8 cells, the experiments below were 
optimized in order to gain preliminary evidence of vRNA and p40/p104, as 
well as other potentially cross-reacting cellular proteins co-localizing in 
these cells.  Co-localization of the auxiliary protein, p40 (and p104 due to 
the use of the anti-p40 antiserum) and PrV vRNA (bromouridine labelling) 
in persistently infected MG8 cells required a dual immunofluorescence 
labelling of these two molecules.  This was achieved following BrUTP 
incorporation in the presence of Actinomycin D so as to eliminate cellular 
RNA background signal.  Accordingly, monolayers of MG8 cells were 
subjected to co-localization experiments by using both anti-p40/anti-rabbit 
FITC and anti-BrUTP/anti-mouse Texas Red primary and secondary 
antiserum/conjugate combinations in order to detect immunofluorescence 
as described in Sections 5.2.4 and 5.2.5.   
 
Cells exhibiting typical p40 expression were identified and selected for 
imaging using filter combinations set to detect Texas Red, FITC and DAPI 
emissions.  The lasers and settings remained unaltered from those 
described in Sections 5.2.4 and 5.2.5 and candidate cells (those with both 
strong Texas Red and FITC signals) were selected for imaging, followed by 
the FITC and finally DAPI channel to minimize the photobleaching effect of 
the shorter wavelengths on the specimen.   The fluorescence signal from 
the Texas Red was digitally summed up four times so as to minimize 
background signal otherwise created by alternatively increasing the laser 
power in order to equalize this signal to that emitted by the FITC 
fluorophore.  Three images of each candidate cell were independently 
acquired using separate channels, digitally superimposed and co-
localization of the FITC and Texas Red signals statistically evaluated using 
the Zeiss LSM image browser software package.   
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5.3. RESULTS AND DISCUSSION 
 
5.3.1. Visualization of Sf9 cells transfected with eGFP-p40 and p40-
eGFP fusion proteins 
 
The optimization of transfection of Sf9 cells was done using the plasmid 
pCW56, expressing just eGFP, as a measure of the transfection efficiency.  
The average transfection efficiency was measured at 25 %.  Next, the 
plasmids pCW55 and pCW57, expressing both the N-terminally fused p40 
to eGFP and C-terminally fused p40 to eGFP respectively,  together with 
pCW56 (expressing only eGFP) were transfected into monolayers of Sf9 
cells grown to confluence on coverslips.  Two representative images of Sf9 
cells transfected with pCW56 (eGFP), pCW55 (p40-eGFP) or pCW57 
(eGDP-p40) are depicted in Figure 5.6 and additional images can be found 
in Appendix 7, Figures A.1 and A.2.  
 
The expression of eGFP under the control of the hr/AcMNPV promoter in 
transfected Sf9 cells resulted in the successful overexpression of eGFP in 
these cells (Figure 5.6 panels A - B).  Transfection efficiencies of 25 % 
were achieved in Sf9 cells transfected with pCW56.  As expected, the 
general distribution of eGFP observed in transfected Sf9 cells was diffuse 
with no particular pattern of accumulation or specific localization in either 
the nucleus or cytoplasm. 
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Figure 5.6.  Distribution of eGFP and eGFP/p40 fusion proteins in transfected Sf9 
cells.  A-B: Distribution of eGFP in Sf9 cells transfected with pCW56.  C - D: Distribution of 
p40 fused to the N-terminus of eGFP in Sf9 transfected with pCW55.  E - F: Distribution of 
p40 fused to the C-terminus of eGFP in Sf9 transfected with pCW57. Nuclei were stained 
with DAPI.  Images A - F acquired at 2 X scanning zoom. Scale bars represent 20 µm 
C D
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p40-eGFP 
eGFP-p40 
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Next, Sf9 cells were transfected with pCW55 and pCW57 in order to 
assess if: a) the p40 (fused to eGFP) showed any pattern of subcellular 
distribution within transfected insect cells, b) if the position of the eGFP 
coding sequence fused at either the N- or C-terminus of p40 altered any 
observed pattern of distribution of p40, and lastly c) to observe the general 
pattern of p40 distribution, aggregation and/or oligomerization in the 
context of an insect intracellular environment.   Both p40-eGFP and eGFP-
p40 fusion proteins appear to have a noticeably less diffuse, cytoplasmic 
distribution pattern as compared with eGFP (Figure 5.6 panels C - D and E 
- F, respectively, as compared with panels A - B).  The fusion proteins were 
excluded from the nucleus suggesting the absence of a functional nuclear 
import signal. The intracellular punctate structures observed in cells 
expressing the eGFP-p40 fusion proteins showed no obvious co-
localization with organelles although this remains to be confirmed by co-
localisation with organellular markers.  However, these structures were 
larger and thus emitted a stronger signal closer to the nuclei of transfected 
cells, indicating the accumulation or targeting of p40 and its fusion partner 
in this location.   
 
This observation could be an artefact of the protein post-translational 
modification pathway, with many of these structures still in transit within the 
ER adjacent to the nucleus. These structures could also represent 
accumulated membranes derived from organelles, which have been 
rearranged in the presence of p40 such as those observed in many 
picornaviral infections (reviewed by Netherton et al., 2008).  Alternatively, 
they could be composed of membranes contributed by more than one type 
of organelle.  Based on the general volumes of ER within the average cell, 
they could include a large percentage of ER and located closer to the 
nucleus.   Also, these apparent aggregations of eGFP could be an artefact 
of the fixation method used on these samples, but live cells transfected and 
imaged under the same conditions as above and viewed by confocal laser 
scanning microscopy were still found to contain these distinct punctate 
structures of eGFP so this is unlikely.  Ultimately, co-localization with 
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cellular organelles cannot be ruled and still needs to be investigated based 
on the unusual distribution pattern observed in these experiments.   
 
No obvious differences in the rate of expression or overall distribution were 
observed between the p40-eGFP (Figure 5.6 panels C - D) and eGFP-p40 
(Figure 5.6 panels E - F).  In a significant number of transfected cells, both 
versions of the fusion protein appear to localize in a slightly polarized 
fashion within the cell (See additional images in Appendix 7, Figures A.1 
and A.2).  Upon closer examination of magnified cells expressing the two 
forms of the fusion protein, one could contend that the p40-eGFP fusion 
protein (Figure 5.6, panels C - D) produces larger punctate structures 
which, due to their size and overall fluorescence, were more noticeable 
relative to the disseminated, more diffuse pattern observed by eGFP-p40 
fusion protein expressed in these cells (Figure 5.6 panels E - F).  These 
punctate structures varied in size and to an extent, also in shape, with 
some structures being more oblong than others (Figure 5.6 panels C - F).   
 
5.3.2. Biochemical fractionation of Sf9 cells transfected with eGFP-
p40 and p40-eGFP fusion proteins 
 
The next objective was to determine whether the punctate structures 
observed in transfected cells were membrane-associated complexes 
formed in the presence of tagged p40, or if the structures observed were an 
artefact of aggregating protein within the cell.   To answer this question, 
transfected cells were fractionated into membrane-associated and insoluble 
protein/ aggregate fractions and these sub-cellular components subjected 
to Western analysis to determine the presence of the eGFP-p40 fusion 
protein. 
 
The subcellular fractionation procedure was validated using the membrane-
associated VDAC protein as an experimental control.  Monolayers of Sf9 
cells transfected with pCW55 (p40-eGFP) and pCW57 (eGFP-p40) were 
subjected to the same subcellular fractionation protocol.  The resultant 
subcellular fractions were analyzed in duplicate by SDS-PAGE followed by 
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Western analyses.  One set of resolved, transferred proteins was probed 
with monoclonal anti-VDAC antibodies, and the other with polyclonal anti-
p40 antiserum (Figure 5.7).   
 
 
Figure 5.7.  Distribution of p40-eGFP fusion proteins in subcellular fractions of Sf9 
cells.  (A):   Western analysis of subcellular fractions probed with anti-VDAC antibodies 
(1 in 500).  (B):  Western analysis of subcellular fractions probed with anti-p40 antiserum 
(1 in 100 000).  Key:  PNF – post-nuclear fraction; SMF – soluble membrane fraction; IP & 
A – insoluble protein and aggregates; 55 – pCW55; 57 – pCW57.  The molecular weight 
standards are indicated on the left of the blots and are represented in kDa, while the 
arrows on the right either indicate cellular VDAC (30 kDa) or fusion protein (~68 kDa).  
 
 
VDAC was detected in the post-nuclear and soluble membrane fractions 
(Figure 5.7 panel A, lanes 1 - 4).  No carry-over of VDAC protein was 
evident in either the second soluble membrane wash or the insoluble 
protein and aggregate fraction (Figure 5.7 panel A, lanes 5 - 8).  No VDAC 
protein was detected in the second soluble membrane wash because of the 
small amounts of total protein available for fractionation from a single 
monolayer originating from a 24-well culture plate well.  This suggested that 
the biochemical fractionation protocol had successfully separated the 
soluble membrane-associated proteins from cytosolic and aggregated 
protein fractions.   
 
The 68 kDa protein, corresponding to p40-eGFP and eGFP-p40 was 
detected in both the post-nuclear and soluble membrane fractions (Figure 
5.7 panel B, lanes 1 - 4).  The reasons for the lack of immunoreactive 
protein in the post-nuclear fraction of pCW57 (Figure 5.7 panel B, lane 2) is 
unclear although the amount of fusion protein fractionated from pCW57 
was, in general lower, than that observed for pCW55 suggesting that this 
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particular fraction might have been over-diluted. This would explain the 
weak immunoreactive signal at this particular time exposure. Also, a small 
amount of the fusion protein was detected in the insoluble protein and 
aggregate fraction (Figure 5.7 panel A, lanes 7 - 8).    Considering the high 
levels of heterologous protein expression observed in this system, it is not 
surprising that a (small) proportion of p68 was insoluble and/or aggregating 
possibly because of its intracellular concentration.   
 
Based on the efficient fractionation of a marker cellular protein (VDAC) 
from Sf9 cells (Figure 5.7 panel A), the procedure was repeated and the 
fractionated fusion proteins subjected to SDS-PAGE and Western analysis 
using anti-p40 antiserum (Figure 5.7 panel B).  The analysis revealed that 
both p40-eGFP (pCW55) and eGFP-p40 (pCW57) fusion proteins were 
membrane-associated (Figure 5.7 panel B, lanes 3 - 6), with a small 
percentage detectable in the insoluble fraction (Figure 5.7 panel B, lanes 7 
– 8).    
 
Initially, one would predict that the punctate structures observed within Sf9 
cells transfected with both pCW55 (Figure 5.6, panels C - D) and pCW57 
(Figure 5.6, panels E - F) may possibly represent aggregating protein 
especially since these foci showed no pattern of distribution similar to any 
network of organelles or central nuclear structure.  Further biochemical 
analysis of these proteins suggested that the majority of this heterologous 
protein is membrane-associated (Figure 5.7, panel B).  Due to a lack of 
antibodies generated towards mammalian organelles that sufficiently cross-
react with insect organelles or stains available for the subcellular co-
localization of p40/p104 to a particular intracellular location, it was decided  
to direct further studies towards co-localization of vRNA and p40/p104 in 
the PrV-infected MG8 cell line.  This approach was decided upon since the 
exact role or contribution, if any, of eGFP in the formation of the punctate 
structures observed in Sf9 cells transiently expressing the eGFP-p40 
fusions is unknown.  Also, the availability of the MG8 cell line and anti-p40 
antiserum for the direct analysis of p40 would eliminate potential artefacts 
created by the transient expression of eGFP fusion proteins.   
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5.3.3. Biochemical fractionation and Western analysis of the MG8 cell 
line 
 
The aim of these experiments was to determine whether similar patterns of 
distribution of p40 could be observed in PrV-infected MG8 cells.   This 
would also eliminate any artefacts due to the presence of eGFP.   
Preliminary data on the localization and solubility of transiently expressed 
p40-eGFP fusions suggested that the eGFP tag did not significantly change 
any inherent localization of the protein when fused to either the N- or C-
termini of the coding sequence.  Although mainly membrane-soluble, the 
foci imaged during expression of these protein within Sf9 cells could 
represent aggregating protein within the subcellular environment.  To 
compare the behaviour of p40 in PrV-infected cells and within the host cell 
environment, MG8 cells were subjected to subcellular fractionation.  Based 
on the efficient subcellular fractionation of VDAC protein within MG8 cells 
(Figure 5.8 panel A, lanes 3 and 4), subcellular fractions from this 
procedure were analyzed by SDS-PAGE followed by Western analyses 
using monoclonal anti-VDAC antibodies and polyclonal anti-p40 and anti-
PrV antisera (Figure 5.8 panels B and C).   
 
 
                         
Figure 5.8.  Subcellular localization of VDAC, p40 and VCap proteins in PrV-infected 
MG8 cells as determined by biochemical fractionation.  (A):  Western analysis of 
soluble and insoluble fractions of MG8 cells, using anti-VDAC antibodies.  (B):  Western 
analysis of soluble and insoluble fractions of MG8 cells, using anti-PrV antiserum.  (C):  
Western analysis of soluble and insoluble fractions of MG8 cells, using anti-p40 antiserum.   
Key:  CF – cytoplasmic fraction; MF – membrane fraction; SM – soluble membrane 
fraction; AI – aggregate and insoluble protein fraction.  The molecular weight standards 
are indicated on the left of the blots and are represented in kDa while the arrows on the 
right either indicate PrV capsid precursor and major capsid protein (p68/p60) or p40. 
 
 
1 2 3 4
115
66
45
35
2 1 3 4 
115
66
45
35
p68
p60
p40
CF CF MF MF SM SM AI AI 
A B C
1 2 3 4 
115 
66 
45 
35 
CF MF SM AI 
VDAC 
                          Chapter 5 – subcellular distribution of PrV p40/p104 and vRNA  
 
147
 
The PrV virus capsid proteins were shown to be associated with both the 
membrane fraction and cytoplasmic fraction based on the detection of the 
capsid precursor and major capsid protein in both of these fractions (Figure 
5.8 panel B, lane 1 - 2).  A large proportion of the capsid precursor and 
major capsid protein were shown to be soluble but a lesser amount of 
these proteins were detected in the insoluble protein/aggregate fraction 
(Figure 5.8 panel B, lane 1-3 vs. lane 4).  Interestingly, the majority of the 
viral protein detected in the cytoplasmic fraction is capsid protein α (p68) 
(Figure 5.8 panel B, lane 1) suggesting that PrV might be translated in the 
cytoplasm but is assembled and matures in membrane inclusions.  This 
theory is supported by the imaging of large membrane-bound vesicles in 
infected MG8 and FB33 cells harbouring PrV virions, whereas in the 
regions outside of these vesicles far fewer virus particles were observed 
(Pringle et al., 2003).    
 
The distribution of p40 within various subcellular fractions of MG8 cells was 
determined by Western analysis using anti-p40 antiserum.  Although some 
p40 was detected in the soluble fraction, a substantial percentage of this 
protein was insoluble or in aggregates (Figure 5.8 panel C, lanes 1 - 3 vs. 
lane 4).  p40 was clearly detectable in the membrane fraction (Figure 5.8 
panel C, lane 2), but was present in much lower concentrations in the 
soluble membrane fraction (Figure 5.8 panel C, lane 3).   
 
No p104 was detected, possibly because only 2 µg of total protein could be 
analyzed in each fraction, the amount of p104 was probably below the 
detection limit of the antiserum used.  Although the replicase (p104) should 
theoretically be isolated with the membrane faction, more protein needed to 
be analyzed in order to detect p104 using this protocol.  Since p40 was 
present in abundance, it was decided to focus on this protein in further 
experiments, as a ‘marker’ in the subcellular localization of viral replication 
complexes and co-localization of p40 and vRNA in MG8 cells.   
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5.3.4. Bromouridine labelling of viral RNA in the MG8 cell line 
 
It was decided to examine the subcellular distribution of vRNA and virus 
replication complexes in PrV-infecting MG8 cells.  PrV vRNA was initially 
labelled in the presence of 5 µg/ml or 20 µg/ml of Actinomycin D, in order to 
distinguish between MG8 cells transcribing both viral and cellular RNA, 
from those transcribing just vRNA (in the presence of the inhibiting 
concentration of 20 µg/ml Actinomycin D). Control experiments were 
performed by excluding either the primary or secondary antibodies from the 
immunofluorescence procedure described above.  Cells were then imaged 
so as to confirm that the signal detected was not the result of non-specific 
binding by either antibody or due to inherent auto-fluorescence from the 
MG8 cells.  In these cells, RNA was seen to be distributed at high levels 
throughout the cell including the nucleus (see white arrows in Figure 5.9 
panels A and B).  However, transcription was inhibited in the majority of the 
cells, and replicating vRNA was observed to take on a distinct distribution 
pattern and at low levels compared to uninhibited cellular transcription 
(Figure 5.9 panel C - D).   An optimal dilution of primary antibody, mouse 
anti-BrUTP, was determined to be 1 in 50 and the dilution of the secondary 
antibody, goat anti-mouse antibody conjugated to Texas Red (sulphur 
rhodamine), was 1 in 750.   Additional representative images of BrUTP-
labelled vRNA detected by immunofluorescence can be seem in Appendix 
7, Figure A.3. 
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Figure 5.9.  Immunofluorescence detection of viral RNA accumulation and 
distribution within MG8 cells. BrUTP was incorporated into PrV vRNA in the presence of 
5 mg/ml Actinomycin D (A – B) or 20 mg/ml Actinomycin D (C – D) for 3 hours.  BrUTP-
incorporated vRNA was detected by immunofluorescence using anti-BrUTP and goat anti-
mouse antibody conjugated to Texas Red. Cells were imaged by confocal laser scanning 
microscopy.  Nuclei were stained with DAPI.  Images A and B were acquired at 1 X 
scanning zoom and C and D, at 2 X scanning zoom.  Scale bars represent 20 µm. 
 
 
The cells were stained with this nuclear marker so as to identify all the cells 
on the fixed coverslip and not limiting the analysis of cells just emitting 
fluorescence from the Texas Red fluorophore.  The visualization of vRNA 
by immunofluorescence resulted in a number of noteworthy observations in 
the infected MG8 cells. Firstly, not all of the DAPI-stained MG8 cells were 
harbouring active RNA replication complexes.  Secondly, the detected viral 
RNA levels appeared to quite attenuated, emitting low levels of 
fluorescence (compare indicated cells in panels A and B with the cells in 
A B
C D
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panels C – D of Figure 5.9), which is to be expected since PrV is a 
persistent infection in the MG8 cell lines and exhibits no obvious cytopathic 
effect (CPE), possibly indicating low levels of replication.  Thirdly, viral RNA 
appears to be transcribed in a polarized fashion within the cytoplasm of 
MG8 cells, forming variably sized punctate structures within these polarized 
regions of viral transcription.  The levels of vRNA synthesis based on the 
signal attained in these experiments varied between cells, and certain cells 
harbouring transcribing viral RNA showed brighter zones of transcription on 
the cell periphery and more dominantly in perinuclear clusters.   
 
The finding that not all of the MG8 cells subjected to immunofluorescence 
were supporting active viral replication complexes was not unexpected 
when one considers a) the small quantities of PrV purified from MG8 cell 
monolayers (observed in this study and by Pringle et al., 2003) b) the lack 
of any observable CPE or other side-effect on the MG8 cells as a result of 
the persistent tetravirus infection (observed in this study and by Pringle et 
al., 2003), and c) the lack of cell typing and other histopathological 
experiments on the MG8 cell line has not ruled out the possibility that more 
than one cell type is present within this particular cell line.  Lepidopteron 
midgut tissue is made up of four distinguishable cell types:  columnar, 
goblet, basal regenerative and endocrine cells (Billingsley and Lehane, 
1996).  Current knowledge of tetraviral infection only reports whole larval 
midgut tissue as permissive to these viruses with no extensive reports on 
the susceptibility of these individual cell types to tetraviral infection (Grace 
and Mercer, 1965; Hanzlik and Gordon, 1997; Bawden et al., 1999; 2002).  
 
The general distribution of the viral RNA appeared to be polarized to 
varying degrees in MG8 cells supporting active replication complexes 
(Figure 5.9). The punctate structures forming in these polarized regions 
were variable in size and general location, based on observations in a 
sample set of cells.  Furthermore, the punctate, polarized distribution bore 
similarities to transiently expressed p40-eGFP fusions in Sf9 cells (see 
Figure 5.6 panels C - F), in particular with respect to the variable 
aggregate-like formation and the polar clustering of these foci in the cell.   
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Immunofluorescence detection of p40 (and p104) in PrV-infected MG8 cells 
 
MG8 cells were subjected to the same procedure described in the 
immunofluorescence-based detection of labelled RNA, but without the use 
of the inhibitor of cellular transcription, Actinomycin D.  The primary and 
secondary antibody combination used to detect p40/p104 was anti-p40 
antiserum and anti-rabbit conjugated to FITC, respectively.  Negative 
controls involving the exclusion of either the primary or secondary antibody 
were performed in parallel to these experiments to confirm that the 
distribution pattern observed here was not a general effect from the 
secondary antibody nor autofluorescence.    Following this, MG8 cells were 
imaged by scanning confocal microscopy (Figure 5.10).    
 
Following the immunofluorescence of p40 within MG8 cells, imaging of 
cells expressing p40 showed that this protein was readily detectable in 24 
% of the general cell population.  Since the antibodies used here were 
directed against a peptide region also present on p104, it is likely that some 
fluorescence observed might be due to the presence of the read-through 
version.       
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Figure 5.10. Immunofluorescence detection of PrV p40 (and p104) accumulation and 
distribution in MG8 cells.  The predicted quantitatively dominant p40 auxiliary protein 
was detected by immunofluorescence using rabbit anti-p40 and goat anti-rabbit antibody 
conjugated to FITC. Nuclei were stained with DAPI.  Cells were imaged by confocal laser 
scanning microscopy.  Images A – D) were acquired at 1 X scanning zoom and E – F, at 2 
X scanning zoom.  Scale bars represent 20 µm. 
A B
C D
E F
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Once again, not all cell types appeared to be expressing p40/p104 (Figure 
5.10 panels A - F). The weak signal, seen in the remainder of the MG8 
cells (Figure 5.10), was investigated and shown not to be a result of cellular 
auto-fluorescence or background signal from the secondary antibody 
conjugate, and thus may potentially represent cells expressing p40.  Here, 
p40 expression is probably occurring at low levels and the protein is not 
aggregating or causing an aggregating effect in the cell.  The phenomenon 
of only ~ 25 % of the imaged cells were expressing p40 (adjudged by the 
bright foci as opposed to weak diffuse expression) could be a result of not 
all of the four midgut cell types being permissive to PrV infection, or 
perhaps a defective virus replication cycle whereby only a portion of 
(permissive) cells are infected.  The fluorescence detected in the above 
experiment again shows the formation of punctate-like structures clustering 
in a polarized fashion within p40-expressing cells.  These structures show 
both variably sized ‘aggregates’ as well as shapes of these individual foci 
(Figure 5.10).   
 
Importantly, the structures observed here were similar in localization and 
general morphological structure to transiently expressed p40 fused to 
eGFP.  In MG8 cells, as compared with Sf9 cells, the general size and 
structure of these fluorescent foci were similar (Compare Figure 5.10 with 
Figure 5.6).  
 
 
5.3.5. Co-localization of PrV p40 and vRNA in MG8 cells 
 
The similarity in appearance (although not intensity) of these p40/p104-
related structures and the polarized foci associated with viral RNA in MG8 
cells (Figure 5.9) warranted further investigation.  To determine whether 
p40/p104 is associated with the PrV replication complex in vivo, MG8 cells 
were cultured in the presence of Actinomycin D and vRNA labelled with 
BrUTP.  The presence of vRNA and p40/p104 was then detected using 
anti-p40/anti-rabbit conjugated to FITC, and anti-BrUTP/anti-mouse 
conjugated to Texas Red antibody combinations with minor alterations to 
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the existing protocol (Section 5.2.6).   Figures 5.11 and 5.12 represent two 
examples of cells where co-localization of the two fluorophore signals was 
detected.  Appendix 7, Figure A.4 contains a further montage of 
representative co-localized fluorophore signals.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11.  Co-localization of p40 and viral RNA in PrV-infected MG8 cells.  BrUTP 
was incorporated into PrV vRNA in the presence of Actinomycin D for 3 hours. The 
BrUTP-incorporated vRNA was detected by immunofluorescence using anti-BrUTP/goat 
anti-mouse antibody conjugated to Texas Red.  p40 was detected by immunofluorescence 
using rabbit anti-p40/goat anti-rabbit antibody conjugated to FITC.  Cells were imaged by 
confocal laser scanning microscopy. A: fluorescent signal from Texas Red indicating 
vRNA.  The Texas Red signal was digitally summed up four times during acquisition of 
each image; B: fluorescent signal from FITC indicating p40 (and p104); C: fluorescent 
signal from DAPI stain indicating the nucleus; D: merged image of all three fluorescence 
emissions.  The images were acquired at 1 X scanning zoom.  Scale bars represent 20 
µm. 
 
A B
DC
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Figure 5.12.  Co-localization of p40 and viral RNA in PrV-infected cells.  BrUTP was 
incorporated into PrV vRNA in the presence of Actinomycin D for 3 hours. The BrUTP-
incorporated vRNA was detected by immunofluorescence using anti-BrUTP/goat anti-
mouse antibody conjugated to Texas Red.  p40 auxiliary protein was detected by 
immunofluorescence using rabbit anti-p40/goat anti-rabbit antibody conjugated to FITC.  
Cells were imaged by confocal laser scanning microscopy. A: fluorescent signal from 
Texas Red indicating vRNA.  The Texas Red signal was digitally summed up four times 
during acquisition of each image; B: fluorescent signal from FITC indicating p40 (and 
p104); C:  fluorescent signal from DAPI stain indicating the nucleus; D: merged image of 
all three fluorescence emissions.  The images were acquired at 1 X scanning zoom.  Scale 
bars represent 20 µm. 
 
 
 
The co-localization of p40 and vRNA was clearly evident in the confocal 
laser scanning images of dual-labelled vRNA and p40 (Figure 5.11 and 
5.12).  Again, a polarized distribution of both fluorescent signals was 
observed in MG8 cells expressing both p40 and exhibiting replicating vRNA 
(Figure 5.11 and 5.12).   As observed with the immunofluorescent detection 
A B
C D
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of p40/p104 alone (Figure 5.10) and BrUTP-labelled vRNA alone, not all of 
the MG8 cells were expressing either vRNA or p40/p104 however the 
absence of one of these molecules within a cell did not exclude the 
presence of the other, i.e. vRNA might be labelled in a cell where no 
p40/p104 was detectable above background levels and vice versa (Figure 
5.12 panel A, indicated by arrow).  
 
Analysis of this phenomenon revealed that, of the seventy four MG8 cells 
imaged in this particular experiment: p40/p104 was detected in eighteen 
cells (24 %); replicating vRNA was detected in twenty nine cells (39 %) and 
fifteen cells (20%) were observed to be expressing both p40/p104 and 
vRNA, suggesting co-localization of the two signals.  Cells were marked as 
positive or negative for either fluorophore based on the strong, punctate 
distribution of both molecules previously observed (Figure 5.9 and 5.10) 
and not the weak, diffuse signal.   
 
The extent of the co-localization of five randomly selected MG8 cells 
exhibiting co-localization was digitally analyzed in terms of pixel distribution 
and overall percentage area of co-localization.  These cells all showed 
grouping of pixels from both Texas Red and FITC emissions in a co-
localized pattern based on histogram analysis followed by calculation of the 
percentage area of this co-localization.  The average percentage area 
exhibiting co-localization in these five representative cells was measured at 
19 %.  However, this value is based on a two dimensional area which was 
imaged because of its significant co-localization and is thus not 
representative of the three dimensional area of co-localization within a 
larger group of MG8 cells exhibiting varying degrees of co-localization.   
 
This analysis represents only a preliminary investigation and could over-
represent the number of cells exhibiting co-localized p40 and vRNA, 
because these cells were being actively selected during the imaging 
process.  Also, the number of vRNA-harbouring cells could be over-
represented because of the need to employ digital summing up of the 
fluorescence signal during acquisition, thereby potentially leading to false 
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positives.  More cells should be imaged in a completely unbiased fashion in 
order to acquire a more representative sample for statistical analysis.  
Based on this data the following two conclusions can be drawn:  (a) 
p40/p104 and vRNA do co-localize in a polarized, punctate fashion within 
the cell at a frequency of 20 % relative to the general population of MG8 
cells, and (b) a significantly larger proportion of MG8 cells support actively 
replicating vRNA (39 %) when compared to those which appear to be 
expressing p40/p104 and not supporting vRNA replication (24 %). 
 
 
5.4. CONCLUSION 
 
Following on from the analysis of the PrV replication proteins, p40 and 
p104 discussed in Chapter 4, this chapter provides insight into the 
presence and distribution of p40 (and probably p104) in PrV-infected MG8 
cells.  Initially, a transient expression system was used to detect eGFP-
tagged p40 fusion proteins in Sf9 cells, serving as a system of studying 
solely p40.  The results suggested that p40-eGFP fusions exhibit an 
unusual punctate distribution pattern in the cytoplasms of Sf9 cells and 
suggest that these fusion proteins may be mostly membrane associated.  
These data suggested that p40 might actively induce and associate with 
membranous structures originating from the transfected cells into atypical 
patterns of diffusion.  However, this system has several potential flaws:  
firstly, the inclusion of the eGFP tag to the fusion protein adds substantial 
molecular weight to the fusions which could impact on the mobility and 
distribution of these fusions in the cells.  Also the transient expression was 
controlled by an enhanced viral promoter which could have produced large 
amounts of insoluble and/or aggregating proteins, thus creating an artefact 
during the imaging of transiently expressed Sf9 cells.  Another potential 
drawback to the transient expression system would be the absence of 
p104, expression which is likely to play a role in replication complex 
formation and morphology albeit in smaller amounts compared to an 
auxiliary protein.    
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Given the potential problems with the transient expression of eGFP fusion 
proteins, it was decided to focus on ‘endogenous’ p40 and p104 in PrV-
infected MG8 cells.  These immunofluorescence studies revealed a similar 
distribution pattern that was often polarized to one side of the cell.  Not all 
of the imaged MG8 cells exhibited this pattern of intracellular p40/p104 
accumulation and some were shown to emit a very weak signal 
corresponding to low levels of diffuse p40/p104 expression.  This could be 
attributed to a mixed cell line where only certain cell types within the midgut 
tissue are permissive to PrV infection or alternatively, these cells exhibiting 
little to no p40 expression could represent various stages of replication 
complex formation and p40 expression.  Since the antibody used for these 
studies is unable to distinguish between p40 and p104, it is possible that 
these cells may be in fact expressing p104, rather than p40.  It would be 
important to use antibodies that would be able to detect only p104 (raised 
against the C-terminus of this protein) to eliminate this possibility.   
 
Immunofluorescence studies on the distribution of BrUTP-labelled vRNA 
revealed a distribution and accumulation of vRNA similar to that observed 
in the detection of p40.  Polarized accumulations of vRNA could be 
observed as well as ‘hot spots’ of signal at the cell membrane interface 
most likely representing accumulation of virion particles at the cell 
membrane as observed by Pringle et al. (2003).    Again, not all MG8 cells 
appeared to support actively replicating RNA although it was interesting 
that more cells on average exhibited actively replicating vRNA compared to 
cells expressing p40.  No particular pattern could be observed between 
cells expressing either p40 or containing actively replicating vRNA and cells 
undergoing mitosis, cell lysis or membrane blebbing (an indicator of 
apoptosis).  Phase contrast microscopy and the analysis of various unfixed 
cell structures would need to be performed in order to confirm this 
observation.     
 
Upon dual immunofluorescence detection of both p40 and vRNA in the 
MG8 cells, several cells exhibiting co-localization were observed.  Although 
the vRNA fluorescent signal was weak due to the combination of 
                          Chapter 5 – subcellular distribution of PrV p40/p104 and vRNA  
 
159
conjugated secondary antibody and detector parameters as well as a 
potentially low level of vRNA replication, compounding of and merging of 
this amplified signal with that from p40 resulted in the detection of co-
localized punctate and polarized structures within these cells.  Biochemical 
fractionation of MG8 cells revealed that p40 is largely insoluble and/or 
associated with aggregates, although a portion of this protein is membrane-
associated.  It is possible that the structures observed to form were the 
result of virus-induced aggresomes that act as sites of replication mediated 
by at least p40 and, most likely, p104.  Co-localization experiments using 
markers specific for organelle-derived membranes as well as markers 
specific to autophagy and aggresomes (such as anti-LC3 antiserum) are 
required for further analysis into the site and nature of PrV replication.   
 
CHAPTER 6 
General discussion and future avenues of research 
 
 
Providence virus, discovered by Pringle et al. (2003), was the first 
tetravirus able to infect cultured insect cell lines.  Apart from this novel 
characteristic, PrV was found to be a member of the genus Betatetravirus, 
based on its monopartite genome, outer capsid appearance and moderate 
capsid sequence conservation with other betatetraviruses.  Unpublished 
data generated by Dr. Fiona Pringle and Prof. Andrew Ball at the University 
of Alabama at Birmingham, shortly after their 2003 publication detailing the 
discovery and characterization of PrV, began to suggest an atypical 
replicase gene sequence, organization and gene conservation.  These 
unique features and the availability of a tetravirus that infects insect cell 
lines lead to the conceptualization of the research described in this thesis.  
The overall aim of this study was to characterize the translation products of 
PrV and to set up an experimental system for studying virus replication in 
PrV-infected MG8 cells.   
 
 
6.1. PrV has a unique set of replication proteins and might follow a 
replication strategy similar to the Tombus- and Umbraviridae 
families 
 
The bioinformatic analysis of the coding sequences, protein products, 
phylogenetics and possible post-translational modifications or processing 
mechanisms predicted in the PrV genome resulted in the accumulation of 
data supporting the initial theory on the divergent genome organization and 
protein processing of PrV.  The presence of a highly conserved read-
through stop signal, significant sequence conservation and phylogenetic 
relationships with other tombus- and umbraviruses suggested that the 
putative PrV replicase protein might have originated, or evolved in a 
convergent manner from a (+)ssRNA plant virus.  The in-frame group I 
160
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read-through stop signal is a recoding mechanism found mostly in plant 
viruses and mammalian retroviruses (Beier and Grimm, 2001, Harrell et al., 
2002).  Based on its position in the replicase ORF, this stop signal is likely 
to function in a similar fashion to those found in the replicase ORFs of 
exclusively plant viruses and was thus predicted to function as a recoding 
mechanism, resulting in the translation of asymmetric quantities of auxiliary 
versus replicase protein.    
 
In PrV, the protein sequence preceding the stop signal (p40) may act as an 
auxiliary protein binding to other auxiliary, host proteins and the read-
though product, the replicase (p104), to form the basis of a replication 
complex.  Given the relatedness of PrV to carmo-like plant viruses, 
bioinformatic analysis was focused on uncovering characteristics of the 
PrV genome that are known to exist in the well-studied tombusviruses.  
Further analyses of the replicase ORF and its predicted protein product, 
p104, revealed a carmo-like replicase based on the presence of only the 
essential catalytic RdRp domain situated at the C-terminus of p104.  
Furthermore, this RdRp domain showed significant protein sequence 
conservation with other tombus- and umbraviruses despite its unusual 
permuted RdRp motif arrangement - a feature not associated with carmo-
like viruses.  Both sequence and spatial orientation of the motifs within the 
PrV RdRp domain appear to be divergent from the permuted domains of 
two other betatetraviruses, EeV and NβV.  The exact structural and 
catalytic alterations that might occur because of these differences should 
be experimentally determined since homology modelling will prove difficult, 
based on the lack of crystallographic data on related RdRp domains.  
Furthermore, a measure of the fidelity and catalytic activity of the PrV 
RdRp would provide indirect evidence of its evolutionary stability and 
overall rate of vRNA polymerization in its permissive host, the MG8 cell 
line.  
 
Other similarities also exist between the replicases of PrV and 
tombusviruses.  Numerous potential sites of phosphorylation, a functional 
modification often associated with replication-related proteins and 
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demonstrated in both the auxiliary and replicase proteins of tombusviruses 
(Shapka et al., 2005) are predicted to be present in the coding sequences 
of both p40 and p104.  The prediction of two hydrophobic helices further 
substantiates the hypothesis that p40 and p104 could be membrane-
associated proteins, forming part of a replication complex associated, and 
most likely anchored to a subcellular membrane by these transmembrane 
domains.  The presence of these two helices provides further evidence of 
the similarities between the p40/p104 PrV replication proteins and the 
auxiliary/replicase proteins of the tombusviruses.  The helix-to-helix stretch 
in the tombusvirus, CymRSV, has been found to be essential for both the 
anchoring of p33 as well as the targeting of this protein to the peroxisome 
(Navarro et al., 2004).   If such an anchoring event did occur in p40, it 
would be as a result of a single transmembrane helix, although p104 is 
predicted to contain two helices that could result in the insertion of more 
than 400 amino acids into a theoretical subcellular lumen.   
 
The availability of polyclonal antiserum raised against a peptide stretch of 
p40, thus recognizing both the predicted (and correctly folded) p40 and 
p104 replication proteins resulted in experimental proof of the existence of 
an auxiliary (p40) and replicase (p104) protein combination, detected in the 
persistently infected MG8 cells.  Western analysis of PrV-infected MG8 
cell-free extracts confirmed the presence of p40 and p104 and showed that 
they were expressed in an asymmetric ratio similar to that of 
tombusviruses (Skuzeski et al., 1991; Panaviene et al., 2003).  In vivo 
metabolic radiolabelling of PrV proteins resulted in the detection of a 40 
and a 104 kDa protein.  In vivo metabolic labelling of PrV in the MG8 cells 
also led to the detection of a further five proteins potentially translated from 
the PrV genome.  Two of these (p68 and p60) were identified by Western 
analysis as the viral capsid protein precursor and mature capsid protein.   
A 128 kDa protein, proposed to be the translation product of p130, was 
also detected in metabolically labelled MG8 cells and the 
transcription/translation of p130 was confirmed in vitro.  The function of 
p130, unique to PrV, and not present in the genome of any other 
sequenced tetraviruses, remains unknown.   
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In the rabbit reticulocyte coupled in vitro transcription/translation system, 
the p104 ORF was translated into a 40 and 104 kDa protein, although not 
in the asymmetric ratios expected to result from the in-frame stop signal 
and was observed by Western analysis of PrV-infected MG8 cells using 
anti-p40 antiserum.  Interestingly, the ratio of p40 to p104 resulting from 
translation of the p104 ORF in the wheat germ system resulted in 
substantially higher levels of p40 as compared with p104.  This provided 
support for the proposed plant virus origin of the PrV replicase and the 
conserved read-through stop signal.  Importantly, these results showed 
both the presence of two replication proteins as well as demonstrating the 
functionality of the read-through stop signal in two coupled in vitro 
transcription/translation systems.  The functionality of the PrV read-through 
stop signal needs to be tested in a more analogous (invertebrate) system 
since the in vitro analyses of viral read-through stop signals can lead to 
ambiguous results (Sasaki et al., 1998).   
 
 
6.2. Establishing a system for studying the subcellular distribution of 
p40 and viral RNA in MG8 cells   
 
With both the presence and origins of p40/p104 established, the next 
objective was to investigate the presence and distribution of both viral RNA 
and PrV replication proteins in PrV-infected MG8 cells. Since p40 was 
shown to be translated in greater quantities than p104 and an antiserum 
was available for the detection of both p40 and p104, it was elected to 
study the presence and distribution of this protein and BrUTP-labelled 
vRNA in PrV-infected MG8 cell line. The results of these experiments 
revealed the presence of punctate, polarized distribution patterns of p40 
(and possibly p104) as well as newly synthesized vRNA in a proportion of 
MG8 cells.  Although not every cell supported either replicating vRNA or 
p40, the co-localization of these two molecules was evident in a fraction of 
cells.  Even though p40 was shown to be associated with the membrane 
fraction of biochemically fractionated cell-free extracts, it was most strongly 
associated with the insoluble protein and aggregates fraction of MG8 cells.  
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The question that arises from this result is whether the punctate structures 
observed in the immunofluorescent detection using anti-p40/p104 
antibodies represent aggregated proteins (or perhaps viral-induced 
aggresomes) or whether they are the result of membrane rearrangements 
induced by PrV infection and replication.  Future work would involve 
attempting to localize p40/p104 and vRNA to an autophagosome or a 
subcellular membrane.  Such analyses would also lead to a better 
understanding of the location and mechanism of replication employed by 
PrV in the MG8 cell line.  The availability of a p104-specific antiserum 
would allow for the confirmation of the presence and distribution of only 
p104 in relation to p40 and vRNA in PrV-infected MG8 cells. 
 
Although very little is known about the replication strategies of other 
tetraviruses, inherent differences in replicase sequence and motif 
arrangement have already been established in TaV and EeV (Gorbalenya 
et al., 2002), and from this study, also in PrV.  Based on the data 
summarized above, PrV has been demonstrated to translate proteins both 
with proposed functions and in a mechanism similar to other (+)ssRNA 
plant viruses and instead of other members of the Tetraviridae family. 
 
 
6.3. Co- and post-translational processing mechanisms of PrV 
 
During this study, it became increasingly evident that PrV is an unusual 
tetravirus, not only in terms of its divergent replication strategy but also 
because of the number of co- and post-translational processing 
mechanisms identified in the protein coding sequences of the three major 
ORFs of this virus.  Three major mechanisms exist, firstly the PrV read-
through stop signal is only the second reported occurrence of a functional 
signal found in a virus infecting exclusively invertebrate hosts.  Such a 
signal has been discovered in the dicistrovirus, PSIV, although this stop 
signal was shown to be inactive in vitro and the capsid protein precursor 
translated by the re-initiation of translation from an IRES signal in this 
region and not a leaky read-through mechanism (Sasaki et al., 1998; 
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Sasaki and Nakashima et al., 1999).  The regulation of polymerase 
expression is widely observed in both (+)RNA viruses and is especially 
well-documented in retroviruses (Shehu-Xilaga et al., 2001).  Although the 
mechanism of polymerase expression control in these lineages of viruses 
occur by very different means, the resultant polymerase attenuation and 
accessory protein overexpression are essential for effective virus 
assembly, release and infectivity (reviewed in Ahlquist, 2006).  It is 
interesting to speculate on the proposed multifunctional nature of the 
ribosome coding mechanism in PrV.  Does this mechanism result in 
attenuated levels of replication or does it play a more active role in the 
divergent replication mechanism of this unique virus? 
 
A second co-translational processing mechanism is the presence of a 2A-
like processing sequence at the N-terminus of the capsid protein precursor 
coding sequence, which is also present in the betatetraviruses, TaV 
(Pringle et al., 1999) and EeV (Donnelly et al., 2001b).  In TaV, this 
processing sequence results in the processing of the translated capsid 
protein precursor into a smaller 17 kDa protein and the capsid precursor 
(Pringle et al., 1999; 2001).  The capsid precursor is then further cleaved 
during particle maturation by thirdly, an autoproteolytic site at the C-
terminus of the precursor, resulting in the major and minor capsid proteins.  
2A-like sequences are found in analogous positions in both EeV and PrV 
(PrV-2A3).  PrV has a second 2A-like processing sequence (PrV-2A2) in 
the p13 sequence further upstream of the PrV-2A3 sequence, although this 
sequence has been shown to exhibit a lowered activity in an in vitro 
reporter system (Luke et al., 2008).  PrV-2A2 was not active in vitro in the 
context of the wild-type surrounding sequence reported during this study 
and, since neither p13 nor the predicted products of PrV-2A2 processing 
have been detected in vivo, the function of this sequence in this context is 
unknown.  In this study, PrV-2A3 was shown to be active upon in vitro 
transcription/translation of the p81 coding sequence, suggesting that PrV 
undergoes a similar sequence of processing and cleavage events in the 
production of the major and minor capsid proteins.  A third 2A-like 
processing sequence, PrV-2A1, was identified in the N-terminal region of 
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the theoretical p130 protein and this sequence was shown to be inactive in 
vitro although interpretation of these data were complicated by the 
ambiguous translation products produced from the p130 coding sequences 
and two truncations thereof.   
 
Phylogenetic analysis of these three 2A-like sequences relative to 
analogous sequences in TaV, EeV and certain members of the 
Dicistroviridae, predicted a clade of four out of the five betatetravirus 
sequences excluding PrV-2A2 (Luke et al., 2008).  The exact role and 
functionality, if any, of PrV-2A1 and PrV-2A2 in the in vivo processing of 
p130 and p81 respectively, need to be examined further.   
 
 
6.4. Is PrV an attenuated or latent infection in the MG8 cell line or are 
only a proportion of the cells or cell types infected? 
 
A survey on publications in the last 5 years reporting the discovery of latent 
viruses shows that a number of (typically (+)ssRNA carmo-like) viruses 
have been discovered by researchers and reported in various peer-
reviewed publications or by less formal means (Ohki et al., 2006; 
Tzanetakis and Martin, 2008; Vaira et al., 2008).  Many of these viruses 
were unintentionally discovered, yet when one considers the number of 
latent plant and animal viruses that potentially exist, a fascinating account 
of virus replication and genome processing mechanisms would surely be 
revealed.  A number of facts and observations discovered during the 
course of this work make the possibility of PrV being a latent or highly 
attenuated virus plausible.  These include:  (1) the very low levels of virus 
particle recovery from infected MG8 cells despite attempts to optimize this 
process (supported by Pringle et al., 2003), (2) the steady growth rate of 
the MG8 cell line in medium excluding foetal calf serum (FCS) and the 
marked decrease of cell growth leading to eventual cell death in the 
presence of this supplement, (3) a lack of replicating vRNA 
structures/accumulated p40 protein in a large percentage of cells in the 
MG8 cell line, (4) the presence of a read-through stop signal in the 
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replicase of an animal virus, and (5) large amounts of unprocessed capsid 
precursor protein (p81) detected in radiolabelled viral translation products 
in MG8 cells by Western analysis of purified particles and MG8 cell-free 
extract and also evident by the lack of autoproteolytic processing of this 
protein in vitro.  It is not common for a differentiated cell line to proliferate 
over the long term in the absence of growth supplements usually supplied 
in the form of FCS.  FCS provides essential growth and mitogen proteins in 
addition to the basal cell medium and exclusion of FCS has been shown to 
induce cell differentiation in embryonic and/or stem cell lines leading to cell 
mitosis.  In the case of cell lines harbouring latent retroviruses, shifting of 
the cell cycle into mitosis can then further lead to the induction of latent 
virus back into the active form.  An essential future experiment will be the 
cell typing of the MG8 line so that the presence of any undifferentiated cell 
types potentially supporting latent PrV can be investigated. 
 
Alternatively, it could also be argued, that PrV is not an attenuated or latent 
virus.  PrV has been shown to be able to infect at least two other insect cell 
lines.  Although the labelling of both viral RNA and p40 in MG8 cells could 
be an indication of an attenuated rate of replication based on an average of 
20 % of examined cells exhibiting co-localization of these two molecules, it 
could also be the likely result of a mixed cell line.  When one considers the 
size of midgut tissue in early instar lepidopteran larvae, it is quite possible 
that this cell line is composed of all four cell types making up midgut tissue 
and perhaps even peripheral cell types.  A mixed cell line might contain cell 
types not permissive to tetraviral infection explaining the low numbers of 
cells supporting active vRNA replication and/or p40 expression and not as 
a result of attenuated replication in a single cell type.  A quantitative study 
of the cell populations in HaSV-infected midgut tissue of H. armigera larvae 
showed that the endocrine cells of virus-challenged midgut tissue were 
excluded during infection by HaSV (Brooks et al., 2002).  As mentioned 
earlier, further cell sorting and sub-culturing experiments would need to be 
performed on this particular cell line to confirm its mixed cell type status 
and also to separate out the proposed different cell types that could 
potentially be supporting actively replicating PrV vRNA.  The relatively 
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large amount of capsid precursor detected in both purified PrV virions and 
in cell-free extracts of MG8 cells was often observed in this study and, 
although not evident by Coomassie staining of PrV proteins resolved by 
SDS-PAGE, comparative levels of the precursor protein was detected by 
Western analysis of FB33 cells infected with PrV, 48 hours post-infection 
(Pringle et al., 2003).  The degree of autoproteolytic cleavage from p68 into 
p60 and p8 might not be as efficient in PrV as observed in other 
tetraviruses (Hanzlik et al., 1993; Pringle et al., 1999; Yi et al., 2005; 
Walter et al., 2008).   
       
What role, if any, does p130 play in the lifecycle of PrV?  This proposed 
non-structural protein is the first ORF in the PrV genome and positioned in 
a good context for initiation of translation.  Could p130 play a role in the 
attenuation of PrV replication and infection at a translational, RNA or 
protein level or would the apparent low levels of infection and replication of 
vRNA be a result of a read-through stop signal amounting to low levels of 
replicase protein?  Again, additional analyses on the transcription, 
translation and the functions of p104 and p130 need to be addressed 
further in order to begin to answer some of these questions.   
 
 
6.5. CONCLUSIONS 
 
With the first feasible opportunity to study tetravirus replication possible 
since the discovery of the unique tetravirus, PrV, the overall aims of this 
work were fulfilled.  The genome organization and protein processing of 
PrV have been both bioinformatically and experimentally investigated.  A 
hypothesis on the replication strategy of PrV has also been put forward 
following the discovery of two replication proteins and a recoding 
mechanism controlling their expression. Based on data generated in this 
work, it is likely that PrV is not a tetravirus and it is suggested that this virus 
undergoes reclassification at the family level.  
APPENDICES 
 
APPENDIX 1 – PRIMERS USED IN THIS STUDY  
 
Table A.1.  Name, sequence and description of primers used in this study.   
 
Name Sequence Description 
AI11 5`CTAGAGGTACCAAGGAGAAAAAAATGCATCATCATCACCATCA`3  
3` TCCATGGTTCCTCTTTTTTTACGTAGTAGTAGTGGTAGTAT`5 ds oligonucleotides XbaI/NdeI - pCW20   
CW5 5`CGAACCTTGCTACCACGAACGAAAACAGC`3 Csp45I - pCW21 
CW6 5`AAGCTTCAATACCCTGACGGCCAGTCAATATCGG`3 Hind III - pCW21, pCW22 
CW7 5`GGATCCAACCTTGCTACCACGAACG`3 Bam HI - pCW22 
CW9 5`CATATGTGCGAGCCTTTAAGTTTACGC`3 NdeI - pCW26,27, pCW35 
CW10 5`AAGCTTCCGCCGGTCCCATT`3 HindIII - pCW26, 27 
CW11 5`GATCTGGTACCAAGGAGAAAAAAATGC`3 BglII - pCW28 
CWF3 5`CATACCGTCCCACCATCGGGCGCGG`3 pFB Dual, pCW30 
polR 5`ACCTCTACAAATGTGGTATGGCTGAT`3 pFB Dual, pCW30 
pUCF 5`CGCCAGGGTTTTCCCAGTCACGAC`3 pFB Dual, pCW30 
pUCR 5`TCACACAGGAAACAGCTATGAC`3 pFB Dual, pCW30 
CW23 5 GGATCCCTACTGGAGGAGGGGGAG’3 Bam HI - pCW52, pCW53 
CW24 5`AAGCTTTTGGTGGTCTATCAGAGACTCG’3 Hind III - pCW52 
CW01 5`GCTGTGAACACTTCAGGTAAAAC ‘3 pSTA1 
CW02 5`TATATAGCGGCCGCTTACACTGCTCCGTTGGCGAAATG`3 NotI - pSTA1-3 
CW03 5`CCCATCGGCTCTTGGCTTCGAGGA`3 pSTA2 
CW01b 5` AAGGAGTCTAATAGTGGTTACG`3 pSTA3 
CW04 5`TGCGAGCCTTTAAGTTTACGC’3 pSTA4, pSTA5 
CW05 5`TATATAGCGGCCGCTTACTTTGTCGGGATTGTTCTTCC`3 NotI - pSTA4  
CW06 5`TATATAGCGGCCGCTCAATACCCTGACGGCCAGTCAATATC`3 NotI - pSTA5 
CW09 5`CAGAATTTACCAGTACCCAATG`3 pSTA7 
CW10 5`TATATAGCGGCCGCTTACTTGGCTCGTCTAGCGCGG`3 NotI - pSTA7 
CW11 5`CCCCAGATGACCCGCGAGAATAAAG`3 pSTA7 
CW13 5`TGATCATTTGTCGGGATTGTTC`3 pCW35 
CW19 5` GACGTCGCTCACTCATTAGGCACC`3 AatII - pCW44 
CW20 5` AAGCTTGGTTGTTCACGATCTTGTCG`3 Hind III - pCW44 
 
Key:  Complete restriction sites are in bold and underlines.  Partial restriction sites are in 
bold.  Stop codons are in italics.  Mutated nucleotides are represented in lower case and 
are in bold.  5`:  five prime direction of sequence.  3`:  three prime direction of sequence 
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APPENDIX 2 – DESCRIPTION AND MAINTENANCE OF CELL LINES 
USED IN THIS STUDY 
 
 
H. zea fat body BCIRL-HZ-FB33 (referred to in text as FB33) (Kariuki et 
al., 2000) and Spodoptera frugiperda  ovarian cell line 9 CRL 1711 
(referred to as Sf9 cells) (Vaughn et al., 1977)  were grown at 28 °C in 
TC100 medium containing 1 % penicillin/streptomycin and 5 % heat-
inactivated foetal calf serum (FCS).  H. zea midgut cell line BCIRL-HZ-
MG8 (Pringle et al., 2003) (referred to in text as MG8) were grown at 28 
°C in Excell 420 complete medium containing 1 % penicillin and 
streptomycin. Attempts to proliferate this cell line in complete medium 
supplemented with FCS were unsuccessful and resulted in cell death 
after two passages in the presence of FCS.  
 
Baby Hamster (Syrian) Kidney cell line IZSBS BS CL 21 (Macpherson 
and Stoker, 1962) (referred to as BHK 21 cells in text) and the HeLa S3 
immortalized human cervical cancer cell line ECACC 93021013 (Gey et 
al., 1952) (referred to as HeLa cells in text) were grown in the presence of 
10 % CO2 at 37 °C in Dulbecco’s Modified Eagle Medium (DMEM) 
containing 100 U/ml penicillin, 25 µg/ml Amphotericin B and 10 % heat-
inactivated FCS.   
 
APPENDIX 3 – SEQUENCING OF THE p104 ORF OF PrV 
 
The PrV p104 ORF in the plasmid pFLM1, was sequenced using the 
dideoxy chain termination principal and the products resolved by 
automated gel separation using an ABI sequencer (v. 3100) (Rhodes 
University DNA Sequencing Unit).  The chromatograms were visualized 
using the Chromas v.2.1 program.  Primers used in the sequencing 
reactions of p104 within pFLM1 were designed to be complimentary to 
the theoretical sequence provided by Prof. L Andrew Ball (Department of 
Microbiology, University of Alabama at Birmingham, Alabama, USA).  
Nucleotide sequences were analyzed using the Vector NTi10 sequence 
analysis and data management software. 
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The plasmid pFLM1 (generously donated by Prof. L. Andrew. Ball), 
contained the entire 6155 nt of cDNA sequence of the PrV genome 
cloned into the vector pTVT7R.    Analysis of the replicase sequence 
(completed in triplicate) resulted in the detection of the following 
substitutions when compared to the original p104 sequence:  a 
substitution at nt 2466 (T - C base change) did not result in an amino acid 
substitution.   Three amino acid substitutions were detected in the p104 
coding sequence: 1496 nt (A - G) resulting in a glutamine to an arginine 
substitution; 1499 nt (G - A) resulting in an alanine to a threonine 
substitution and finally, 1553 nt (A - G) resulting in a histidine to an 
arginine substitution.  These substitutions are not located within the RdRp 
domain of the replicase protein and therefore should not impact on the 
genome replication ability of PrV. 
 
 
APPENDIX 4 – UNIFORM RESOURCE IDENTIFIERS (URI) AND 
ACCESS DATES OF ONLINE BIOINFORMATIC PROGRAMS AND 
SERVERS  
 
Table A.2.  Name, address and date of access of bioinformatic programs used in 
this study  
 
Name of 
program 
URL Date 
accessed 
ClustalW http://www.ebi.ac.uk/Tools/clustalw2/index.html 28-
29/09/2008 
MFold http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi 29/09/2008 
MitoProt II 
v1.101 
http://ihg2.helmholtz-muenchen.de/ihg/mitoprot.html 26/09/2008 
NCBI – 
BLAST 
http://blast.ncbi.nlm.nih.gov/ 
 
26-
27/09/2008 
netNES 1.1 http://www.cbs.dtu.dk/services/NetNES/ 26/09/2008 
NetPhos 2.0 http://www.cbs.dtu.dk/services/NetPhos/ 26/09/2008 
PESTfind https://emb1.bcc.univie.ac.at/toolbox/pestfind/pestfind-analysis-
webtool.htm 
29/09/2008 
ProtScale http://ca.expasy.org/tools/protscale.html 09/11/2008 
SOSUI http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html 26/09/208 
TargetP 1.1 http://www.cbs.dtu.dk/services/TargetP/ 
 
26/09/2008 
The PTS1 
Predictor 
http://mendel.imp.ac.at/mendeljsp/sat/pts1/PTS1predictor.jsp 26/09/2008 
TMpred http://www.ch.embnet.org/software/TMPRED_form.html 27/09/2008 
WoLFpSORT http://wolfpsort.org/ 26/09/208 
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APPENDIX 5 – ACCESSION NUMBERS OF NUCLEOTIDE AND 
AMINO ACID SEQUENCES USED IN THIS STUDY 
 
Table A.3.  Sequence names and accession numbers of amino acid sequences 
used this study   
 
Sequence name Accession number 
Nudaurelia capensis ω virus p70  AAY54604  
Nudaurelia capensis β virus p67 and RdRp AAC97510 and AAC97509 
Dendrolimus punctatus tetravirus p71 and p17 YP0250956 and YP025095 
Helicoverpa armigera stunt virus p71 and RdRp AAC37885 and NP049235 
Euprosterna elasaea virus p83 NP573542 
Thosea asigna virus p83 AAC 97195 
Providence virus p81 AAO 73881 
Infectious pancreatic necrosis virus  RdRp BAA 05533 
Infectious bursal disease virus RdRp NP 690839 
Cricket paralysis virus structural polyprotein and RdRp NP647482 and AAA 42889 
Pelargonium chlorotic ring pattern virus replicase YP05295 
 
 
 
APPENDIX 6 – MEMBRANE-STABILISING IPB BUFFER (CHAPTER 5) 
 
10 X IPB 
24.2 g Tris base 
36 g NaCl 
8 ml 0.5 M EDTA (pH 8.0) 
 
Made up to 500 ml in double-distilled water after adjusting to pH 7.8 with 
HCl and stored at room temperature. 
 
1 X IPB 
50 ml 10 X IPB 
1 g iodoacetamide 
1 tablet of Complete™ EDTA-free protease inhibitor cocktail (Roche 
Applied Science) 
5 ml x 100 PMSF (100 mM stock in 70 % ethanol) 
17 ml Brij-30 
 
Made up to 500 ml in double-distilled water on the day of each subcellular 
fractionation and stored at 4 ºC. 
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APPENDIX 7 – ADDITIONAL CONFOCAL MICROSCOPE IMAGES OF 
Sf9 CELLS TRANSFECTED WITH pCW55 AND pCW57 
 
 
 
Figure A.1.  Distribution of eGFP/p40 fusion proteins in Sf9 cells transfected with 
pCW55.  A - D:  Punctate, cytoplasmic distribution of p40 fused to the N-terminus of 
eGFP in Sf9 cells transfected with pCW55. Images acquired at 1 X scanning zoom.  
Scale bars represent 20 µm.   
  
A B
C D
                                                                                                     Appendix 
 
174
 
 
Figure A.2.  Distribution of eGFP/p40 fusion proteins in Sf9 cells transfected with 
pCW57.  F - I:  Punctate cytoplasmic distribution of p40 fused to the C-terminal of eGFP 
in Sf9 cells transfected with pCW57. Images acquired at 1 X scanning zoom.  Scale bars 
represent 20 µm.   
  
F G
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Figure A.3.  Immunofluorescence detection of viral RNA accumulation and 
distribution in PrV-infected MG8 cells. A - B:  BrUTP was incorporated into PrV vRNA 
in the presence of 20 mg/ml Actinomycin D for 3 hours.  BrUTP-incorporated vRNA was 
detected by immunofluorescence using anti-BrUTP and goat anti-mouse antibody 
conjugated to Texas Red. Cells were imaged by confocal laser scanning microscopy.  A 
- B were acquired at 1 X scanning zoom and C - D, at 2 X scanning zoom.  Scale bars 
represent 20 µm. 
A B
C D
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Figure A.4.  Co-localization of p40 and viral RNA in PrV-infected MG8 cells.  A - D:  
BrUTP was incorporated into PrV vRNA in the presence of Actinomycin D for 3 hours. 
The BrUTP-incorporated vRNA was detected by immunofluorescence using anti-BrUTP 
and goat anti-mouse antibody conjugated to Texas Red.  p40 auxiliary protein was 
detected by immunofluorescence using rabbit anti-p40 and goat anti-rabbit antibody 
conjugated to FITC.  Cells were imaged by confocal laser scanning microscopy.  The 
Texas Red signal was digitally summed up four times during acquisition of each image.  
Images were captured at 1 X scanning zoom.  Scale bars represent 20 µm. 
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